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Abstract:
This study combined confocal microscopy with the use of a tau-GFP (green
fluorescent protein) transgenic mouse strain to study cell fate in two main
types of chimeric blastocysts. In each case one component of the chimera was
known to contribute poorly to the fetal lineage at later stages. The
experiments were designed to test whether this was due to non-random
allocation to different tissues at the blastocyst stage.
The initial part of this thesis involved the establishment of confocal
microscopy techniques and the characterisation of two novel tau-GFP
transgenic mouse strains. A method of culturing embryos on the confocal
microscope was established for use in further studies. Two tau-GFP
transgenic mouse lines, TgTP6.3 and TgTP6.4, were evaluated for their use in
following chimera studies by assessing the timing of the onset of GFP
expression during preimplantation development and the viability of
heterozygote and homozygote mice.
The remaining studies involved the use of tau-GFP chimeric embryos. Mouse
tetraploid«-*diploid chimeras have previously been used as a model of
confined placental mosaicism (CPM). Approximately 2% of human
conceptuses investigated by chorionic villus sampling contain
chromosomally abnormal cells that are confined to the placenta. This
condition, known as human CPM, can lead to incorrect prenatal diagnosis.
Animal models would be useful for investigating the mechanisms
responsible for the exclusion of abnormal cells from the fetus. As
spontaneous chromosomal mosaicism is rare in mouse embryos, mouse
aggregation chimeras have been used as a model. Previous results have
shown that tetraploid cells are excluded from the epiblast derivatives,
including the fetus, of mid gestation tetraploid*-* diploid chimeras.
Tetraploid cells have been shown to be preferentially allocated to the
trophectoderm, in particular the mural trophectoderm, of mouse
tetraploid-^diploid blastocysts. However, tetraploid cells are present within
the inner cell mass region of the blastocyst. Therefore, the current study used
tau-GFP tetraploid*-*diploid aggregation chimeras to determine if tetraploid
cells are present within the epiblast and lost later or are excluded from the
epiblast region by preferential allocation to the hypoblast.
Tetraploid<-*diploid chimeras were produced using TgTP6.3 embryos.
Analysis of these chimeras at E3.5 and E4.5 has confirmed that tetraploid
cells are preferentially allocated to the mural trophectoderm. However,
tetraploid cells were present within the region of the blastocyst that forms
the epiblast. Analysis of expanded chimeric blastocysts at E5.5 and E7.5,
produced by transferring them to delayed implantation females, also showed
that tetraploid cells were present within the epiblast region. This suggests
that tetraploid cells are initially present within the epiblast region but lost
from the epiblast later by some mechanism of cell selection against tetraploid
cells.
Embryos from some inbred strains, such as BALB/c, also tend to contribute
poorly to chimeras, so producing 'unbalanced chimeras'. Therefore
unbalanced BALB/c chimeras could be a possible model of CPM.
BALB/c^GFP aggregation chimeras were analysed using the established
time-lapse technique. This was to determine if BALB/c cells are
underrepresented in mid-gestation BALB/c chimeras by preferential
allocation of BALB/c cells to the mural trophectoderm. These results showed
that BALB/c cells were not preferentially allocated to the mural
trophectoderm and indicate that a general cell selection mechanism takes
place.
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Human confined placental mosaicism (CPM) occurs when chromosomally
abnormal cells are present in the extraembryonic membranes of the human
conceptus, but are excluded from the fetus (Kalousek and Dill, 1983). Using
chorionic villus sampling approximately 2% of conceptuses analysed have
CPM. This can lead to incorrect prenatal diagnosis and it is important to
understand the mechanisms leading to the exclusion of aneuploid or
polyploid cells from the fetus.
The experimental work in this thesis describes the analysis of two mouse
models of CPM, using tau tagged green fluorescent protein (tau-GFP)
aggregation chimeras and confocal microscopy. Two transgenic tau-GFP
mouse lines were evaluated for their use in this analysis and a method for
confocal microscopy of living preimplantation mouse embryos were
established.
This first chapter provides a review of polyploidy, polyteny and aneuploidy
in mammals, specifically in preimplantation embryos. The exclusion of
chromosomally abnormal cells from mammalian fetuses, illustrated in the
occurrence of human CPM and several animal models of CPM, is discussed.
The experiments in this thesis involve the use of chimeric preimplantation
mouse embryos. Therefore, an overview of preimplantation embryo
development, and preimplantation mouse aggregation chimeras is given.
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1.1 Development of the Preimplantation Embryo
An overview of the aspects of mouse preimplantation development, which
are relevant to the experimental chapters of this thesis follows.
Fertilisation of the mouse oocyte takes place in the ampulla of the oviduct,
and is followed by the completion of meiosis and the formation of the second
polar body. Approximately one day later the first cleavage division occurs to
produce a 2-cell embryo. As the embryo develops to the blastocyst stage it is
swept towards the uterus by the cilia in the oviduct (Theiler, 1989; Kaufman,
1992; Hogan et al., 1994). Following cleavage to the 8-cell stage the mouse
embryo undergoes compaction to form a morula (Pratt et al., 1982; Peyrieras
et al., 1983; Sutherland and Calarcogillam, 1983; Winkel et al., 1990). The
morula divides to the 16-cell stage after which the blastocyst cavity is
formed, by the secretion of fluid from the trophectoderm (TE) cells. The cell
membranes of the TE cells contain a sodium pump (a Na+/K+-ATPase) facing
the blastocyst cavity. The accumulation of sodium ions in the cavity draws in
water osmotically. As a result the blastocyst cavity expands (Wiley, 1984). As
the 128/256-cell blastocyst expands it hatches from the zona pellucida and
implants in the uterine wall (Strickland et al., 1976; Brenner et al., 1989;
Carson et al., 1993).
The chimera experiments in this thesis involve the analysis of blastocyst
stage preimplantation embryos. The early blastocyst contains three main








Fig 1.1: Schematic Diagram of a Mouse Blastocyst
mural trophectoderm (mTE) (Fig 1.1 & 1.2). The ICM then differentiates into
the epiblast (primitive ectoderm) and hypoblast (primitive endoderm) at
E4.5. The epiblast lineage forms the entire fetus. It also produces the
chorionic mesoderm, allantois, amnion and the visceral yolk sac mesoderm
of the postimplantation conceptus. The hypoblast lineage produces the
visceral yolk sac endoderm and the parietal endoderm (Reichert's
membrane). The pTE lineage produces the trophoblast giant cells,
spongiotrophoblast, labyrinthine trophoblast and the chorionic ectoderm,
which form part of the chorioallantoic placenta. Some pTE along with the
mTE differentiate into trophoblast giant cells, which contribute to the
parietal yolk sac.
Fig1.2:Lineaged agramofmousedev lop ent Figure1.2:Mo slineagd agramshowingthf tesofdiffer ntregionsft ebl tocyst,Inn rc llma s (ICM),polartrophect derm( TE)andmuraltrophectoderrm(mT ).
1.1.1 The Onset of Zygotic Gene Expression
An important aspect of preimplantation development is the transformation
from a differentiated oocyte to a totipotent 2-cell stage embryo. The oocyte
contains a vast diversity of maternal mRNAs and biosynthetic apparatus for
making proteins, which are necessary to control this oocyte to embryo
transition (Bachvarova and DeLeon, 1980; Gardner, 1996). The translation of
these stored maternal mRNAs is regulated during this stage, one mechanism
being the polyadenylation of transcripts (Stutz et al., 1998; Svoboda et al.,
2000).
For many genes the onset of zygotic gene expression occurs at the late 2-cell
stage (Taylor and Piko, 1987; Telford et al., 1990; Rothstein et al., 1992; Ko et
al., 2000). However, there is evidence of some genes being activated at the 1-
cell stage (Clegg and Piko, 1983; Ram and Schultz, 1993; Ko et al., 2000). More
recent understanding of this process has suggested that there is a global
onset of gene expression during the 1 to 2-cell stage. The transcription of
specific genes is repressed by changes in chromatin structure (Ma et al.,
2001).
A substantial amount of maternal mRNA transcripts are degraded at the 2-
cell stage (Bachvarova and DeLeon, 1980; Piko and Clegg, 1982; Ko et al.,
2000). During this period, the mRNAs coding for actin and histones decline
by as much as tenfold (Giebelhaus et al., 1983; Giebelhaus et al., 1985).
Following this, there is another substantial reduction in maternal transcripts
between the 8-cell and the blastocyst stage, which coincides with a large
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increase in embryonic mRNA (Bachvarova and DeLeon, 1980; Steuerwald et
al., 1999). Therefore, some maternal transcripts remain to late
preimplantation stages and possibly have a role in blastocyst formation.
Renard et al., (1994) confirmed this by demonstrating a maternal factor that
was required for the formation of the blastocyst.
1.1.2 The Cleavage Rate of Preimplantation Embryos
The timing of the initial cleavage divisions depends on the genetic
background of the embryo (McLaren and Bowman, 1973; Niwa et al., 1980).
Following the 4-cell stage the timing of the cell cycle doesn't vary
significantly and is approx lOhrs (Pedersen, 1986). However, if the initiation
of cleavage is later this can significantly delay embryo development
(McLaren and Bowman, 1973).
One gene, which controls the rate of cleavage, has been identified as the pre¬
implantation embryo development (Fed) gene (Warner et al., 1998). The Ped
gene encodes the Qa-2 antigen, which is a class lb major histocompatibility
complex (MHC) protein. There are two alleles of the Ped gene, fast (which is
dominant) and slow. Mouse strains, homozygous for the fast allele tend to
have larger litter sizes and increased pup weights at birth and weaning.
Other genes must be involved in the control of cleavage rate as certain strains
of embryo, for example some BALB/c substrains, including the substrain
used in this thesis develop slowly despite having a Ped-fast genotype
(Flaherty et al., 1985).
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1.1.3 The Establishment of the Inner Cell Mass and Trophectoderm
There are several factors involved in determining the fate of a blastomere to
become either TE or ICM.
At the 8-cell stage there is a structural and functional reorganization of the
individual blastomeres. Each blastomere becomes polarized, with apical
(outward facing) and basolateral (inward facing) domains (Randle, 1982;
Johnson and Ziomek, 1983; Fleming and Pickering, 1985; Maro et al., 1985).
Following the next division the fate of the two daughter cells is dependant
on the orientation of the cleavage plane (Fig 1.3). If the cleavage plane is
oriented approximately perpendicular to the axis of polarity a differentiative
division occurs. One cell inherits the apical domain and remains polar, and
the other cell lacks an apical domain and is apolar. A conservative division,
when the cleavage plane runs parallel to the axis of polarity, produces two
polar cells (Johnson and Ziomek, 1981a). There is an equal probability of a
conservative or a differentiative division occurring at this stage (Pedersen,
1986). Therefore, at the 16-cell morula stage two types of cells exist, outer
(polar) cells and inner (apolar) cells. These two types of cell have similar
properties to the differentiated cells of the blastocyst, as TE cells are polar
and ICM cells are apolar (Fleming et al., 1984).
Although two morphologically distinct populations of cells exist at the
morula stage, previous experiments have shown that they are totipotent
(Handyside, 1978; Rossant and Vijh, 1980; Ziomek et al., 1982). By the 32-cell
stage when the definitive blastocyst is formed the outer cells are a clonally
7
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Fig 1.3 : Division of the blastomeres of a morula. A differentiative division
produces a polar and an apolar cell, whereas a conservative division
produces two polar cells.
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distinct population from the inner cells (Pedersen, 1986).
Early studies indicated that cells that happen to be on the inside of the 16-cell
morula produced ICM cells and cells on the outside of the morula form TE
cells (Tarkowski and Wroblewska, 1967; Hillman et ah, 1972; Graham and
Deussen, 1978; Sutherland et al., 1990). This work lead to the "inside outside"
hypothesis. However, it was subsequently shown that polar (outside) cells
are capable of contributing to the ICM lineage up to the 32-cell stage. Studies
have shown that the majority of ICM cells are descended from inner apolar
blastomeres (approximately 75%). However, the remainder of the ICM cells
are derived from outside, polar blastomeres (Fleming, 1987).
Although apolar (inner) cells are totipotent they are normally prevented
from occupying an outer position, as polar cells are adhesive on their
basolateral surface (Johnson and Ziomek, 1983). Therefore, they do not
express their potential to polarise and as a result do not contribute to the TE
lineage. The TE lineage is therefore derived entirely from polar (outer) cells
of the morula.
At the 16-cell stage the ratio of polar to apolar cells differs among different
embryos. The number of inner cells can range from 2-7 cells (Fleming, 1987).
This is determined by the proportion of conservative to differentiative
divisions in the 8-cell stage embryo (Johnson and Ziomek, 1981b; Pedersen,
1986). However, at the 32-cell stage the ratio of ICM to TE cells is similar
among different embryos. Therefore, the outer, polar, cells contribute to the
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ICM through differentiative divisions to compensate for the variation among
inner and outer cell numbers. The number of polar cells that contribute to the
inner population is possibly controlled by the relative size of the outside cell
population at the 16-cell stage (Fleming, 1987).
The division of the blastomeres within the mouse embryo is asynchronous
and frequently odd numbers of cells can be found. The first cell to divide to
the 4-cell stage produces descendants, which tend to divide ahead of those
cells produced by its slower partner, up to the blastocyst stage. It has been
found that the advanced blastomeres contribute disproportionately more
descendants to the inner cells of the morula or the ICM of the blastocyst
(Barlow and Sherman, 1972; Kelly et al., 1978; Graham and Lehtonen, 1979;
Piotrowska and Zernicka-Goetz, 2001).
More recently it has been claimed that the position of sperm penetration in
the oocyte determines the first blastomere to divide from the 2-cell stage
(Piotrowska and Zernicka-Goetz, 2001; Piotrowska and Zernicka-Goetz,
2002). In contrast to these findings Davies and Gardner, (2002) claim there is
no relationship between the sperm entry point and the first blastomere to
divide at the 2-cell stage.
It is possible that the initial blastomere to divide contributes more to the ICM
as it gives rise to a greater proportion of smaller cells. These would be
preferentially enclosed by later dividing cells. However, the analysis of
parthenogenetic embryos has revealed that despite dividing asynchronously,
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the first blastomere to divide does not necessarily contribute more cells to the
ICM (Piotrowska and Zernicka-Goetz, 2002). Therefore, on its own,
asynchronous cleavage divisions might not be responsible for determining
blastomere fate.
Fate mapping experiments have also shown that, if left undisturbed, one of
the cells at the 2-cell stage tends to produce mTE and hypoblast and the other
tends to produce pTE and epiblast (Ciemerych et al., 2000; Piotrowska and
Zernicka-Goetz, 2002).
1.2 Mouse Aggregation Chimeras
The use of mouse chimeras is an established technique for the study of
developmental biology and as a model for studying human pathologies. The
experiments in this thesis use mouse aggregation chimeras as a model for
human confined placental mosaicism.
A chimera is defined as an organism that consists of cells derived from more
than one individual, usually of different genotype (Rossant and Spence,
1998). The first aggregation chimeras were produced in 1961 by Tarkowski
(Tarkowski, 1961). The method used involved the mechanical removal of the
zona pellucida following which the "naked" embryos were pushed together
in a drop of culture medium. Currently acid tyrode solution is commonly
used to remove the zona pellucida and exposure to phytohaemagglutinin
(PHA) is widely used to facilitate adhesion of the embryos (Mintz et al.,
1973).
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1.2.1 Markers Used to Identify Cells in Aggregation Chimeras
The experiments in this thesis analyse the allocation of cells in aggregation
chimeras at the blastocyst stage. It is therefore crucial to be able to identify
the origin of cells within a chimera. Several markers are available for the
analysis of chimeric adult mice, postimplantation chimeric embryos and
specifically preimplantation chimeras.
Coat and eye pigmentation is commonly used as a marker for adult
chimeras, however another marker is required for investigating non-
pigmented tissues or specifically preimplantation embryos. A cell marker
used to distinguish one chimera component from another should ideally
fulfil a number of criteria. The marker should be cell-localised, cell
autonomous, stable and distributed ubiquitously among all the tissues and
cell lineages of the mouse. It should be easy to detect, both grossly and in
histological sections, and ideally could be used to analyse chimeras during
several stages of development (McLaren, 1976). A cell marker should also not
affect cell selection or cell mixing within a chimera and therefore be
developmentally neutral (West, 1984).
Glucose phosphate isomerase-1 (GPI-1) was developed as a marker in
chimeras. This technique makes use of allelic variants of this enzyme, which
can be visualised by electrophoresis and histochemical staining for GPI-1
enzyme activity (Chapman et al., 1971; West, 1999). GPI-1 is particularly
useful as a quantitative marker, and is used in chapter 6 to analyse the
percentage contribution of each type of embryo to E12.5 postimplantation
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chimeras. However, this type of marker does not give spatial information,
which is required for the following studies.
There have been several techniques developed to show spatial information in
chimeric preimplantation blastocysts. A single blastomere or group of cells
can be labelled by the injection of a fluorescent dye (Gardner and Cockroft,
1998; Piotrowska and Zernicka-Goetz, 2001). Alternatively an embryo can be
labelled with a vital dye. An analysis of the use of vital dyes to label one half
of a chimera is given in Chapter 3.
Transgenes are now largely used to identify the origin of different cells in
chimeras, as they can be detected easily, are non-invasive and provide spatial
information.
The E.coli (3-galactosidase gene is a widely used marker for chimera analysis.
Activity of the (3-galactosidase gene can be detected by a histochemical stain
for lac-Z expression on whole embryos or sectioned material. The ROSA26
transgenic mouse line (Friedrich and Soriano, 1991) expresses the (3-
galactosidase gene almost ubiquitously so provides a lineage marker for
chimeras made by the aggregation of a ROSA-26 embryo with a non-
transgenic embryo (Wong et al, 1996; Zambrowicz et ai, 1997). Previous
attempts by our group to use this marker for the analysis of chimeric
blastocysts were unsuccessful possibly because the protein is not expressed
sufficiently at this stage (Tang & West, unpublished). However, this marker
has been used to analyse cell fate in aggregation chimeras to the blastocyst
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stage (Neganova et al., 1998). This technique requires the use of a
chromogenic substrate, as a result blastocysts must be fixed for (3-
galactosidase staining and can only be analysed at one developmental stage.
It is possible to spatially analyse the contribution of cells in chimeric
blastocysts using DNA-DNA in situ hybridisation, using probes to multicopy
transgenic sequences. The (3-globin TgN(Hbb-bl)83Clo transgene can be
detected by DNA-in situ hybridisation following fixation and sectioning.
This transgene has previously been used to detect polyploid nuclei for
example by counting the number of hybridisation sites per nucleus (Lo, 1983;
Lo, 1986; Keighren and West, 1993; Everett and West, 1996). This technique
was used in the studies that preceded this thesis, to analyse the contribution
of tetraploid cells in tetraploid^diploid blastocysts (Everett and West, 1996).
However, this technique is very laborious for analysing preimplantation
embryos, as a large number of histological sections are required. Again
embryos can only be imaged during one stage of development.
The transgenic marker chosen to identify cells in the chimeric blastocysts
analysed in this study was green fluorescent protein (GFP). There are several
properties of GFP that make it a potentially valuable cell marker for
preimplantation chimeras. It can be easily detected using standard long wave
UV, or blue light. There is no requirement for the introduction of a substrate,
unlike (3-galactosidase. There are no special conditions required and it avoids
the need to chemically fix cells. Therefore, for the purpose of analysing
chimeric blastocysts the majority of the criteria described above are fulfilled.
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It was therefore decided to use GFP embryos to identify cells that comprise
one half of the aggregation chimeras in this study. As a laser scanning
confocal microscope had recently been purchased, it was possible to image
whole mount, live blastocysts.
GFP expressing ES cells were established, and used to produce the first GFP
expressing transgenic lines of mice (Hadjantonakis et ah, 1998b). These mice
expressed GFP ubiquitously throughout development and adulthood.
Subsequently several other GFP transgenic mice lines have been produced,
including the ones used in this study (Hadjantonakis et ah, 1998a; Pratt et ah,
2000).
The two transgenic mouse lines evaluated in this study, were produced by
Pratt et al (2000). Embryos from one of these transgenic lines were used to
create aggregation chimeras. These transgenic mice ubiquitously express a
tau-GFP fusion protein. As tau is a microtubule binding protein, cellular
features can be visualised. The GFP is therefore attached to the microtubule
component of the cytoskeleton, and is excluded from the interphase nucleus.
Further characterisation of both transgenic mouse lines is discussed in
Chapter 4.
The use of GFP as a cell marker has already made a contribution to
developmental studies in mouse preimplantation chimeras. Zernicka-Goetz
et al. (1997) injected single blastomeres at the 2-cell stage with mRNA
encoding MmGFP. They then used confocal microscopy to follow the fate of
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the GFP blastomeres to the blastocyst stage. Weber et al. (1999) injected ICM
cells of the early blastocyst with MmGFP mRNA to determine the fate of
these cells in postimplantation development. Confocal microscopy has also
been combined with the use of GFP to analyse the fate of GFP expressing ES
cells in postimplantation chimeras (Zernicka-Goetz et al., 1997). Shimada et
al. (1999) used ES cell lines expressing GFP to follow the fate of ES cells
during blastocyst formation.
Other applications of GFP include a mechanism for non-invasively sexing
preimplantation embryos by the production of a transgenic mouse line that
have an X-linked GFP transgene (Hadjantonakis et al., 1998a). The potential
use of double stranded RNA to disturb specific genes during
preimplantation development, and its general use in the mouse have also
been assessed using GFP. Preimplantation embryos expressing MmGFP
provide a rapid visual assay for the elimination of expression of the marker
gene. Thus it was shown that injection of MmGFP dsRNA into the single cell
zygote prevents the onset of the appearance of green fluorescence at 2-4 cell
stages (Wianny and Zernicka-Goetz, 2000).
1.3 Chromosomal Abnormalities
Polyploid cells have three (triploid), four (tetraploid), five (pentaploid) or
more complete chromosome sets. These are described as 3n, 4n or 5n where n
denotes a full chromosome set and 2n describes a diploid nucleus.
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Polyploidy is a relatively common occurrence in the plant kingdom. The
spontaneous origin of polyploid individuals, by meiotic non-disjunction, has
played an important role in the evolution of plants (Culotta, 1991). In
contrast to this, naturally occurring polyploids in the animal kingdom are
rare.
Polyploidy and binucleate diploidy (2x 2n) are normal features in some
mammalian somatic cells. However, there is a large variation in the number
of polyploid cells present in specific tissue types, even between species of the
same order such as mice and guinea pigs (Brodsky and Uryvaeva, 1985).
Some polyploid cells are obligate as they develop a polyploid DNA content
regularly during the normal life cycle of the organism. Other polyploid cells
develop in response to certain stimuli such as great functional stress or age.
For example polyploid cells often occur in cancer, often with an intermediate
DNA content present, for example 3n and 4.5n (Zimmet and Ravid, 2000).
Aneuploidy is also a common feature of malignant tumours (Barlogie, 1984).
In mice and humans a proportion of the hepatocytes of the liver and
cardiomyocytes in the heart, and all megakaryocytes are normally ployploid
(Brodsky and Uryvaeva, 1985; Epstein, 1986; Zimmet and Ravid, 2000).
Bladder epithelium cells, fibroblasts and mesothelium have also been
reported to be polyploid in mice and humans contain polyploid (3-cells of the
islets of Langerhans (Brodsky and Uryvaeva, 1985). The polyploid cells in
these adult tissues arise during postnatal development, by polyploidizing
mitosis (Brodsky and Uryvaeva, 1977). Polyloidy is also achieved in some of
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these tissues by an intermediate binucleate diploid cell state, formed by
acytokinesis, followed by the production of mononucleate polyploid cells
during the next mitotic cycle (Zimmet and Ravid, 2000). The advantage of
polyploidy is unknown but it may be to increase the synthetic capability of
the cell, caused by an increase in gene copies (Klisch et al., 2000). Another
consequence of polyploidy is the enlargement of these cells accompanied by
a change in the surface to volume ratio (Brodsky and Uryvaeva, 1977;
Epstein, 1986).
During prenatal development polyploidy is normally found in the placental
trophoblast, of a variety of mammals including humans, rats and ruminants
and is also a normal occurrence in the human amnion (Gardner, 1982;
Brodsky and Uryvaeva, 1985; Klisch et al., 2000). In the mouse trophoblast
polytene cells are found (Chapman et al., 1972; Snow and Ansell, 1974).
Polyteny is the repeated doubling of the number of chromatids in the diploid
set of chromosomes, without a subsequent mitosis. This shortened mitotic
cycle is frequently called endoreproduction, endoreplication or
endoreduplication.
In the mouse blastocyst the cells of the mTE form primary trophoblast giant
cells (TGCs), these stop dividing and accumulate huge quantities of DNA by
repeated endoreduplications leading to polyteny (Snow and Ansell, 1974;
Bower, 1987; Varmuza et al., 1988; Barlow and Sherman, 1972; Chapman et
al., 1972). Following implantation some pTE cells spread around the embryo
replacing the primary TGCs and become polytene.
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The mouse placenta (Fig 1.4) is composed of a maternal tissue layer, the
decidua basalis, and zygotic cells of both trophoblast and mesoderm origin.
The onset of gastrulation in the mouse leads to the formation of the
embryonic and the extraembryonic mesoderm from which the allantois and
chorionic mesoderm are formed. The allantois fuses to the chorionic plate
resulting in the chorioallantoic part of the placenta that occupies the
labyrinthine zone. The labyrinthine zone contains embryonic trophoblast cell
strands containing maternal blood and it is in this zone that maternal and
embryonic circulation comes closest to each other and where gas and
nutrient exchange takes place. The hormone and growth factor producing
junctional zone, spongiotrophoblast zone and trophoblast giant cell zone
isolate the embryo from the mother (Rinkenberger et al., 1997).
Studies of the rat trophoblast have shown that polyploid cells exist in the
junctional zone of the placenta in addition to the polytene TGCs. However, it
is not known if these cells are polyploid in the mouse trophoblast (Brodsky
and Uryvaeva, 1985).
Although polyploid cells are a normal feature in the development of the
human placenta, polyploid or aneuploid cells are detrimental to the
mammalian fetus. Approximately 2% of humans are born with a genetic
defect, half of which are due to chromosome imbalance (Delhanty and
Handyside, 1995).
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Fig 1.4: Diagram of the Mouse Placenta
Fig 1.4 : Schematic diagram of the mouse placenta at E15.5 from Sapin et al,
1997. BC, blood chord (umbilical cord); CP, chorionic plate; DB, decid.ua
basalis; FS, fetal side; GC, giant cells; JZ, junctional zone; LZ, labyrinthine
zone; MS, maternal side; SZ, spongiotrophoblastic zone.
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Polyploidy, including tetraploidy in full or mosaic form is a very rare
abnormality in live born human infants and very few are detected prenatally
as the majority are spontaneously aborted (Kohn et al., 1967; Kelley and Rary,
1974; Golbus et al., 1976; Wilson et al., 1988; Eiben et al., 1990; Alonso et al.,
2002). Triploid/diploid mosaics often have congenital asymmetry due to an
unbalance of the sex chromosomes (Gardner, 1982). The majority of trisomies
do not survive and are responsible for approximately 75% of early pregnancy
failures (Goldstein et al., 1996).
In the mouse all trisomies have been experimentally produced. With the
exception of trisomy 19, TS19, these do not survive beyond birth (Gropp,
1976; Epstein, 1985; Dyban and Baranov, 1987). Likewise experimentally
produced mouse 4n embryos do not normally survive. Tarkowski et al (1977)
found that 4n embryos failed to survive beyond 10 days in utero, whereas
Henery et al. (1992) produced 4n embryos that survived up to 14 days in
utero. Tetraploid liveborn mice have been produced, however they were
eaten shortly after birth (Snow, 1975).
Thus polyploidy is a normal feature in certain types of extraembryonic and
adult tissue during mammalian development. However, aneuploidy and
polyploidy are not associated with normal fetal development. Despite this
polyploid and aneuploid cells are frequently found in human
preimplantation embryos.
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1.4 Chromosomal Mosaicism in Preimplantation Embryos
Mixoploidy, mosaicism of diploid/polyploid or diploid/aneuploid cells, has
been shown to occur in preimplantation embryos of several mammalian
species, including humans and cattle (Delhanty et al., 1997; Viuff et al., 1999).
These chromosomal abnormalities can arise before the 2-cell stage, during
gametogenesis or fertilization, and be subsequently corrected in some cells
following the 2-cell stage resulting in mosaicism. Alternatively chromosomal
errors can arise in some cells during embryogenesis (Delhanty and
Handyside, 1995). The high incidence of chromosomal errors in human
embryos could be due to the lack of cell cycle check points during the early
cleavage stages of the preimplantation human embryo (Harrison et al., 2000).
Studies of chromosome abnormalities in bovine embryos using fluorescent in
situ hybridization (FISH) have revealed that a high percentage of bovine
blastocysts are mixoploid. It has been found that the most common
chromosomal abnormalities in cattle embryos are diploid/triploid (2n/3n)
and diploid/tetraploid (2n/4n) mosaics (Viuff et al., 1999). Viuff discovered
that 72% of in vitro produced (IVP) bovine blastocysts were mixoploid,
however the majority of these mixoploid blastocysts (83%) contained low
levels (less than 10%) of polyploid cells, with only a small proportion, 4%,
containing more than 25% polyploid cells (Viuff et al., 1999). This study also
revealed a lower level ofmixoploidy in bovine blastocysts developed in vivo,
25%, all of which contained less than 10% polyploid cells. However, this is
still a relatively high frequency of mosaicism suggesting that mixoploidy is a
common occurrence both in vivo and in vitro produced bovine embryos. It is
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possible that the in vitro culture of either bovine oocytes or embryos is
responsible for the increase in mixoploidy in bovine IVP embryos.
Several studies have shown that mixoploid bovine embryos are
morphologically normal and develop at the same rate as diploid embryos
(Kawarsky et ah, 1996; Viuff et ah, 1999; Viuff et ah, 2000). Further studies
have also indicated that mixoploid embryos are capable of normal
development, and the presence of polyloid cells does not appear to influence
the establishment of pregnancy (Viuff et ah, 2000; Viuff et ah, 2001). A
pregnancy rate of 64% from blastocysts with a mixoploidy level of 72%
indicates that mixoploidy is of minor importance in the establishment of
pregnancy (Viuff et ah, 2000).
In contrast polyploid bovine embryos develop at a slower rate, possibly as a
result of an increase in the duration of the cell cycle due to an increase in the
time taken to replicate the cells chromosomes (Kawarsky et ah, 1996).
Polyploid bovine embryos arrest during the third cell cycle, this is prior to
the major activation of the cattle embryonic genome (Viuff et ah, 2000).
Therefore it is interesting that the presence of polyploid cells in mixoploid
bovine embryos does not appear to affect the developmental rates of these
embryos.
It has been demonstrated that chromosomal abnormalities occur in early
preimplantation development in human embryos (Angell et al., 1987; West et
al., 1987; West et ah, 1988). Subsequent studies using FISH on spare
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preimplantation embryos derived by in vitro fertilization (IVF) have
demonstrated that chromosome mosaicism is common in human embryos
(Delhanty et al., 1993; Delhanty et al., 1997; Laverge et al., 1997).
Mixoploidy has been observed in human morulae and blastocysts with
earlier studies, using FISH with three probes, showing mixoploidy
frequencies of approximately 30.8% of morulae and 29.3% of blastocysts
(Benkhalifa et al., 1993). As early FISH analysis revealed chromosomal
mosaicism was common in human preimplantation embryos, FISH has been
used with a variety of chromosome probes in the analysis of spare IVF
embryos showing a high incidence of mosaicism (Delhanty et al., 1993;
Delhanty et al., 1997; Laverge et al., 1997). In one study analysing only normal
developing embryos, approximately 30% were shown to be mosaic with a
minor cell line showing aneuploidy or ploidy abnormalities (Harper et al.,
1995; Delhanty et al., 1997). Subsequent more advanced studies using
multicolour FISH of 11 chromosomes in 5 sequential hybridisations have
confirmed a high incidence of postzygotic chromosomal mosaicism
including both aneuploid and ploidy mosaicism (Harrison et al., 2000). G-
banding analysis of human IVF embryos has also revealed a high level of
mosaicism, 23%, the majority being diploid/polyploid mosaics (Clouston et
al, 1997).
The frequency and types of mosaicism observed in in vitro produced human
preimplantation embryos varies. The cause of this is possibly due to
differences in certain culture conditions or hormonal stimulation protocols
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(Murine et al., 1997). Some couples also have an inherited predisposition
towards producing chaotic mosaic embryos. It is also possible that the
quality of preimplantation embryos available for use in these studies varied.
The fact that IVF patients have difficulty achieving a viable pregnancy might
also suggest a reason for the high levels of chromosome abnormalities
observed. However, studies analysing IVF embryos from fertile women,
requesting preimplantation genetic diagnosis (PGD), has revealed similar
results. This indicates these chromosomal abnormalities are a common
occurrence among fertile couples (Harper and Delhanty, 1996; Delhanty et al.,
1997).
Although the use of FISH has given some insight into the degree of
mosaicism in human preimplantation embryos this technique is limited as it
is not possible to look at all 23 pairs of chromosomes. A new technique based
on whole genome amplification and comparative genomic hybridisation has
made it possible to analyse the copy number of every chromosome in almost
every cell of a cleavage stage embryo (Wells et al., 1999; Wells and Delhanty,
2000). Using this method to analyse morphologically normal embryos, a high
frequency (50%) of mosaic embryos was detected (Wells and Delhanty, 2000).
Wells & Delhanty also showed that 25% were chromosomally normal.
Therefore, it is interesting that the mosaic embryos could not be
distinguished morphologically from the chromosomally normal embryos. It
has been shown in previous studies that the second and third highest quality
IVF embryos are equally likely to be chromosomally abnormal or normal
(Delhanty et al., 1997). This demonstrates that high rates of abnormalities are
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tolerated during the early stages of human embryo development.
Although it would be predicted that a high proportion of these mixoploid
embryos do not survive, it is possible that some do survive to produce
chromosomally normal fetuses. There are several proposed mechanisms,
which would exclude chromosomally abnormal cells from the fetus. It is
possible that polyploid and aneuploid cells in both human and bovine
mixoploid blastocysts are excluded from the fetus by preferential allocation
to the trophectoderm.
However, a study examining the degree of mosaicism in the ICM of human
blastocysts suggests a mechanism of selection against whole embryos
containing abnormal cells as opposed to a selection eliminating abnormal
cells from the ICM (Evsikov and Verlinsky, 1998). Using FISH analysis for
chromosomes 13, 18 and 21 they found the mosaicism rate in the ICM was
not significantly different from the overall blastocyst mosaicism rate of
10.5%. This mosaicism frequency is significantly lower than that of early
cleavage stage embryos, which can be up to 50% of 4- to 8-cell embryos.
Eviskov & Verlinsky (1998) conclude that a general selection mechanism
against mixoploid embryos takes place at the morula-blastocyst transition. It
has been suggested that this possibly takes place when the number of
abnormal cells reaches a threshold level. However, it should be noted that
the presence of abnormal cells in some human blastocysts suggests that in
some cases these abnormalities are not detrimental to preimplantation
development. Although Eviskov & Verlinsky suggest that a mechanism of
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selection for a euploid ICM does not take place it is possible that this type of
selection occurs following a general selection against whole mixoploid
blastocysts. Thus perhaps there are a large number of mosaic embryos not
capable of blastocyst formation due to gross chromosomal errors. Therefore,
these embryos would be eliminated during cleavage stages. Following this
initial selection there could be selection acting in the blastocyst itself to
eliminate abnormal blastomeres.
Following implantation it is likely that there are several possible fates of a
mixoploid blastocyst, which could be determined by the proportion of
chromosomally abnormal cells and the type of chromosomal abnormality.
Mixoploid conceptuses could therefore be spontaneously aborted, produce a
low proportion of mosaic fetuses, or produce a chromosomally normal fetus.
Confined placental mosaicism (CPM) demonstrates that chromosomally
normal fetuses can be produced from a mixoploid conceptus (Lestou and
Kalousek, 1998). The experiments in this thesis are designed to determine the
mechanisms involved in the production of a diploid fetus from a mosaic
preimplantation embryo.
1.5 Human Confined Placental Mosaicism
Confined placental mosaicism (CPM) is a human condition in which
chromosomal abnormalities are found in the placenta but not in the embryo.
This genetic inconsistency between the fetus and placenta was first described
in 1983, and is now a medically recognised condition (Kalousek and Dill,
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1983; Lestou and Kalousek, 1998). CPM usually involves trisomies but
tetraploidy can also occur (Ledbetter et al., 1992). CPM is identified in
approximately 2% of human conceptuses analysed cytogenetically by
chorionic villus sampling (CVS). This mosaicism could be incorrectly
interpreted to represent the whole conceptus (Kalousek, 1994).
CVS can be carried out between 10 and 14 weeks gestation. It is
advantageous as genetic defects can be diagnosed early on, it provides a
rapid Karyotype analysis and it is a relatively safe technique. There is a 0.5 %
risk of induced pregnancy loss from this method of tissue sampling for
genetic diagnosis, which is higher than amniocentesis (Carroll et al., 1999;
Jenkins and Wapner, 1999; Eisenberg and Wapner, 2002). The procedure
involves the removal of a sample of 10-20mg of chorionic villus. Two types of
cells can then be enriched by two different methods. The direct method
allows karyotype analysis of spontaneously dividing cytotrophoblasts,
which is derived from the TE lineage of the human blastocyst (Hassold,
1980). The long term culture method analyses cells of the chorionic villous
stroma, which are descended from the extraembryonic mesoderm (the
epiblast lineage of the human blastocyst).
The discovery of CPM has highlighted the need for follow-up genetic
diagnosis. Therefore, if a mosaicism is identified by CVS then amniocentesis
or fetal blood sampling should follow to differentiate between generalised
mosaicism, and CPM (Smith et al., 1999).
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There are three types of CPM, which are categorised according to the
placental cell lineage, which contains the chromosomal abnormality.
Chromosomally abnormal cells can be confined to the cytotrophobast, (Type
I), the chorionic stroma (Type II) or both types of cell (Type III) (Kalousek
and Vekemans, 1996). Type I CPM is more common than type II, and the
occurrence of type III is the lowest. Mosaic types I and II mainly arise
through somatic mitotic errors during early development. Non-mosaic type I
CPM is usually meiotic in origin. Type III arises mainly by meiotic errors
(Kalousek and Vekemans, 1996; Wolstenholme, 1996; Lestou and Kalousek,
1998). The mouse model for CPM analysed in this thesis relates to type I
CPM, which is the most common type with the most severe consequences.
The outcome of pregnancies with CPM varies depending on the type of CPM
and the specific chromosomal abnormalities involved (Fig 1.5). Severe
complications have been documented for cases of type I CPM.
Approximately 22% of pregnancies affected by type I CPM have resulted in
spontaneous abortion, intrauterine growth retardation (IUGR), intrauterine
death, or perinatal morbidity (Vaughan et al., 1994; Lestou and Kalousek,
1998; Johnson et al., 2000; Stipoljev et al., 2001). In contrast, type II CPM
mainly results in a normal pregnancy. IUGR and intrauterine death is
common in type III CPM, specifically in cases of mosaicism of trisomy 16
(Benn, 1998). Another complication of CPM is uniparental disomy (UPD),
where the fetus contains two chromosomes of only one parental origin. This
can result in abnormal development if the chromosome involved contains
imprinted genes. UPD mainly affects cases with type III CPM and sometimes
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Fig 1.5: Trisomy Involvement for human types I, II
and III Confined Placental Mosaicism

























Fig 1.5: Illustration of the frequency of chromosome involvement of
reported cases of trisomies for CPM. The colour of shading indicates the
percentage of the total of analysed cases where red > 10%, yellow > 3%
but < 10%. m indicates a commonly reported monosomy.
Figure adaptated from Lestou & Kalouek, 1998, results taken from two
collaborative studies, Ledbetter et al, 1992 & Hahnemann Vejerslev, 1997.
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type I CPM. This arises from zygotic "rescue" of a meiotic error, by non¬
disjunction during an early cleavage stage (Hahnemann and Vejerslev, 1997;
Robinson, 2000). The mean maternal age of CPM cases involving trisomic
meiotic errors is higher as spindle failure during meiosis is more likely to
occur in older women (Robinson, 2000). Chromosome abnormalities in the
intrauterine placenta may have an adverse affect on postnatal development
therefore it could also be useful to detect CPM at birth by the cytogenetic
analysis of the placenta (Lestou et al., 2000).
Individual trisomies tend to be associated with specific types of CPM (Fig
1.5) (Lestou and Kalousek, 1998). This is interesting as it suggests that certain
trisomies can be tolerated in the cytotrophoblast but not in the chorionic
stroma and vice versa. Most studies have revealed similar trends of trisomy
involvement relating to specific types of CPM. However, Wolstenholme,
(1996) reviewed that trisomy 8 was only associated with type II CPM. In
contrast to this a European collaborative found a similar frequency of
trisomy 8 occuring in type I and type II cases (Hahnemann and Vejerslev,
1997).
Type I CPM has also been shown to occur in aneuploid gestations, where a
diploid cell line is present in the placental cytotrophoblast. It is possible that
the diploid cell line facilitates intrauterine survival. This has most commonly
been described for viable trisomies 18 and 13 (Kalousek et al., 1989). The most
common chromosomal abnormalities involving the sex chromosomes in type
I CPM are monosomies. Tetrasomy X is also relatively common. Trisomy X
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however has not been found in conjunction with type I CPM (Kalousek, 1994;
Noomen et al., 2001).
The reasons for chromosomally abnormal cells being confined to the
placental trophoblast in type I CPM are presently unclear. They may arise
preferentially in the trophectoderm lineage after it has differentiated, this is
not investigated in the models but is a possibility. Another possibility, which
is investigated by the current models, is that two cell populations may arise
during preimplantation development and become restricted to this lineage.
As has been discussed earlier very few blastomeres contribute to the embryo
proper. However, if there was no selection or random allocation against
abnormal cells the distinct chromosomal patterns of CPM would not be seen.
It could be that type I CPM arises by the preferential allocation of abnormal
cells to the trophectoderm during development. Alternatively, there may be
selection against the abnormal cells in the epiblast lineage.
1.5.1 Animal Models of Human Confined Placental Mosaicism
It would be useful to have an animal model of CPM to investigate the
mechanisms leading to the unbalanced distribution of chromosomally
abnormal cells within the human conceptus. Three different types of mouse
aggregation chimeras have been analysed to determine if the cells of one
embryo contribute preferentially to the extraembryonic membranes.
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1.5.1.1 Aneuploid^diploid Chimeras
Unlike human embryos, spontaneous aneuploidies and mosaicism are not a
common occurrence in laboratory animals such as mice and rats (Epstein,
1986). Also, mouse chromosomes are not syntenic with human
chromosomes, and the production of mouse trisomy•'-►diploid (TS<-*2n)
chimeras is technically demanding. As a result relatively few TS<-A2n
chimeras have been produced and analysed.
Mouse TS<-^2n chimeras have been produced for TS 15, 16, 17 and 19
(Epstein and Travis, 1979; Magnuson et ah, 1982; Cox et ah, 1984; Epstein et
ah, 1984; Fundele et ah, 1985). The analysis of these chimeras at late gestation
revealed they were phenotypically normal, and the TS cells were not
excluded from the fetal cells with a TS cell contribution to the majority of
embryonic tissues. Therefore, this would suggest that these would not be
suitable models of CPM. These chimeras were not specifically analysed as
potential CPM models therefore the extraembryonic tissues were not studied
in detail. A small series of TS3*->-2n chimeras have been produced by our
group, and the composition of embryonic and extraembryonic tissues were
analysed. These chimeras did not show mosaicism confined to the
extraembryonic tissues either (West, in preparation). Although mouse
TS<-^2n aggregation chimeras would be the mouse models of choice to study
CPM, these do not display specific compartmentalisation of TS cells.
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1.5.1.2 Tetraploid^diploid Chimeras
Mouse tetraploid<->diploid (4n<-»2n) chimeras and mosaics show a restricted
tissue distribution, with an exclusion of 4n cells from the epiblast lineage in
mid-gestation chimeras (Tarkowski et al., 1977; James et al., 1995). Therefore,
4n<-^2n chimeras have been analysed as a mouse model of CPM.
Tarkowski et al, (1977) produced 4n/2n mosaic mouse embryos composed of
two 2n blastomeres and one 4n blastomere. Analysis of these mosaics at mid-
gestation showed that the 4n cells were excluded from the fetus, or
contributed to less than 4% of dividing cells. Subsequently 4n cells have been
used as "carrier" blastomeres to produce fetuses entirely derived from
embryonic stem cells (Nagy et al., 1990; Nagy and Rossant, 1993; Wang et al.,
1997; Tanaka et al., 2001).
There has only been one report to date of a contribution of 4n cells to the
adult tissues of chimeras, produced using standard chimera techniques (Lu
and Markert, 1980). In this instance one chimera was retarded in growth with
neurological abnormalities and the other chimera was slightly retarded in
growth. Tarkowski et al., (2001) found one 4n^2n chimera from a series of 8
contained 4n cells in the heart and lungs. This chimera was produced by
aggregating one 4-cell blastomere with either a two or three-cell 4n embryo.
It is therefore likely that the reduced proportion of 2n blastomeres led to a 4n
contribution to the epiblast derivatives. Goto et al., (2002) also reported a
contribution of 4n cells in live-born mice and in embryonic tissues of mid-
gestation chimeras following aggregation of 4-cell stage diploid and
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tetraploid embryos. It is possible that the difference in age between the 2n
and 4n embryos led to a contribution of 4n cells in the epiblast derivatives, as
the 2n embryo was produced a day later than the 4n embryo. Other chimeras
with a contribution of 4n cells to the epiblast derivatives were also produced
by Goto et al (2002), by aggregating a 2n, 8-cell stage, embryo with two 4n, 4-
cell stage, embryos. Therefore, there was a reduced proportion of 2n cells to
these chimeras. In addition to this the diploid cells carried a Robertsonian
X-autosome translocation which might have had an effect on cell allocation.
Mouse 4n<-^2n chimeras have been extensively studied as a potential mouse
model of CPM in our lab. James et al, (1995) revealed that 4n cells rarely
contribute to any tissues of the epiblast lineage but are frequently present in
the hypoblast and trophectoderm lineages at 7.5 and 12.5 days of gestation.
In comparison to normal diploid chimeras, tetraploid chimeras were smaller
at E7.5. However, at E12.5 4n<->2n chimeras only differed from diploid
chimeras by having a significantly larger placenta. One possible explanation
for this difference in conceptus size is that prior to E7.5 4n cells are
eliminated from the epiblast thus resulting in smaller fetuses however by
E12.5 they might have caught up with normal diploid chimeras by size
regulation mechanisms.
It is possible that selective cell death acts on a few chimeras that have
extensive contributions of 4n cells in the epiblast derivatives. A few
abnormal E7.5 embryos that had 4n cells in epiblast derived tissues were
present but were not seen at E12.5. However, there were no massive
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embryonic losses observed at either stages, therefore it is unlikely that
selective embryonic death of 4n<->2n chimeras is the main mechanism for
eliminating 4n cells from the epiblast of chimeras.
Analysis of 4n<->2n blastocysts, using DNA in situ hybridisation to a (3-globin
transgene, has shown that 4n cells contribute to all tissues of the blastocyst
but make a significantly greater contribution to the trophectoderm,
specifically the mural trophectoderm at E3.5 (Everett and West, 1996, 1998)
As it is already known that 4n cells are largely eliminated from the epiblast
by E7.5, a mechanism for this removal must be acting between E3.5 and E7.5.
The contribution of 4n cells to 4n<->2n chimeras was reduced between E3.5
and E4.5 indicating that cell selection was taking place (Everett and West,
1998).
It is possible that the restricted distribution pattern of the tetraploid cells in
4n<->2n chimeras is a result of the blastocyst cavity forming at the tetraploid
half of the chimaera. This could be due to over-expression of the genes
encoding the Na/K-ATPase, which causes the formation of the blastocyst
cavity in the tetraploid cells. However analysis of reconstructed 3-d images
of blastocysts did not show strikingly different distribution patterns between
2ne^2n chimeras and 4n<->2n chimeras. In all 4ne->2n chimeras however,
some 4n cells were located adjacent to the blastocyst cavity, thus further
evidence is needed (Everett et al., 2000).
Studies have shown that tetraploid cells are present in the ICM of 4ne-^2n
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chimeric blastocysts (Everett and West, 1996). However, due to technical
difficulties, Everett and West were unable to differentiate between the
epiblast and hypoblast in histological sections.
These studies of 4n<->2n chimeras as a mouse model of type I CPM have
given insights into the possible mechanisms taking place to reduce abnormal
cells from human fetuses. However, it is still not known if tetraploid cells in
the ICM are preferentially allocated to the hypoblast or if cell selection
against tetraploid cells is taking place within the epiblast. Therefore, the
experiments in chapter 5 were designed to distinguish between these two
possibilities.
The 4n embryos that were used to create the 4n*-^2n chimeras, studied as
models of CPM and in this thesis, were the same age but differed from the
diploid embryos in cell size and cell number as well as ploidy. Therefore,
these factors may have an effect on the restricted tissue distribution seen in
4n<->-2n chimeras.
Previous evidence has indicated that the more advanced, smaller blastomere
makes a significantly greater contribution to the ICM than the TE, during
embryo development (see Chapter 1.1.3). However analysis of chimeras has
revealed conflicting results.
By aggregating a single blastomere from a 2-cell stage embryo to two
blastomeres from a 4-cell embryo it was shown that the progeny of the 2-cell
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stage blastomere made a significantly greater contribution to outer rather
than inner cells (Surani et al., 1984). Therefore, this evidence indicates that in
chimeras the smaller more advanced blastomeres have a significantly greater
chance of contributing to the inner cells and forming the ICM. Spindle also
investigated this by creating giant aggregation chimeras (Spindle, 1982).
When an 8-cell embryo was aggregated to three 4-cell embryos the 8-cell
embryo contributed more to the ICM than expected by chance. However,
results from the reciprocal combination of one 4-cell embryo aggregated to
three 8-cell embryos were inconclusive due to technical reasons. When two 4-
cell embryos were aggregated to two 8-cell embryos the contribution of the 4-
cell embryos to the ICM were not significantly different to the contribution of
the 8-cell embryos. These aggregates involved unequal numbers of embryos,
which could prejudice the outcome of the experiments.
In contrast, three separate analyses of 4-celle->8-cell chimeras, failed to show
a preference of the 8-cell embryo to contribute to the ICM (James et al., 1995;
Everett and West, 1996; Tang and West, 2000). It is possible that differences
in cell stage do not affect the contribution of cells in chimeras. Alternatively it
is possible that in these instances there was insufficient time for spatial
reorganisation to occur.
Tang et al. (2000) however did show that, in a one cell embryo aggregated to
a blastomere from a two-cell embryo, the smaller blastomere contributed
more to the ICM. They also showed that 4n cells, which differed in ploidy
but not in cell size or cell number from cells of the aggregated partner 2n
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embryo, made a significantly greater contribution to the mTE than the ICM.
Therefore, it was concluded that both ploidy and cell size are likely to affect
the allocation of 4n cells in 4n<->2n chimeras.
It is possible that 4n cells divide at a slower rate than 2n cells. This could be a
factor responsible for reducing the percentage of 4n cells in the epiblast
derivatives at mid gestation. Polyploid bovine embryos develop at a slower
rate than diploid embryos (Kawarsky et al., 1996). However, studies on
mouse embryos have given conflicting results. Koizumi and Fukuta, (1995)
demonstrated that the cell cycle of 4n cells, produced by cytochalasin B
treatment, were longer than 2n cells. However, Henery and Kaufman, (1991)
showed there was no difference in doubling times of 4n embryos, produced
by electrofusion, compared to 2n embryos.
1.5.1.3 Unbalanced Chimeras
Another possible mouse model of CPM is an unbalanced aggregation
chimera combination. Initial analysis of the contribution of coat pigmentation
in different series of mouse aggregation chimeras revealed that some inbred
strains including BALB/c tended to show a poor contribution (Mullen and
Whitten, 1971). In E12.5 BALB/c<->(C57BL x CBA)F2 chimeras, aggregated at
the 8-cell stage, the BALB/c component was underrepresented typically
contributing less than 20% of the chimera (West and Flockhart, 1994). This
was true of the fetus, placenta, yolk sac endoderm, yolk sac mesoderm and
trophoblast overlying Reicherts membrane. This showed that the BALB/c
39
cells were underrepresented in the derivatives of three main lineages of the
blastocyst: polar trophectoderm (pTE), epiblast and primitive endoderm (Fig
1.1). However, the mural trophectoderm (mTE) contributes little to the 12.5
day conceptus, therefore it is possible that the BALB/c cells are preferentially
allocated to the mTE. In 20 out of 34 chimeras analysed, BALB/c cells were
not present in the fetus but contributed to at least one of the extraembryonic
tissues. This raises the possibility that BALB/c unbalanced chimeras could
provide another mouse model that is relevant to CPM. It is, therefore, of
interest to determine whether the BALB/c cells are preferentially allocated to
the mTE or depleted from all lineages.
It has been shown that the lower contribution of BALB/c embryos to
chimeras cannot be attributed to the death of chimeras with a significantly
higher proportion of BALB/c cells (West et al., 1995). This is because the
proportion of pre or post-implantation losses is not significantly higher in
BALB/c chimeras than in other series of chimeras. More recently it has been
shown that acute selection during size regulation does not cause BALB/c
cells to be depleted in BALB/c chimeras. Tang and West, (2001) showed that
the BALB/c strain made a poor contribution to the tissues of mid gestation
chimeras made from aggregates of two half embryos when size regulation
was absent or minimal (Tang et al, 2000).
In a previous study, Dvorak et al. (1995), also showed a significantly lower
contribution of BALB/c cells in the embryonic and extra-embryonic tissues
of E7.5 C3H/HeN«->-BALB/c chimeric conceptuses. An overall reduction of
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BALB/c cells was not seen at the E3.5 blastocyst stage. However, they did
not analyse late or expanded blastocysts or look specifically for preferential
allocation of cells to the mTE within the chimera.
There is little cell mixing at the blastocyst stage (Garner and McLaren, 1974;
Dvorak et al, 1995; Gardner and Cockroft, 1998). However, it is possible that
the blastocyst cavity forms within the BALB/c half of the chimera resulting
in a high proportion of BALB/c cells confined to the mTE, as discussed for
4n«->2n chimeras in Chapter 5.
1.6 Aims of the Study
The aims of this study were to investigate the fate of 4n cells in 4n^2n
chimeras and to investigate the fate of BALB/c cells in chimeras.
Experiments were designed to determine if 4n cells are present within the
epiblast region of 4n<-^2n chimeras and to determine if BALB/c cells are
preferentially allocated to the mTE of aggregation chimeras.
The analysis of these mouse aggregation chimeras (in chapter 5 and 6 of this
thesis), involve the use of confocal microscopy and tauGFP mouse embryos.
Therefore, this thesis also includes an evaluation of this method of chimera
analysis and further characterisation of the transgenic mice used. Chapter 3
describes the use of confocal microscopy, in particular the establishment of a
new technique used to analyse GFP preimplantation embryos. The use of a
possible live cell marker is also analysed. The experiments in chapter 4 were
designed to determine if tauGFP embryos are suitable for use in mouse
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aggregation chimeras. This was by establishing if the onset of zygotic
expression occurred at a suitable stage and further characterising both
transgenic mouse lines.
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Chapter 2: Materials and Methods
Methods that only apply to one chapter are described in the appropriate chapter.
Methods that are used more widely are described below.
2.1 Animals
2.1.1 Mouse Strains




albino gfP Gpi 1
AAF, (BALB/c x A/DFj hybrid c/c -/- a/a
BALB/c BALB/c/Eumm c/c -/- a/a
BF, (C57BL/Hsd x CBA/Ca)^ hybrid C/C -/- b/b
CF1 (CC x CALB)F1 hybrid c/c -/- c/c
GFB BFj x TgTP6.3 C/C +/- b/b
Table 2.1 Details of mouse stocks
Female genotypes are shown first in any cross. Transgenic tauGFP mice (strain
TgTP6.3 on a largely outbred MF1 background; Pratt et al (2000) were
maintained by crossing to (C57BL/Hsd x CBA/Ca)Fj hybrid ("BF/') mice. The
stock was made homozygous for Gpilb/b and hemizygous for the GFP transgene.
"CFj" mice used as embryo recipients are Fj hybrids of two homozygous c,
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Gpilc/c, Gpilc strains, which were partially congenic on C57BL (strain "CC") and
BALB/c (strain "CALB") genetic backgrounds respectively, (West, 1984). The
(C57BL/Hsd x CBA/CajFj hybrid (BFj) female mice were purchased from the
Anne Walker animal facility, University of Edinburgh. These mice were also
used as embryo recipients and were mated with vasectomised males at the Anne
Walker animal facility, University of Edinburgh. All other animals were bred and
maintained in the Medical Faculty Animal Area (MFAA), Universily of
Edinburgh, with a light dark cycle of 14 hours light (05:00h-19:00h) and 10 hours
dark (19:00h-05:00h).
2.1.2 Superovulation
Adult female mice were superovulated by intraperitoneal injections of 5 i.u.
pregnant mare's serum gonadotrophin (PMSG) at midday, followed by 5i.u
human chorionic gonadotrophin (hCG) 48hrs later. The females were mated
individually to males, and checked for the presence of a vaginal plug the
following morning; this is designated 0.5 days post coitum.
2.1.3 Production of Pseudopregnant Females
CFj females were selected in oestrus and mated to vasectomised CFj males.
Those females with a vaginal plug the following morning were designated as 0.5
days of pseudopregnancy. Some pseudopregnant BFj females were purchased
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from the Anne Walker animal facility, University of Edinburgh (see section
2.1.1).
2.1.4 Embryo Transfer to Produce E12.5 Chimeras
On 2.5 days of pseudopregnancy these females were anaesthetised with 0.25ml
per 30g body weight of a 1:1 (v/v) mixture of a 50% aqueous dilution of
Hypnorm (0.315 mg/ml fentanyl citrate and lOmg/ml fluanisone; Janssen
Pharmacuticals) and a 50% aqueous dilution of Hypnovel (2mg/ml midazlam
hydrochloride; Roche). Between 6 and 8 chimeric morula or blastocysts were
transferred into a uterine horn. The resulting pregnancies were timed according
to the pseudopregnant females, with the day of transfer being E2.5.
2.2 Embryos
2.2.1 Preimplantation Embryo Collection
Plugged females were sacrificed by cervical dislocation at 0.5 days for 1-cell
embryos, 1.5 days for the collection of 2-cell embryos, 2.5 days for 8-cell embryos.
1-cell embryos were flushed from the oviducts in KSOMH handling medium and
transferred to hyaluronidase (Sigma, 100 I.U. per ml PBS) to remove the cumulus
cells (Appendix B). Embryos were subsequently washed in KSOMH handling
medium and cultured in KSOM (Appendix B).
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2-cell embryos were flushed from the oviducts and 8-cell embryos were flushed
from the oviducts or uterus using M2 or KSOMH handling medium (Appendix
A & B). Embryos were subsequently washed in handling medium and kept in
eitherMl6 or KSOM culture medium before use (Appendix A & B).
8-cell embryos that were heterozygous for the GFP transgene were identified
using a Leica fluorescent dissecting microscope.
2.2.2 Chimera production
The zona pellucidae was removed from the embryos using acid Tyrode's
solution, pH 2.5, at 37°C (Nicholson, 1975 ). Embryos were subsequently washed
in M2 or KSOMH handling medium. Aggregation chimeras were produced by
standard procedures involving aggregation of pairs of zona-free embryos
(Tarkowski, 1961), in the presence of phytohaemaglutinin (Mintz et al., 1973).
Pairs of zona free embryos were pushed together in individual drops of medium
containing phytohaemagglutinin (PHA, M-form, Gibco, cat. No. 10576-015)
which was made up by adding one part PHA to 19 parts M2 or KSOMH (Pratt,
1987). Aggregates were then washed in M2 medium or KSOMH.
Chimeras were cultured in M16 or KSOM culture medium under mineral oil
(SIGMA) or silicon oil (BDH) in an incubator (37°C, 5% C02 in air) prior to either
culture on the confocal microscope, imaging without culture on the confocal
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microscope or embryo transfer. Methods used to culture embryos in an
incubation chamber on the confocal microscope are described fully in chapter 3.
2.3 Confocal Microscopy
Images were captured with a Leica TCS NT confocal system attached to a
DMIRBE inverted microscope. GFP images were taken using the 488nm line of
excitation. The emission signal was collected by passing through a 525/50
BandPass filter, which limits the collection of emission wavelengths to between
500 and 550. TRITC images were taken using the 568nm line of excitation. The
emission signal was collected through a 600/30 BandPass filter, which collects
emission wavelengths between 585 and 615nm. Brightfield images were acquired
simultaneously, with the transmitted light photomultiplier detector. These
images are non-confocal.
2.4 Statistical analysis
As chimera data is always presented as percentages and the resulting chimerism
is often not normally distributed, this was analysed using non-parametric
statistical tests. The Kruskal-Wallis test (a non-parametric, 1-way analysis of
variance type of test) was used to compare percentage data among three or more
groups. If this revealed significant differences among the groups, multiple
pairwise tests were performed using the Mann-Whitney U-test (a non-parametric
equivalent of the unpaired t-test) to identify the sources of the variation.
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Parametric tests were used to compare physical parameters such as fetal and
placental weight and crown rump length. The unpaired t-test was used to
compare two groups.
Statistical tests were performed on an Apple Macintosh computer using the
statistical package 'StatView 4.0' (Abacus Concepts Inc., Berkley, USA). A routine
established on an Excel spreadsheet (Microsoft corporation) was used to
calculate Chi-square values.
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Chapter 3: Techniques used to image live
preimplantation embryos using confocal microscopy
3.1 Introduction
This chapter is intended to provide an overview of the methods that were
established to culture and image live preimplantation embryos on a confocal
microscope.
Confocal microscopy is a useful tool for imaging live preimplantation
embryos as it allows direct non-invasive serial optical sections from intact
specimens. Single photon confocal microscopy was chosen for the following
studies as conventional fluorescent microscopy generates out-of-focus blur.
This is because the entire field of view of a specimen is illuminated in
conventional fluorescence microscopy. Therefore, this excites fluorescence
emmissions or reflections throughout the whole depth of the specimen.
Much of the light collected by the objective lens to form the image comes
from regions above and below the selected focal plane thus seriously
degrading the image by reducing the sharpness and contrast.
In contrast to this, confocal microscopy virtually eliminates out-of-focus blur.
Fig 3.1 shows a schematic diagram of the confocal principle. Light from the
confocal laser is passed through a pin-hole to a dichroic mirror which splits
the laser light into one, two or three separate wavelengths. The light is then
passed through an objective lens, which focuses the wavelength to a specific
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Fig. 3.1:
Schematic diagram of the confocal principle, showing the path of the laser
light to the specimen and the resulting emission signal. (Figure from
Leica Microsystem Web site http: / /www.leica-microsystems.com)
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direction by a galvanometer. Emission from the fluorochromes is focused
back through the lens towards a confocal aperture. For each optical lens there
is an optimum confocal aperture size, which rejects as much out-of-focus
light as possible without compromising the image. The light is then passed
through the first of a series of filter blocks. The first of these is a short pass
filter block which selects light below 580nm. This emission is further refined
by passing through a bandpass filter which selects for wavelengths between
500-550nm (green fluorescent light). Light above a wavelength of 580nm
passes through to the next short pass filter block, which selects for
wavelengths under 660nm. This part of the emission is passed through a
bandpass filter, which selects light of a wavelength between 585 and 615nm
(red fluorescent light). The remaining light above 660nm is reflected by a
mirror and passed through a long pass filter, which only collects emissions
above 665nm (Cy5). Each selected range of wavelengths of light pass from
the emission filters to a separate photomultiplier tube where the signal is
converted by the software into a digital image.
A series of optical sections can be generated by moving the sample in the z-
axis in a series of measured steps, while scanning in an x-y direction. A
projected focus image can be built up by stacking these images together
using the computer software. Providing enough sections are imaged
throughout the sample, a 3D image can be generated and rotated using
computer software.
For conventional fluorescent microscopy a maximum usable thickness of
tissue section is approximately 10 microns whereas relatively thick objects
such as mouse blastocysts can be imaged using confocal microscopy.
Several of the experiments described in later chapters require tauGFP
preimplantation embryos to be analysed on the confocal microscope during
constant time intervals over a period of 24hrs. A method for culturing
preimplantation embryos on the heated stage of the inverted confocal
microscope was established, to allow the same embryo to be analysed by
time-lapse confocal microscopy during different stages of development. This
is a useful technique as the embryos can be imaged in the same orientation
over an extended period of culture. It is also beneficial, as it does not involve
sudden changes in temperature and C02 levels, which could be caused by
removing embryos from a culture incubator for imaging.
As tauGFP was being used as a marker in chimeric preimplantation embryos
the possibility of using a fluorescent vital dye to label the other half of the
chimera was also evaluated. This would especially benefit the analysis of
images taken, as the transmitted light imaged is not acquired using confocal
microscopy thus generating out-of-focus blur. Therefore, in-focus sections of
the non-tauGFP part of the chimera could be generated. It would therefore
be possible to produce surface rendered objects from a stack of optical
sections using advanced computer software (e.g. Imaris software packages,
Bitplane). This would be useful to analyse the compositions of mouse
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blastocysts as it would be possible to calculate volumes from 3D surface
rendered objects using this software.
Several vital dyes have been assessed for use as cell markers for pre-
implantation embryos. To be a useful marker for GFP chimeras they must
complement GFP and not interfere with pre-implantation development.
3.2 Materials and Methods
3.2.1 Confocal Microscopy
Images were captured on the confocal microscope as described in section 2.3.
Details of the culture dishes and methods used for time-lapse microscopy are
described in section 3.3.1 of this chapter.
3.2.2 Preimplantation Embryos
Details of the mouse strains used in this chapter can be found in Table 2.1.
Embryos were collected, cultured and aggregated as described in section 2.2.
Blastocysts were staged according to the size of the cavity. In early
blastocysts the blastocyst cavity compromised <50% of the total area, the
cavity was 50-75% of the total area in late blastocysts and greater than 75%
for expanded blastocysts (see chapter 6, Fig 6.2).
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3.2.2 Staining of Embryos with Vital Dyes
The SYTO red sampler kit containing 7 SYTO dyes, SYTO 17 and SYTO 59-
64, which stain the nucleus red, was purchased from Molecular Probes,
Netherlands (cat no s-11340). 5mM stock solutions were diluted in M2
handling medium. Individual embryos were transferred to drops of diluted
dye and incubated for 2 hours (as directed by the Molecular Probes protocol),
washed in M2 handling medium twice and transferred to M16 culture
medium, using a manual pipette for transferring the embryos. Embryos were
also incubated for less than a minute and washed in M2 culture medium,
giving the same results.
Lysotracker red, which stains lysosomes was purchased from Molecular
Probes, Netherlands (cat no 1-7528). Lysotracker was diluted 1:1000 in PBS or
M2. 8-cell embryos were incubated for less than a minute and washed in
fresh M2 medium.
CM-Di-I was purchased from Molecular Probes, Netherlands (cat no c-7001).
This was diluted lmg in 200pl of ethanol then further diluted 1:10 in 0.3M
glucose. Embryos were transferred to a drop of diluted dye and immediately
removed and washed in M2 medium.
A PKH-26 dye kit was purchased from Sigma (cat no MINI-26) and diluted




3.3.1 Time-Lapse Confocal Microscopy of Living Tau-GFP Embryos
Several methods of culturing embryos on the stage of the confocal
microscope were tested before establishing the method used in later studies.
As embryos are cultured under mineral oil it was not possible to use an
upright confocal microscope. This is because there is a possibility of getting
oil on the objective lens and the quality of the image is reduced. The
fluorescent confocal laser image is seriously degraded through plastic, so
several types of culture dishes were evaluated to allow scanning from an
inverted confocal microscope.
Imaging Coverwell perfusion chamber gaskets (Molecular Probes cat no c-
24727) (Fig 3.2a) were sealed to tissue culture flasks (Iwaki, cat no. 3100 025)
with a hole mechanically punched out of the base (Fig3.2b). Embryos were
transferred to a pre-equilibrated drop of culture medium, which was on top
of the gasket under mineral oil. The flasks were kept in an incubator,
maintained at 5% C02 and 37°C, for 1 hour. Following this they were sealed
by tightening the top and placed on the heated stage of the confocal
microscope. Four time-lapse experiments were initially carried out
overnight, however the chimeric embryos did not survive probably because
the C02 level would not be maintained within the flask at a constant 5%.
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Fig 3.2
Embryo Culture Dishes for Time-Lapse Microscopy
Fig 3.2
a: Coverwell imaging gasket which consists of a 1mm layer of optically clear plastic
sealed to a hollow rubber square which attaches to glass or plastic, b: Sealed plastic
culture flask with a hole punched out of the base and a gasket sealed across the hole, c:
plastic culture dish with a hole punched out of the base and a gasket attached across the
hole, d: plastic culture dish with a glass coverslip attached across the hole, e: Leica
perfusion chamber, with a glass coverslip base, which fits directly onto the microscope
stage, f: SterileWillco glass coverslip bottomed microwell dish (35mm diameter, glass
22mm diameter, 9.9mm high).
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For subsequent trials an incubation chamber (Leica ref no 11521587) was
purchased creating a sealed environment on top of the stage of the confocal
microscope (Fig 3.3 & 3.4). Various types of embryo dishes (discussed below)
were placed on top of the heated stage (at 37°C) and a foam sleeve was
placed around the lens for insulation. An infra-red gas monitor was
purchased (Model 3600, Mine safety appliences, Pennsylvania) to maintain
the C02 level at 5%.
2 successful time-lapses of experimental BALB/c<-+(BF1 x TgTP6.3) and
control (BALB/c x A/J)<->(BF1 x TgTP6.3) chimeras were carried out using an
imaging gasket sealed to a plastic petri dish (Sterlin Ltd, cat no.123) with a
hole in the base (Fig 3.2c). These time-lapse images were taken using the lOx
objective (Fig 3.5a-c) and are included in the analysis in chapter 6. However,
as there were problems with the gaskets not attaching to the plastic dish
properly it was decided not to use them in case mineral oil leaked onto the
microscope.
Three time-lapse studies were carried out using nail varnish to attach a glass
coverslip (with a drop of culture medium under mineral oil) to a plastic petri
dish with a hole cut in the bottom (Fig 3.2d). This method was not suitable as
the nail varnish interfered with the GFP, making the fluorescent image
appear grainy. Other methods of attaching a glass coverslip to a plastic petri
dish were evaluated. Super glue (Henkel Home Improvement & Adhesive
Products, Cheshire) and rubber glue (Weldtite, South Humberside) appeared
to stop the growth of embryos, and both aquarium sealant (Building
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Fig 3.3
Inverted Leica Confocal Microscope with Incubation Chamber
Fig 3.3
The Leica Incubation Chamber for time-lapse confocal microscopy. The plastic tube on
the left hand side (arrow) is attached to an infra-red gas monitor (not in view), to sample
the C02 level. C02is pumped into the chamber from the plastic tube on the right hand





Incubation chamber for time-lapse confocal microscopy. An embryo dish
is placed on top of the heated stage of the inverted confocal microscope.
The heating block can be seen at the right hand side of the chamber (blue





Fig 3.5 : Time-lapse confocal microscopy of GFP chimeras cultured from the morula to the
blastocyst stage. Overlay images ofGFP and transmitted light optical sections, a-c: Images, taken
using 10X lens, of chimeras cultured on a gasket sealed to a plastic dish, d-f: Images, taken using
20X lens, of chimeras cultured in aWillcowell glass bottomed dish.
Scale bar =15 microns.
Chemical Research Ltd, Manchester) and Aquamount (BDH cat no 362262H)
were dissolved by the mineral oil. A POC perfusion chamber (Perfusion,
Open and Closed Cultivation Chamber, H. Saur, Rentlingen, Germany,
supplied by Leica, D-72734) (Fig 3.2e) was used, which has a glass coverslip
in the base. However either the gasket expanded in the chamber or oil on the
gasket breached the seal, causing the oil to leak and as a result the drop of
culture medium containing the chimeras dried out.
Glass-bottomed Willco microwell dishes (Intracel Ltd, HBSt.3522) (Fig3.2f),
were purchased. Tests carried out in a normal incubator, maintained at 5%
C02 and 37°C, confirmed that preimplantation embryos cultured from the 8-
cell stage to the blastocyst stage grow at the same developmental rate as
embryos cultured in plastic petri dishes. This confirmed that these glass-
bottomed dishes do not affect the growth of embryos from the 8-cell stage to
the blastocyst stage and are not affected by the mineral oil.
8-cell embryos were cultured without exposure to the confocal laser. Table
3.1 shows the stages of development achieved following culture of 8-cell
embryos in a standard C02 incubator and in the incubation chamber without
exposure to the laser. After 29hrs of culture the proportion that reached the
late or expanded blastocyst stage in the incubation chamber (12/16; 75%)
was not significantly different from those in the standard incubator (11/15;
73.3%; x2=0.11 ;P>0.999). These experiments show that a comparable rate of
development can be achieved over a period of 24-29hrs culture in KSOM in
both types of incubator.
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Time-lapse confocal microscopy experiments of embryos cultured in these
dishes within the incubation chamber, have been successful (Fig 3.5d-f).
However, sporadic problems were encountered when trying to culture
embryos on the confocal microscope using this technique. Table 3.2 shows
the stages of development achieved following the culture of chimeric
embryos for 24hrs using this system, compared to culture in a normal C02
incubator. Chimeric embryos were cultured from the compacted morula/
early blastocyst stage to the late/ expanded blastocyst stage over a period of
24hrs. 5 optical sections at a wavelength of 488nm were taken every 20mins
using the laser scanning confocal microscope. Table 3.2a shows that 73.3% of
75 chimeric embryos reached the blastocyst stage and 60% reached the
expanded blastocyst stage. However 12% did not survive to form a late
blastocyst and 14.7% of the blastocysts had started to collapse and die. Some
of the chimeras that were cultured in the incubation chamber were slightly
delayed, at the late blastocyst stage, compared to the chimeras that were
cultured in the normal incubator (Table 3.2b). All 16 of the chimeras cultured
in the normal incubator formed expanded blastocysts. Four of 14 time-lapse
experiments failed to produce any expanded blastocysts. This could be due
to sporadic technical failure (discussed below). If these experiments are
ignored, 77.6% of 58 blastocysts reached the expanded blastocyst stage. The
proportion of expanded blastocysts produced after exposure to the 20x lens
(excluding these four failed experiments) was not significant than the
proportion of expanded blastocysts in the control experiment (45/58 versus
16/16; P=0.0582).
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Table 3.2: Stages of Development achieved following
Time-Lapse Confocal Microscopy or Culture in a normal
C02 Incubator, from E2.5
a









12.06.00 20x 7 1 6
26.06.00 20x 5 2 3
10.07.00 20x 6 6
25.07.00 20x 5 5
08.08.00 20x 5 2 3
22.08.00 20x 5 1 4
30.08.00 20x 3 2 1
20.09.00 20x 5 4 1
31.10.00 20x 4 1 1 2
07.11.00 20x 6 3 1 2
14.11.00 20x 3 3
12.12.00 10x 5 1 4
30.01.01 10x 9 9
06.02.01 10x 7 3 4
total 7 5 9 1 1 1 0 4 5
% of total 12.0 14.7 13.3 60.0
b














Total 1 6 0 0 0 1 6
% of Total 0 0 0 1 00
Table 3.2: BALB/c or (BALB/c x A/J)F2 Embryos were flushed and aggregated to (BFj x
TgTP6.3) embryos at the 8-cell stage, cultured in M16 for 24hrs to the late morula, early
blastocyst stage in a normal C02 incubator then transferred to a drop of M16 in aWillco
glass coverslip bottomed microwell dish and cultured a: for a following 24hrs in the
incubation chamber for time-lapse confocal microscopy, b: for a further 24hrs in a
standard C02 incubator.
Embryos were classified as abnormal if they were dead or unrecognisable as any
preimplantation stage. Blastocysts were classified as abnormal if they had collapsed or
contained several degenerating blastomeres.
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2-cell mouse embryos were also imaged using the same time-lapse
microscopy technique. A single optical section was taken every 15 mins.
Table 3.3 shows the stages of development achieved following time-lapse
microscopy for 24hrs. A total of 47.9% out of 192 2-cell embryos survived at
the 4-cell stage, 2.1% survived at the 3-cell stage and 0.5% reached the 6-cell
stage. 7 embryos (3.6%) reached the 4-cell stage but did not survive for the
full 24hrs of culture. Therefore, 50.5% of the embryos cleaved and survived,
23.9% failed to survive for 24hrs in the culture chamber and 14.1% remained
at the 2-cell stage. Table 3.3 shows considerable variation among time-lapse
experiments. Most time-lapse experiments either contained high numbers of
embryos that cleaved and survived or high numbers of embryos that did not
survive. Although direct controls in a normal incubator were not included
for these time-lapse experiments the same batches of culture medium were
used successfully on other preimplantation embryos being cultured for
different experiments. Sporadic technical failure in the chamber probably
accounts for most of the problems encountered (discussed below).
The system is dependent on the correct level of C02 and temperature being
achieved and maintained. There was a consecutive run of unsuccessful time-
lapse series (22.08.00 - 07.11.00) most likely due to a fall in environmental
temperature. As a result of this, the heating block was added to the
incubation chamber to try and maintain the temperature closer to 37°C.
It is generally known that the laser power can cause damage to live cells
during confocal imaging (Squirrell et al, 1999) (discussed in section 3.4 of this
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chapter). As a result of this, the laser power that the chimeric blastocysts
were exposed to during the time-lapse microscopy was attenuated to 10%.
This did not affect the resolution of the green fluorescent images. An
objective lens no greater than 20x was used for time-lapse microscopy.
Following a time-lapse experiment some embryos were imaged at a higher
resolution, using a 40x lens. These blastocysts usually collapsed shortly after
imaging. This was probably due to exposure of a high intensity of laser
power. Other blastocysts, which had only been imaged using a 20x lens were
transferred to a normal C02 incubator. However, these embryos failed to
survive culture for a further 24hrs whereas control embryos, which had not
been cultured in the incubation chamber or exposed to the confocal scanning
laser were still viable (expanded blastocyst stage). Twelve out of 16 (75%)
expanded blastocysts, which were imaged using the lOx lens, survived for a
further 24hrs in a normal C02 incubator.
On some occasions the chimeric blastocysts could not be analysed because
they moved out of focus. To counteract this problem the confocal pinhole
diameter was widened, which effectively increases the depth of field of the
lens. An increase in pinhole diameter causes a consequent loss in image
resolution, as more "out-of-focus" signal is collected. However, this did not
have a marked effect on the images collected, and prevented the loss of focus
previously encountered. Chimeras could not be analysed if they floated out
of view, or if it was not possible to see the inner cell mass
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In conclusion, a successful time-lapse experiment could be achieved
providing the incubation chamber was maintained at approximately 5% COz
and 37°C. Although there are several factors that can go wrong using this
technique, it has been possible to culture embryos from the 2-cell to the 4-cell
stage or from the late morula to the expanded blastocyst stage over a period
of 24hrs. This indicates that this technique could be a valuable tool for the
analysis of preimplantation development.
3.3.2 Exogenous Cell Markers For Living Preimplantation Embryos
Pre-implantation embryos were stained with 7 different red SYTO nuclear
dyes 17, 59-64 initially at concentrations of 5pM, lOOnM and lOnM. 8-cell
stage embryos stained with these dyes and imaged on the same day, did not
show specific nuclear staining possibly due to penetration problems. There
was no visible staining in embryos cultured at a concentration of lOnM.
SYTO dyes 17 and 59 were detrimental to embryonic development at a
concentration of 5pM. The other SYTO dyes exhibited poor staining with the
exception of SYTO 64 at lOOnM. Further analysis of GFP embryos stained
with SYTO 64 at varying concentrations lOOnM, 50nM, 25nM and 12.5nM
revealed a diffuse staining throughout the embryo (Fig 3.6 a & b). However,
these embryos failed to develop and started to die 24 hours after staining.
Di-I has been previously used for studies without impairing development
(Dr. Jenifer Nichols, pers. com.). This dye was assessed as a cell marker for
possible use with GFP. However, following aggregation of GFP embryos to
Di-I (non-GFP) embryos it was found that Di-I fluoresces in the green
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Fig 3.6:
Embryos Stained With VitaJ Dyes
Fig 3.6: Comparison of vital dyes, a: 8-cell GFP embryo stained with SYTO 64 at 50nM, showing
red fluorescence, b: GFP image of the same embryo showing green fluorescence, c: Red fluorescent
image of a GFP embryo aggregated to a non-GFP embryo stained with Di-I. d: Green fluorescent
image of the same chimera showing bleed through emission from Di-I in the lower embryo (not
GFP). e: Image of a GFPolysotracker red (non-GFP) chimera showing overlay of green and red
fluorescence, the lysotracker red dye has passed into the non-stained GFP embryo, f: the same
chimeras 24 hrs later showing very little red fluorescence.
Scale bar=30microns
channel. Usually during confocal microscopy emissions from all selected
wavelengths are collected simultaneously. When there is cross talk between
two fluorochromes it is possible to scan sequentially. This involves exciting
and collecting one fluorochrome at a time. However, this did not reduce the
level of Di-I fluorescence in the green channel. Therefore Di-I is not suitable
as a cell marker for GFP chimaeras as the curve of emission is so wide that
bleed-through occurs in the green channel, which could not be separated by
sequential scanning (Fig 3.6 c & d).
Embryos incubated in lysotracker red (Molecular Probes), which stains the
lysosomes were aggregated to GFP embryos. This marker diffused rapidly
into the GFP partner embryo (Fig 3.6 e) and was diluted out after 24 hours
(Fig 3.6 f). Therefore, lysotracker red would not be a suitable marker for use
in time-lapse studies of chimeras.
PKH-26, a membrane dye, was used to stain non-GFP embryos which were
aggregated to GFP embryos. This dye was used in some initial 4n<->2n
chimera experiments, which were not analysed (Fig 3.7). This cell dye
showed a fragmented labelling of the cell membrane and is not diluted
following 24 hours of development. However, it was thought that
internalisation of the dye occurred as it appeared to be present within some
GFP cells in the chimera (Fig 3.7c). This can be seen more clearly when
looking at a 3D rotation image of the chimeric blastocyst. The green
fluorescent image of the chimeric blastocyst also shows that there is some
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Fig 3.7 : PKH-26 stained diploid embryos (8-cell stage) were aggregated to GFP tetraploid
embryos (4-cell stage) and imaged at E4.5. a: Optical section of a chimeric blastocyst showing
overlay of green and red fluorescence, b: Projected focus image of a chimeric blastocyst showing
overlay of green and red fluorescence, c: Projected focus image of a chimeric blastocyst showing
overlay of green and red fluorescence. There appears to be internalisation of the PKH-26 dye in
some non-stained GFP cells (arrow), d: Projected focus image showing green fluorescence,
demonstrating bleed through emission from the PKH-26 membrane dye (arrow).
Scale bar =10 microns
was therefore decided that this would not be a suitable embryo marker
aiding the analysis of time-lapse chimeras. As it is a membrane dye it would
have been necessary to check that it did not affect the allocation of stained
cells within the chimera perhaps by altering cell surface properties.
3.4 Conclusion
The experiments carried out in this study indicate that the methods
established to culture embryos for the use of time-lapse confocal microscopy
is a powerful tool for the analysis of preimplantation stage mouse embryos.
The time-lapse experiments carried out have indicated that a stable
environment can be produced for the culture of preimplantation embryos for
a period of approximately 24hrs. The exposure to high intensity wavelengths
using a 20x lens was usually compatible with normal development over this
period, as most reached the expanded blastocyst stage. However, the results
indicate that imaging using the 20x lens, compared to the lOx lens, does
affect the long-term viability of the embryos as they do not survive for a
further 24hrs.
Squirrell et al., (1999) previously showed that exposure to high intensity light
from laser scanning confocal microscopy affected the development of 2-cell
hamster embryos. 2-cell hamster embryos failed to develop over a period of
8hrs during confocal scanning, every 15 mins with a 40x objective lens. They
found that the damage was caused directly by the exposure to these
wavelengths as opposed to damage caused by the excitation of the
fluorophore or the altering of the culture medium. However, these hamster
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embryos were exposed to a higher intensity of laser power than the mouse
embryos imaged using a lOx or 20x objective lens presented in this chapter.
It was shown that the viability of the embryos was affected solely due to
exposure to the confocal laser as embryos grew at the same rate in the
incubation chamber as a standard C02 incubator. The results from the two
time-lapse experiments carried out using the lOx lens also showed that by
reducing the intensity of the laser light, 75% of the embryos survive for a
following 24hrs in a normal incubator.
It was decided that the vital dyes tested were not suitable to label the non-
GFP part of a mouse chimera. Therefore, tauGFP alone was used as a marker
to analyse mouse chimeras in the following studies. Fluorescent images were
overlayed on transmitted light images and the area of GFP was calculated in
optical sections where the ICM could be seen.
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Chapter 4: Characterisation of TgTP6.3 and TgTP6.4
Transgenic Mice
4.1 Introduction
The chimera studies in the following chapters of this thesis involve the use of
transgenic tau-GFP mouse embryos to analyse cell allocation in aggregation
chimeras. The experiments in this chapter characterise the tau-GFP
transgenic mice and assesses the use of tau-GFP as a marker in
preimplantation stage aggregation chimeras.
Two transgenic mouse lines were produced by Pratt et al. (2000), TgTP6.3
and TgTP6.4. These express a tau-GFP fusion protein, under the control of a
CAG promoter which is reported to drive ubiquitous expression of fusion
constructs when randomly incorporated into the genome, tau is a
microtubule associated protein therefore, cytoskeletal features can be
visualised in these mice.
Previous characterisation of these transgenic mouse lines has revealed that
TgTP6.3 and TgTP6.4 differ. TgTP6.3 mice exhibit strong stable expression
throughout all tissues. However, TgTP6.4 mice show expression of tau-GFP
in all tissues except parts of the brain (Pratt et al., 2000; Sharp, 2001). Previous
analysis of fetal weights has shown that TgTP6.3 heterozygotes weigh
significantly less than their wild-type litter mates from E14.5 (M.A. Keighren
& J.H. Flockhart, unpublished). This difference increased following weaning
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at 21 days. Analysis of weight, between birth and 91 days, showed a
significant difference between male TgTP6.4 heterozygotes and their wild-
type litter mates. However, there was no significant difference between
female TgTP6.4 heterozygotes and their wild-type litter mates at these ages.
Breeding evidence has demonstrated that neither of the tauGFP transgenes
are X-linked. Homozygous and heterozygous GFP transgenic mice are not
distinguishable by the intensity of GFP fluorescence or, as yet, by molecular
tests. Previous (unpublished) test mating experiments have shown that out
of 17 GFP-positive offspring of two TgTP6.3 heterozygotes, no homozygotes
were present. (When crossed to non-transgenic mice, each of the 17 GFP-
positive TgTP6.3 offspring produced some non-transgenic progeny). It is
therefore likely that the TgTP6.3 homozygotes do not survive to reproductive
maturity. The viability of TgTP6.4 homozygotes is analysed in this chapter.
The experiments in this chapter were designed to further characterise both
transgenic mouse lines, in order to determine when the transgene was
expressed, for further use in chimeric blastocysts. The viability of adults
homozygous for TgTP6.4, and the viability of fetuses homozygous for each
transgene, was also investigated.
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4.2 Materials and Methods
4.2.1 Genotyping of GFP Mice
The presence of the GFP transgene in adult mice was determined from GFP
fluorescence of ear clips using a Leica dissecting fluorescent microscope. The
offspring of GFP test matings were genotyped at 1-2 weeks by GFP
fluorescence of tail tips. E14.5 whole fetuses were examined under the Leica
fluorescent microscope for GFP expression.
4.2.2 Collection of Embryos
Details of the mouse strains used in these experiments are described in
chapter 2, Table 2.1.
Adult female mice were superovulated as described in chapter 2, section
2.1.2. Injections of pregnant mare's serum gonadotrophin (PMSG) and
chorionic gonadotrophin (hCG) were administered at 12 noon. The time of
mating was assumed to occur at 12 midnight (the middle of the dark period).
The age of the embryo in hours post coitum (h.p.c) was assumed to be hours
post hCG + 12 hrs.
2-cell embryos were collected as described in chapter 2 section 2.2.1.
(CFjXTgTPb.S), (CF^TgTPb.4), (TgTP6.3x(BALB/cxA/J)F2) &
(TgTP6.4x(BALB/cxA/J)F2) embryos were collected in M2 medium at the 2-
cell stage and cultured in M16 culture medium. 2-cell (BF^TgTPbA),
76
(BF1xTgTP6.4)/ (TgTP6.3xBF1) & (TgTP6.4xBF1) embryos were collected in
KSOMH handling medium and cultured in KSOM culture medium.
4.2.3 Time-Lapse Microscopy
2-cell embryos were cultured on the inverted confocal microscope for 24
hours as described in chapter 3. Images were captured as described in
chapter 2, section 2.3.
4.2.4 Analysis of Time-Lapse Images
The average pixel intensity was measured using Scion Image computer
software (www.scioncorp.com). This was calculated from a region of
interest, which was created by drawing round the outline of an embryo, at
each time-point. Embryos which did not divide, or became fragmented were
not included in the analysis. The graphs show the pixel intensity for each
embryo at each time-point. Several time-lapse files were created over the
24hr period as the embryos were re-focused at certain time-points. An initial
l-2hr time-lapse was carried out during which the embryos tended to settle
in the culture dish and therefore drift out of focus. The set-up was also re¬
examined prior to overnight scanning. This resulted in minor differences in
the pixel intensities between each time-lapse file, which can be seen on the
graphs. These were caused by slight fluctuations in the laser power between
the completion of one scan and the start of another. However, this did not
affect the general trend of the graphs.
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4.2.5 E14.5 Fetal Dissections
E14.5 (TgTP6.3xTgTP6.3), (TgTP6.4xTgTP6.4) & control (TgTP6.3xBF1) &
(TgTP6.4xBF1) whole conceptuses were dissected from the uterus and the
placenta and fetus were isolated using forceps (Richardsons of Leicester).
4.2.6 Statistical Analysis
The following formula, used by Kelly and West, (1996) and based on that
used by Lyon, (1970), was used to calculate the percentage of genetically
abnormal embryos induced by the experimental heterozygote x heterozygote
cross and corrects for the presence of sporadic abnormal embryos in the
control heterozygote x wild-type or wild type x heterozygote cross:
Normal embryos in experimental cross
Implantation sites in experimental cross
Normal embryos in control cross \ I
Implantation sites in control cross / I X 100
Statistical tests were performed as described in chapter 2, section 2.4.
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4.3 Results
4.3.1 Onset of GFP Paternal Expression in TgTP6.3 and TgTP6.4
Preimplantation Embryos Using Time-Lapse Microscopy
Time-lapse confocal microscopy was used to determine when the onset of
embryo encoded expression occurred in embryos from crosses between non-
GFP females and GFP males. This mating produced approximately 50%
transgenic embryos and 50% non-transgenic embryos. Therefore, both types
of embryos were imaged during the time-lapse to compare the level of
fluorescence.
The paternal onset of expression was assessed visually from the 1-cell stage
(9hrs p.c) to early 2-cell stage (33 hrs p.c.) TgTP6.3 and TgTP6.4 embryos
using time-lapse microscopy for 24hrs (Fig 4.1). These images showed that
there was no detectable transgene expression, which would be expected in
approximately 50% of the embryos, prior to the 2-cell stage and immediately
after cleavage. These embryos could only be cultured in the incubation
chamber on the confocal microscope for approximately 24hrs (as discussed in
chapt 3). Therefore, the onset of expression was assessed, by imaging
transgenic and non-transgenic embryos from the 2-cell stage.
Two separate time-lapse experiments were carried out to determine the time
of onset of embryo-encoded expression of the tau-GFP transgene in wild-
type x TgTP6.3 embryos.
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Fig 4.1: Single Section Confocal Images of 1-cell &
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Fig 4.1: a & b:Transmitted light & GFP images of 1-2-cell BFjxTgTP6.3
embryos, c & d: Transmitted light and GFP images of 1-cell BF,xTgTP6.4
embryos. Flalf of the embryos should inherit the transgene but both GFP images
show there is no GFP expression at this stage.
Scale bar=50microns.
An initial time-lapse experiment was carried out using 14, CFjXTgTPbB
embryos. These were cultured between the 2-cell and 4-cell stage. The
average pixel intensity was measured at each time-point for each embryo.
This was to demonstrate the level of fluorescence of each embryo, to give an
indication of the expression of the transgene. Of the 14 embryos, 8 were
shown to express the transgene, by an increase in fluorescence at
approximately 42hrs p.c. (data not shown), although both groups of
transgenic and non-transgenic embryos could be distinguished prior to the
start of the time-lapse (34hrs p.c.).
This time-lapse experiment was repeated using BFjXTgTPb.3 embryos. This
was to determine if the timing of the onset of expression varied with genetic
background, and also because CF, mice have an unstable form of glucose
phosphate isomerase and so may have an abnormal energy metabolism. BF!
mice were chosen as both TgTP6.3 and TgTP6.4 mouse lines used in this
study were bred onto a BF, background (see chapter 2, section 2.1.1).
The average pixel intensity of 14 individual embryos, from the BFjXTgTP6.3
cross, was measured at each time-point between 34.5 and 57.5 hours p.c.
(Figure 4.2). The pixel intensity of 6 embryos was higher than the pixel
intensity of the remaining 8 embryos by the end of the time-lapse. Therefore,
this showed that 6 of the embryos were transgenic and 8 were non-
transgenic. Figure 4.2 shows the transgenic embryos had a slightly higher
pixel intensity from the start of the time-lapse but this difference was not
statistically significant. This may be because there were not enough embryos
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Fig 4.2: a: The individual average pixel intensity of 14 BF1xTgTP6.3
embryos b: The mean values of 6 transgenic embryos & 8 non-
transgenic embryos. Embryos were imaged for 23hrs between 34.5 &
57.5 hrs p.c. (2-cell to 4-cell stage). Red arrows indicate when the time-
lapse was restarted causing differences in pixel intensity.
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to detect a small difference. The pixel intensity of the transgenic embryos
was significantly higher than the pixel intensity of the non-transgenic
embryos by 36.25 hours p.c. (p<0.05 by unpaired t-test). However, this
difference appeared to increase at 42hrs p.c. In conclusion, both time-lapse
experiments indicated that the expression of the embryo-encoded TgTP6.3
tau-GFP transgene occurred near the start of the time-lapses and may have
occurred just prior to the start, at 34.5h (2-cell stage).
The timing of the paternal onset of the tau-GFP transgene was also assessed
in TgTP6.4 embryos. An initial time-lapse experiment (data not shown) of 11
CFjXTgTPbA, included 3 transgenic and 8 non-transgenic embryos. Again
both transgenic and non-transgenic embryos were distinguishable from the
start of the time-lapse (at 35hrs p.c.). This experiment was repeated using
BF^TgTPb^ embryos. 20 embryos were imaged which included 9 transgenic
and 11 non-transgenic embryos, which were identified by the differences in
pixel intensity at the end of the time-lapse (Fig 4.3 & 4.4). There was a
significantly higher pixel intensity of the transgenic embryos compared to
the non-transgenic embryos from the start of the time-lapse (P<0.01 by
unpaired t-test). Therefore, the onset of expression occurred before the start
of the time-lapse, at 34.5 hrs. This difference appeared to gradually increase
following 36 hours p.c. The gradual increase in fluorescence, which reflects
the accumulation of GFP protein, can be clearly visualised in the time-lapse
images shown in Figure 4.3.
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Fig 4.3: Time-lapse Images Showing the Paternal Onset of
Expression in BFjxTgTPh^ Embryos
a I b
Fig 4.3:GFP images showing the accumulation of tau-GFP protein in
BF,xTgTP6.4 Embryos.Times shown in hrs p.c.
Scale bar=50microns.
Fig 4.4: Onset of Expression in BF1xTgTP6.4 Embryos
a
Fig 4.4: a: The individual average pixel intensity of 20 BF1xTgTP6.4
embryos b: The mean values of 9 transgenic embryos & 11 non-transgenic
embryos. Embryos were imaged for 22hrs between 34.5 & 56.5 hrs p.c 92-
cell to 4-cell stage. Red arrows indicate when the time-lapse was restarted
causing differences in pixel intensity.
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Fig 4.5: Images Showing GFP Expression in BFjxTgTP6.4
Embryos Cultured In-vivo
Fig 4.5:a: Overlay images of BF1xTgTP6.4 morula, b: GFP images of the same
embryos showing embryo encoded expression has been switched on at this stage
c: An overlay image and d: a GFP image of hatching blastocysts, transgenic and
non-transgenic embryos can be clearly distinguished.
Scale bar=100 microns a & b, 50microns c & d.
Several females had been mated at the same time to provide embryos for the
time-lapse studes. Remaining plugged females were flushed after this stage.
Late E2.5 morula, and E4.5 blastocysts were imaged (Fig 4.5). These images
clearly showed that TgTP6.4 embryos expressed GFP at both the morula and
blastocyst stage. This is also the case for TgTP6.3 embryos, indicating that
both transgenes are useful markers for experiments involving chimeric
blastocysts.
4.3.2 Loss of GFP Maternal (oocyte-encoded) Expression in TgTP6.3
and TgTP6.4 Preimplantation Embryos
Embryos from crosses between TgTP6.3 females and non-GFP males were
analysed from the 2-cell stage using the same techniques to determine the
onset of embryo encoded expression (maternal allele) and the loss of oocyte
encoded expression of the transgene.
A preliminary experiment of 10 TgTP6.3x(BALB/cxA/J)F2 embryos was
initially analysed (data not shown). Of these embryos 5 were shown to be
transgenic, due to a higher level of fluorescence, and 5 were non-transgenic.
Both the transgenic and non-transgenic embryos had a higher pixel intensity
throughout the time-lapse, compared to the pixel intensity of the non-
transgenic embryos analysed in both paternal onset time-lapse experiments
(previous section). This indicated that the remaining maternal mRNA
and/or protein was maintained in 4-cell TgTP6.3 embryos. From the start of
this time-lapse there was a difference between the transgenic and non-
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transgenic pixel intensities, which remained constant, indicating embryo
encoded expression occurred before the start of the time-lapse (33 hrs p.c.).
Again this time-lapse was repeated using BF, male mice. Figure 4.6a shows
the individual average pixel intensity of 20 TgTP6.3xBF! embryos. A group
of transgenic embryos and a group of non-transgenic embryos could be
distinguished from the start of the time-lapse, (at the 2-cell stage) due to the
difference in the levels of fluorescence. This difference was significant,
indicating embryo encoded expression had occurred before the start of the
time-lapse at 34.8 hrs (Fig 4.7a)(p<0.01 by unpaired t-test). However, after
approximately 5 hours of imaging the embryos were failing to thrive, as can
be seen by the drop in fluorescence levels. Therefore, it was decided to image
a group of 7 embryos which had been flushed at the same time and cultured
in an incubator. Analysis of the fluorescence levels of these embryos during
the time-lapse showed that 2 embryos were transgenic and the remaining 5
were non-transgenic (Fig 4.6b). Again there was a significant difference
between both groups of embryos from the start of the time-lapse at 40.3 hrs
(p<0.01 by unpaired t-test). The difference between the pixel intensities
remained constant throughout the time-lapse. This analysis also showed that
the average pixel intensity values of the non-transgenic embryos from
TgTP6.3 mothers were higher than the expected background levels
throughout the time-lapse (see background levels of non-transgenic control
embryos in Figs 4.8 & 4.9). This indicates that oocyte encoded tau-GFP
remained in the 4-cell embryos.
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Fig 4.6: Onset & Loss of Expression in TgTP6.3xBF1
Embryos
Fig 4.6 : The average pixel intensity of two separate groups of TgTPb.SxBF, embryos
which were flushed at the same time (2-cell stage), a: An initial group of 20 embryos
were imaged but these did not survive. Therefore another group of 7 embryos, shown in
b, were imaged. Embryos cleaved from the 2-cell to the 4-cell stage. Red arrows indicate
when the time-lapse was restarted causing differences in pixel intensity.
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Fig 4.7: Onset & Loss of Expression in TgTP6.3xBF1
Embryos
a
Fig 4.7 : Mean values of average pixel intensity of a: 4 Transgenic embryos &
16 non-transgenic embryos imaged between 34.8 & 39.8 hrs p.c., and b: a
separate group of 2 transgenic and 5 Non-transgenic embryos imaged
between 40.3 & 56.7 hrs p.c. Red arrows indicate when the time-lapse was
restarted causing differences in pixel intensity.
90
The TgTP6.3 time-lapse experiments were both similar to each other showing
a difference between the fluorescence levels from the start of the time-lapse
which remained constant. The time-lapse experiments designed to
investigate the loss of maternal expression and the onset of embryo encoded
expression in TgTP6.4 embryos differed from this.
The initial time-lapse experiment of 10 TgTP6.4x(BALB/cxA/J)F2 revealed 5
embryos were transgenic and 5 were non-transgenic. The transgenic group of
embryos had a higher fluorescence level than the non-transgenic embryos
from the start of the time-lapse. Following 40 hours p.c. the fluorescence level
of the transgenic embryos increased. The fluorescence level of the non-
transgenic embryos was higher than background autofluorescence
throughout the time-lapse. This showed that either maternal mRNA and/ or
the tau-GFP fusion protein was still present in the cytoplasm.
This experiment was repeated using 17 TgTPb^xBF, embryos and 2
(BALB/cxA/J)F2 embryos added as a non-fluorescent control (Fig 4.8 & 4.9).
A group of 13 embryos, judged to carry the transgene had a higher
fluorescence level than a group of 4 embryos, which were non-transgenic. At
the start of the time-lapse there was no significant difference between the
levels of fluorescence of the transgenic and non-transgenic embryos although
the mean was higher for the transgenic group. The group of transgenic
embryos had a significantly higher level of fluorescence than the non-
transgenic embryos from 38.08 hours p.c. (p<0.01 by unpaired t-test). The
average pixel intensities of the transgenic group of embryos increased after
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Fig 4.8: Time-lapse Images Showing the Maternal Onset
and Loss of Oocyte-encoded Protein in TgTP6.4xBF1
Embryos
Fig 4.8:GFP images of the TgTP6.4xBFj time-lapse experiment. The black
arrows indicate the control (BALB/c x A/J)F2 embryos, the blue arrow indicates
an embryo that did not cleave during the course of the time-lapse and did not
fluoresce therefore was excluded from the study. Times shown are hrs p.c.
Scale bar=50microns.
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Fig 4.9: a: The average pixel intensity of 17 TgTP6.4xBF1 embryos and 2
(BALB/ cxA/J)F2 control embryos, b: The mean values of 13 transgenic
embryos, 4 non-transgenic embryos and 2 control embryos. Embryos were
imaged for 23hrs between 34.57 & 57.58 hrs PC. Red arrows indicate when





this stage, from a range of 40-60 at the start of the time-lapse, to a range of 90-
110 at the end of the time-lapse. This increase in fluorescence must be due to
an increase in embryo-encoded expression of the transgene. The 2 control
embryos could easily be identified throughout the time-lapse as their
fluorescence levels were low, within a range of 3-15, showing only
background fluorescence. At the end of the time-lapse experiment the
fluorescence of the non-transgenic group of embryos was significantly higher
than the fluorescence levels of the control embryos (p<0.01 by unpaired t-
test). This indicates that the tau-GFP fusion protein was still present in the
cytoplasm at this stage, due to residual maternal mRNA or protein.
Both TgTP6.3x BF! and TgTP6.4x BFj embryos were flushed from plugged
females and imaged at later stages to determine when the maternally
expressed tau-GFP was degraded. A fall in the fluorescence intensity, to
background levels, was shown in TgTP6.3x BFj embryos at the blastocyst
stage. Ffowever, all the compacted morula retained their fluorescence
indicating the degradation of maternal mRNA was stage rather than time
dependant. This was also seen in TgTP6.4x BF, embryos. Figure 4.10 shows a
residual fluorescence in non-transgenic morula. However, non-transgenic
blastocysts had a much lower level of fluorescence, which was similar to the
level of background fluorescence.
In conclusion, both embryonic alleles of TgTP6.3 and TgTP6.4 are expressed
at the 2-cell stage. Oocyte-coded GFP persists to at least the morula stage in
TgTP6.3 and TgTP6.4 embryos.
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Fig 4.10: Images of TgTP6.4xBFj Embryos Cultured In-
Vivo and Flushed on the Day of Imaging
Fig 4.10:a: GFP image of TgTP6.4xBFt morulae. The transgenic embryos can be
clearly visualised by their increased fluorescence. The non-transgenic embryos
also have a higher fluorescence than normal background levels (blastocysts in
image c). b:The transmitted image of the same embryos, c: A GFP image of
blastocysts and morula, showing the fluorescence levels of the non-transgenic
blastocysts is much lower than the non-transgenic morula, d: Overlay image of
the same image, the arrow indicates a non-transgenic morula exhibiting a higher
fluorescence level than the non-transgenic blastocysts.
Scale bar=50microns.
4.3.3. Test Mating of TgTP6.4 Mice to Determine if Adult Homozygotes
are Viable
Previous (unpublished) work has shown that TgTP6.3 homozygotes fail to
survive to adulthood but the viability of TgTP6.4 homozygotes had not been
evaluated.
The offspring of TgTP6.4 heterozygote inter-crosses were test mated to
determine if the homozygotes survived. However, after test mating possible
homozygote mice, it was noted that the original crosses used to produce
these mice gave a particularly low percentage of GFP positive mice. This
suggested that some of the mice were not transgenic. As the original parents
had been killed it was not possible to determine if this was the case. This
study was repeated to ensure the TgTP6.4 mice being tested were the
offspring of a heterozygote inter-cross. 28 of 50 (59.5%) offspring genotyped
from the new first generation cross were GFP positive. The parents of the
original crosses were tested twice to ensure that they were both GFP positive
and therefore heterozygotes.
If all offspring of a heterozygote x heterozygote cross are viable, 1/3 of the
GFP-positive offspring are expected to be homozygous. 19 GFP offspring
were test mated, 17 of which produced offspring. 15 of these mice tested
produced non-GFP offspring in their first litters indicating these mice were
not homozygous for GFP. One female produced only GFP offspring (9/9) in
her first litter. However, there were some non-GFP mice produced in a
further two litters (7/8 and 9/12 GFP-positive) suggesting that it was not
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homozygote for GFP. The high proportion of GFP offspring produced
(25/29) could be explained if this female was a GFP+/+/GFP+/" mosaic. This
female could not be further tested as it was found dead 15 days after
producing a third litter. The first litter from a test-mated male appeared to be
entirely GFP-positive (10/10 analysed E13.5 fetuses) but 5/12 of a second
litter were non-transgenic.
Therefore, none of the 17 mice that produced offspring were homozygous.
The probability of this is (2/3)17=0.00102. These test mating experiments have
shown that it is likely that TgTP6.4 homozygote mice do not survive to
reproduce unless the transgene is lost or inactivated in some cells to make
them functional mosaics.
4.3.4. Analysis of Survival of Homozygous TgTP6.3 and TgTP6.4 Mice
Between Birth and Weaning
It has been shown that homozygous mice of both mouse lines die before
reaching reproductive maturity. Table 4.1 shows the % of GFP and non-GFP
mice present after weaning offspring from heterozygote x heterozygote and
wild-type x heterozygote crosses. The mice were typed for GFP after
weaning. The proportion of GFP positive mice from the wild-type x TgTP6.3
heterozygote crosses was 54/117 (46.2%), which is not significantly different
to the expected percentage of 50% (x2=0.6923; P>0.05) suggesting that
heterozygotes are viable. However, the proportion of GFP positive mice from
the TgTP6.3 heterozygote x heterozygote cross was 68/125 (54.4%), which is
significantly lower than the expected 75% if homozygotes survive ((%2=28.29;
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PcO.Ol). This value is also lower than the expcted 66.7% if all heterozygotes
but no homozygotes survive ((%2=8.51; PcO.Ol). These results are therefore in
agreement with the previous data, suggesting that TgTP6.3 homozygotes do
not survive to this stage. The low percentage of GFP positive mice from the
TgTP6.3 heterozygote x heterozygote cross could be explained if some
heterozygote mice from this cross die prior to weaning.
Table 4.1 also shows the percentages of mice that died between birth and
weaning. 11.8% of mice from TgTP6.3 heterozygote inter-crosses died
between these stages. This was higher than the 2.2% that died from the wild-
type x TgTP6.3 heterozygote crosses. The percentage of induced deaths on
this genetic background was calculated from the total offspring and number
of deaths between birth and weaning (see 4.2.5). 9.8% of the mice die for
reasons attributable to the heterozygote x heterozygote cross, indicating a
high proportion of mice that died were homozygotes. These results suggest
that some TgTP6.3 homozygotes are born but do not survive to weaning.
However, homozygotes from a heterozygote x heterozygote cross represent
25% of the offspring. Therefore, a significant number must die before birth or
the recording of the birth, as the 9.8% of the mice that die do not represent all
25% of the homozygotes produced.
The TgTP6.4 control wild-type x heterozygote crosses produced a lower
percentage of GFP mice than expected (Table 4.1) (%2=6.26; P<0.025). This
could be caused by the sample size. Table 4.1 also shows that 108/194
(55.7%) of mice from the heterozygote x heterozygote crosses were GFP
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positive. This is also significantly lower than the expected 75% or 66.7
(%2=38.66 and 10.63 respectively; P<0.01), suggesting that TgTP6.4
homozygotes die before weaning. The percentage of deaths between birth
and weaning was also higher than the percentage of deaths from the control
wild-type x heterozygote crosses, 11.7% compared to 1.4%. The percentage of
induced deaths before weaning on this genetic background was calculated to
be 8.3%. This data also shows that homozygote mice die between birth and
weaning. The percentage of mice that died between birth and weaning does
not account for the death of all 25% of homozygotes produced. Therefore,
some homozygotes must die prior to birth or the recording of the birth.
4.3.5 Analysis of TgTP6.3 and TgTP6.4 E14.5 Conceptuses
It is possible that homozygotes of both crosses die immediately after birth
and were not counted as they were born during the night. Alternatively
TgTP6.3 and TgTP6.4 homozygote mice could die during pre-natal
development.
To test the second possibility conceptuses from heterozygote x heterozygote
and heterozygote x wild-type crosses were dissected and analysed at E14.5.
It was necessary to use heterozygote females for the control cross to ensure
the uterine environment was the same for both types of conceptuses. Table
4.2 shows the percentages of GFP positive and negative conceptuses, and the
number of moles (reabsorbed conceptuses) produced. If homozygote mice
die before E14.5 the percentage of GFP fetuses would be closer to 66.6% than
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75%. If the homozygotes die between implantation and E14.5, a significantly
higher proportion of moles would be expected from a heterozygote inter¬
cross compared to the control heterozygote x wild-type cross.
Table 4.2 shows that 105/181 (58%) of the offspring of the TgTP6.3
heterozygote x wild-type cross were GFP positive. This is significantly
higher than the expected proportion of 50% of GFP fetuses produced from
this cross (%2=4.65; P<0.05). The TgTP6.3 heterozygote x heterozygote cross
produced 132/175 (75.4%) GFP positive fetuses which is not significantly
different from 75% but is significantly different from 66.7% (x2=0.017 and
6.01 respectively; P>0.05 and P<0.025). This ratio of GFP positive fetuses
would be expected if homozygote fetuses were present at E14.5. However,
there was a high percentage of moles produced from this cross, 15.3%. This is
higher than the 7% of moles produced by the control heterozygote x wild-
type crosses. The percentage of induced deaths on this genetic background
was calculated by comparing the number of moles and dead fetuses from the
control and experimental cross. This value was 9.6%. Therefore, these results
are inconclusive as the percentage of GFP positive mice indicate that TgTP6.3
homozygote fetuses are present at E14.5. However, in contrast to this the
high percentage of moles and dead fetuses would suggest that a proportion
of homozygote fetuses may have died prior to E14.5. As the 9.6% of deaths
does not account for all the 25% of homozygote fetuses however, it is likely
that most homozygotes are present at this stage.
102
Table 4.2 also shows that 127/174 (73%) GFP positive fetuses were produced
from the TgTP6.4 heterozygote x heterozygote cross. This is not significantly
different from 75% or 66.7%, (%2=0.376 and 3.10 respectively; P>0.05),
although it is closer to 75%. This indicates that homozygote mice survive to
E14.5. The proportion of moles from the heterozygote x heterozygote crosses
was 8.3%, compared to 4.7% produced by the control heterozygote x wild-
type cross. The calculated percentage of induced deaths was 3.9% on this
genetic background but may not be significant. The TgTP6.4 data indicates
that TgTP6.4 homozygotes survive to this stage.
Therefore, both results indicate that homozygous GFP mice are present at
E14.5. Along with the previous data, this would suggest that some of the
homozygotes of both transgenic mouse lines die during late postnatal
development (after E14.5) or during the perinatal period. Following this, a
proportion of homozygotes also die between birth and weaning.
4.3.6 Analysis of the Placental and Fetal Weight, and Crown Rump
Length of E14.5 Conceptuses
Previous data has shown a significant difference in weight between green
and non-green litter mates from wild-type x TgTP6.3 heterozygote crosses at
E14.5 (M.A.Keighren and J.H. Flockhart unpublished). Therefore, the fetal
weight, placental weight and crown rump length of the E14.5 conceptuses
(above) were analysed.
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Figure 4.11a shows the mean fetal weights of the offspring of the
heterozygote x heterozygote cross and the heterozygote x wild-type cross of
both transgenic mouse lines. (Male and female fetuses were not
distinguished). These results show that green TgTP6.3 fetuses were
significantly lighter than non-green fetuses produced from the same cross
(P<0.01 by unpaired t-test). TgTP6.4 green fetuses were also lighter than non-
green fetuses however this difference was only significant for the offspring of
the heterozygote x wild-type cross (P<0.05 by unpaired t-test). Figure 4.11b
shows there was no significant difference between the placental weights for
any of the E14.5 comparisons. However, the difference between the mean
crown rump lengths of the GFP and non-GFP fetuses of all four crosses was
similar to the mean weight data (Fig 4.11c). This data shows that the GFP
positive fetuses were smaller than their wild-type litter mates in all cases.
However, this difference was not significant for the offspring of the TgTP6.4
heterozygote x heterozygote cross.
There was no significant difference between the weight and crown rump
length of the non-green fetuses from a heterozygote x heterozygote and a
heterozygote x wild-type cross for TgTP6.3. However, the green offspring
from a heterozygote x heterozygote cross were significantly lighter than
green offspring from a heterozygote x wild-type cross (p<0.01 by unpaired t-
test). The crown rump length of the green offspring of the heterozygote x
heterozygote crosses was also significantly less than the green offspring from
a heterozygote x wild-type cross (p<0.05). Homozygote mice are likely to
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Fig. 4.11! Mean Fetal and Placental Weight and Crown
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Fig.4.11:
Mean fetal and placental weights and crown rump length of E14.5 conceptuses
from GFP heterozygte x heterozygote and heterozygote x wild-type crosses,




survive at this stage, therefore these results suggest that they are lighter in
weight and smaller than TgTP6.3 heterozygotes.
Although the green offspring from the TgTP6.4 heterozygote x heterozygote
cross were significantly lighter and the average crown rump length was
significantly less than the green fetuses from a heterozygote x wild-type
cross, the non-green fetuses from the heterozygote x heterozygote cross were
also significantly lighter than the fetuses from the heterozygote x wild-type
cross (p<0.01 by unpaired t-test). Therefore, no conclusions can be drawn
from this.
The distribution of the weights of TgTP6.3 GFP and non-GFP fetuses from
both crosses is shown in figure 4.12. A group of green mice weighing less
than non-green mice can be seen in the offspring of the heterozygote x
heterozygote fetuses (Fig 4.12b). However, the majority of green mice from
the heterozygote x wild-type cross (Fig 4.12a) were within the same weight
range as non-green fetuses, although overall they were significantly lighter.
The distributions of TgTP6.4 fetal weights show that most of the TgTP6.4
green offspring from both the control and experimental crosses were within
the same weight range as the non-green fetuses (Fig 4.13). However, there is
a number of green mice from heterozygote x heterozygote crosses that





















ooooooooooooooooooooo NCOO)Or-WCO^-ir)CDNCOO)Oi-WCO\t-ir)CDN r!,rliri,T-T-T-,-->--r-T-->--r-T-C\JC\JC\JCMC\JC\lC\JC\JWIi a>o^ojc^5-Lo5i^oo5>o^c\jco^i-mco 1—TT1—C\1C\)C\ CMC\1C\JC\1
o
00CDo CMNJO I oocd CM
10-














I oooooooooooooooooo CDM-lOCONCOmOi-<MCDM-LncDNOOO)0 I-^T-^T-t-T-CMCMCMCMCMCMCMCMCMCMCO It cMco^LoSi^rocDO^CMco^-LoSi^roo) r—T—CMCMCMCMCMCMCMCMCMCM
Weight(mg)
Weight(mg)




















oo T0? oo cor^
ooo CDOr- oTT' 00i—i< CDO-





oooooooooooooooooooooo Oi-C\JCO^tlOCDNCOroOT-C\ICO^LOCDNCOCT)OT- T—T-i—i—i—i—i—-i—-i—i—C\1C\JC\JC\IC\IC\IC\JC\JC\IC\JCOCO CDoi-CMO^tincDNCOroOt-CMCO^-lOCONCOCDO C\JC\]C\1C\JC\IC\IC\IC\1C\1CMC0
Weight(mg)
Weight(mg)
Fig4.13:HistogramsshowingthedistributionfweightTgTP6.4aGFPndnonE14.5fe us s from,a:controlTgTP6.4xBFjrossdb:ss.
4.4 Conclusion
Both maternal and paternal alleles of both transgenic lines were activated
prior to the start of the time-lapses at the late 2-cell stage. Although the
differences between the pixel intensity of transgenic and non-transgenic
embryos were not significant from the start of the time-lapses two groups of
transgenic and non-transgenic embryos could be distinguished. If the
number of embryos analysed in each group were expanded this difference
could be significant from the start. The experiments in this chapter therefore
showed that the onset of the embryo-encoded tau-GFP transgene occurred at
or before the late 2-cell stage. Previous studies have shown the activation of
the zygotic genome begins between the late 1-cell and 2-cell stage (Ram and
Schultz, 1993; Ko et al., 2000).
These results showed that oocyte encoded tau-GFP was present in non-
transgenic embryos from the 2-cell stage to the morula stage. It is possible
that this was due to the translation of maternal transcripts present in the
cytoplasm or alternatively the tau-GFP fusion protein was very stable. There
does not appear to be any remaining tau-GFP protein in non-transgenic
blastocysts shown by the low level of fluorescence at this stage. Some studies
have suggested that substantial degradation of maternal mRNA coincides
with the onset of zygotic gene expression (Clegg and Piko, 1983). However,
some oocyte-encoded products have been shown to persist to the blastocyst
stage or later (West and Green, 1983; Renard et al., 1994; Hadjantonakis et al.,
1998). West and Green (1983) demonstrated that oocyte-encoded GPI-1
enzyme lasted until 5.5 days p.c. Hadjantonakis et al (1998) demonstrated
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maternal GFP expression was maintained in their GFP transgenic mice until
after implantation. The controlled translation of maternal mRNAs is essential
for meiotic maturation and early preimplantation development (Svoboda et
al., 2000). Renard et al (1994), showed that a maternal factor was essential for
blastocyst formation, demonstrating that maternal mRNAs or oocyte
encoded protein can have an effect on late preimplantation development.
Stutz et al (1998) have suggested that the translation of maternal mRNAs is
controlled by a masking mechanism which regulates the polyadenylation of
transcripts. The results presented in this chapter demonstrate that the
maternal mRNA or the maternally encoded tau-GFP protein is rapidly
degraded following the morula stage.
Further characterisation of both transgenic mouse lines has demonstrated
that TgTP6.3 and TgTP6.4 homozygotes die at late fetal and/or early
postnatal stages. Heterozygotes are viable and fertile but are lighter in
weight and smaller than wild-type littermates. An effect of the presence of a
GFP transgene has not previously been reported in transgenic mice. This
could therefore possibly be due to the fact that the GFP protein is fused to
tau.
tau-GFP is expressed by the late 2-cell stage in both transgenic lines and by
the 8-cell stage provides a bright fluorescence marker suitable for the
analysis of preimplantation embryos. It was decided to use the TgTP6.3
mouse line for further studies. TgTP6.3 mice had been shown to exhibit
ubiquitous expression throughout all tissues of the adult mouse, and were
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also more abundant when the experiments were started. All GFP-positive
embryos used for chimera experiments were heterozygous for TgTP6.3
which are viable as adults and fully fertile.
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Chapter 5: Fate of 4n Cells in 4n<->2n Chimeric
Blastocysts labelled with GFP
5.1 Introduction
This study involves the analysis of the allocation of 4n cells in chimeric
blastocysts using tau-GFP and confocal microscopy.
Previous results have shown that 4n cells are largely excluded from the
derivatives of the epiblast of 4n<->-2n chimeras by E7.5, but consistently
contribute to hypoblast and trophectoderm (TE) derivatives (James et al.,
1995) (as discussed in chapter 1, section 1.5.1.2). Therefore, 4n<-»2n chimeras
are a suitable mouse model of human confined placental mosaicism (CPM).
An understanding of the cause of the restricted distribution of 4n cells within
4n<-^2n chimeras could give an insight into how CPM arises.
Previous analysis of 4n<-»2n chimeric blastocysts revealed that 4n cells were
present in both the inner cell mass (ICM) and TE but were preferentially
allocated to the mTE at E3.5 (Everett and West, 1996). The 4n and 2n cells do
not intermingle exclusively until after the blastocyst stage (Garner and
McLaren, 1974; Gardner and Cockroft, 1998). If the blastocyst cavity formed
preferentially within the group of 4n cells this could cause 4n cells to
contribute more to the mTE than pTE and more to the hypoblast than
epiblast. Although previous analysis of reconstructed 3-dimensional (3-D)
images of blastocysts did not show strikingly different distribution patterns
between 2ne->2n chimeras and 4n<->2n chimeras some 4n cells were located
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adjacent to the blastocyst cavity in all 4n<-^2n chimeras analysed (Everett et
al., 2000).
Although 4n cells were largely excluded from the derivatives of the epiblast
at E7.5, 4n cells were present within the ICM region prior to the
differentiation of the epiblast and hypoblast (Everett and West, 1998). 4n cells
could be reduced in the epiblast by preferential allocation of 4n ICM cells to
the hypoblast at the blastocyst stage. Alternatively 4n cells could be present
in the epiblast when it differentiates and some other form of cell selection
acting between the blastocyst stage and E7.5, could be responsible for
removing 4n cells from the derivatives of the epiblast (Fig 5.1). The
experiments presented in this chapter were designed to determine if 4n cells
are preferentially allocated to the hypoblast, using tauGFP as a marker in
living chimeric blastocysts.
Two separate series of 4n<->2n (4nGFP-<->2n, 4n<-» 2nGFP) and control
2nGFP<->2n chimeric blastocysts cultured in vitro were analysed at E3.5 and
E4.5 to determine if 4n cells were preferentially allocated to the hypoblast.
The E3.5 series were also analysed to determine the position of the blastocyst
cavity relative to the distribution of 4n and 2n cells soon after cavity
formation.
Cultured chimeric blastocysts were analysed at E3.5 and E4.5 but, because
the epiblast and hypoblast could not be clearly distinguished, more
advanced blastocysts were also analysed. These were produced by
113
Fig 5.1:









4n cells present in the ICM,
and more abundant in the
presumptive hypoblast
4n cells are excluded from the
epiblast, and allocated to the
hypoblast
Hypothesis 2:
4n cells present in the ICM, 4n cells are present in the
4n cells contribute equally ^ epiblast, and the hypoblast
to the presumptive epiblast
and presumptive hypoblast
Fig 5.1 : Two different hypotheses to explain the fates of 4n cells in the ICM
of 4n<->2n chimeras, a: Hypothesis 1, 4n cells are excluded from the epiblast
by preferential allocation of 4n cells to the hypoblast, b: 4n cells are present
in the epiblast when it differentiates and are subsequently excluded from
the epiblast derivatives by cell selection against 4n cells. 4n cells in the ICM
are shown coloured green, 4n cells in the TE are not shown.
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transferring E3.5 chimeras to pseudopregnant females injected with the anti-
oestrogen tamoxifen to induce diapause. Two separate series of chimeras,
4nGFP<->2n and control 2nGFP<->2n, were analysed at E5.5 and E7.5 to test
whether 4n cells were present within the epiblast and hypoblast regions.
5.2 Materials And Methods
5.2.1 Electrofusion of Embryos
A tetraploid embryo was produced, by fusing the cells of a 2-cell diploid
embryo. The blastomeres were fused using an impulse generator and
electrode chamber (BFS Etd, Biological laboratory equipments, Budapest,
model CF-150 impulse generator and GPT-250 electrode chamber), to
produce a 1-cell tetraploid embryo.
2-cell embryos were flushed and collected in KSOMH handling medium (as
described in chapter 2.2.1). The embryos were washed in a drop of 3M
Mannitol then placed between the electrodes of the electrofusion chamber
containing 200pl of electrofusion medium (0.3M mannitol, O.lmM MgS04,
0.05mM CaCl2 & 0.05mg/ml BSA). An A.C. pulse of 5 volts was applied for 5
seconds to align the embryos, followed by a D.C. pulse of 20 volts for 80
pseconds to degrade the cell membrane and therefore cause cell fusion
(Fig.5.2). Embryos were subsequently washed in fresh KSOMH medium 4
times, using clean pipettes to avoid contamination of Mannitol, and
transferred to pre-equilibrated KSOM culture medium under silicon oil
(BDH) in a 37°C, 5% C02 in air incubator. Fused embryos were selected
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Fig 5.2:
Electrofusion of 2-cell embryos
d:
Fig 5.2 : a: Elecrtofusion machine and chamber, b: 2-cell embryos
before alignment with AC pulse, c: after AC and DC pulse, d:
Fusion of blastomeres to produce a 1-cell 4n embryo, 20 minutes
after electrofusion pulse. The 2-cell embryo on the right hand
side has not fused.
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fifteen to thirty minutes later and cultured overnight in KSOM medium to
the 4-cell stage for aggregation.
5.2.2 Aggregation of Embryos
Details of the mouse strains used are described in Table 2.1. The methods of
embryo collection and chimera production are described in chapter 2.2.1 &
2.2.2.
(BFjXTgTPbA) and (BALB/cxA/J)F2 embryos were flushed at the 2-cell stage
using KSOMH handling medium. Three groups of chimeras were produced
for these experiments. For both experimental chimera series embryos of one
genotype were electrofused and embryos of both genotypes were cultured
overnight before aggregation. Therefore, 4-cell tetraploid (BF1xTgTP6.3)
embryos were aggregated to 8-cell diploid (BALB/cxA/J)F2 embryos or 8-
cell diploid (BFjXTgTPFA) embryos were aggregated to 4-cell tetraploid
(BALB/cxA/J)F2 embryos. The control series (BFjXTgTPbA)
+-»(BALB/cxA/J)F2was made by aggregating 8-cell diploid embryos that had
been collected at the 2-cell stage and cultured overnight. Chimeras were
cultured in KSOM culture medium under silicon oil (BDH) in a 37°C, 5% COz
in air incubator before microscopy or surgical transfer to a pseudopregnant
recipient.
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5.2.3 Embryo Transfer to Produce Expanded Blastocysts
On 2.5 days of pseudopregnancy females were anaesthetised as described in
chapter 2.1.4. Between 8 and 10 chimeras were transferred to each uterine
horn. Following embryo transfer each female was injected i.p. with lOpg
Tamoxifen (Sigma) and s.c. with lmg Depoprovera (Genus Express), as
described in Hunter and Evans, (1999). Blastocysts were staged according to
the age of the embryo, rather than the stage of pseudopregnancy.
Alternatively following the transfer of 8 to 10 chimeras to recipient females,
on 2.5 days of pseudopregnancy, females were ovariectomized and injected
s.c with 2.5mg Depoprovera (Genus Express).
5.2.4 Confocal Microscopy
Chimeras that had been cultured in vitro or flushed from delayed
implantation females were transferred to fresh drops of KSOM culture
medium under silicon oil (BDH) in a glass bottomed Willco microwell dish
(Intracel Ltd, HBSt 3522). These were kept in a 37°C, 5% C02 in air incubator
for at least 3 hours prior to imaging, to ensure the blastocyst cavity re-
expanded if it had collapsed after pipetting. The blastocysts were imaged on
the heated stage of the inverted confocal microscope. Images were aquired as
described in chapter 2.4.
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5.2.5 Analysis of Chimeric Embryos
The % contribution of GFP to chimeric embryos was analysed in selected
overlay confocal images of GFP on bright field, using Image Pro Plus
software (Media Cybernetics, MD, USA). The epiblast and hypoblast cannot
be distinguished in E3.5 blastocysts that have been cultured in vitro.
Flowever, Weber et al. (1999), Ciemerych et al. (2000), and Piotrowska et al.
(2001) have shown that the position of cells within the ICM determines the
fate of these cells. Therefore, the cells adjacent to the blastocyst cavity will
usually develop into hypoblast cells and the cells adjacent to the pTE will
normally develop into epiblast cells. The presumptive epiblast and
presumptive hypoblast regions were determined by drawing a line halfway
across the ICM (Fig 5.3). The % area of green and non-green in the epiblast
and hypoblast were measured for both these regions. The % length of green
and non green in the pTE and mTE were measured around the circumference
(Fig 5.3).
The 4n<->-2n chimeras were analysed by measuring the % GFP-postive and
negative areas in the ICM, presumptive epiblast and presumptive hypoblast
and the % GFP-postive and negative lengths in the TE, mTE and pTE.
Therefore, these results give information about the percentage contribution
of 4n cells to the different regions of the blastocyst but not the percentage of
cell numbers. As the 4n embryos used in this study were produced by the
fusion of a 2-cell embryo it can be assumed that a 4n blastomere is twice the
volume of a 2n blastomere. However, the area of a 4n cell seen in an optical
section within a chimera is not twice the area of a diploid cell. If both
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Fig 5.3 : a: Schematic diagram of the different regions of the blastocyst, b: E3.5
GFP chimeric blastocysts that was cultured in vitro c: E3.5 & E4.5 GFP chimeric
blastocysts that were cultured in vitro were analysed by drawing a line across the
ICM to separate it into two regions , the presumptive epiblast and the
presumptive hypoblast. The area of % GFP was measured in these regions. The
% length ofGFP in the pTE and mTE was also measured. Scale bar=50microns.
blastomeres are thought of as spheres, when the volume of one sphere is 2x
the volume of another sphere, the radius (r) would be 1.26x the radius of the
smaller sphere (as volume is equal to 4/3(7ir3)) (Table 5.1). Therefore, the
length of a 4n cell is expected to be 1.26x the length of a 2n cell. As surface
area=4rtr2, the surface area of the larger sphere would be 1.59x the surface
area of the smaller sphere. These calculations are approximate because they
assume that blastomeres are spherical (Epstein, 1986).
Table 5.1: Calculation of the Ratio of length and areas of 4n/2n cells
radius diameter surface area Area through a cell volume
r 2r 4 n r2 7i r2 (4/3) 7i r3
Value 1 1 2 12.566 3.14 4.189
Value 2 1.260 2.520 19.948 4.984 8.378
Ratio 2/1 1.260 1.260 1.587 1.587 2.001
5.3 Results
5.3.1 In vitro analysis of E3.5 4n<->2n chimeras
Three groups of chimeras were produced and cultured in vitro. These were
imaged using the confocal microscope at E3.5: control 2nGFPe->2n, and
experimental 4nGFP<-»2n and 4n<->2nGFP chimeras. The epiblast and
hypoblast could not be distinguished therefore GFP and non-GFP
contributions were analysed as described in section 5.2.5 of this chapter.
5.3.1.1 Control E3.5 2n<-»2n chimeras
21 control 2nGFPe^2n chimeric blastocysts were cultured in vitro and
imaged at E3.5. Individual overlay images of these chimeric blastocysts are
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shown in Figure 5.4. Table 5.2 shows the measured individual, and mean
percentage GFP contribution to the separate regions of these chimeric
blastocysts.
The histogram in Figure 5.5a shows the mean percentage GFP contribution to
the individual regions of the blastocyst. There was a significantly higher
mean contribution of GFP cells in the TE than the ICM, in the mTE than the
pTE and in the presumptive hypoblast than the presumptive epiblast (p<0.05
by Mann-Whitney U test) (Fig 5.5a). The small but significant difference in
composition of the different tissues of the blastocyst could reflect genetic
differences between the GFP and non-GFP embryos, sample variation or
experimental variation attributable to methods used to estimate %GFP
composition. However, both the 4nGFP<->2n and the reciprocal chimera
combination, 4n<->2nGFP were analysed at E3.5 to ensure the same trends
were observed in both experimental chimera combinations.
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Fig 5.4: Confocal Images of Control E3.5 2nGFP«-»2n
Chimeras
Fig 5.4: Overlay images of 21 E3.5 control 2nGFP<-»2n chimeric embryos.
Scale bar=50microns.
Table 5.2:
% Contribution of GFP cells in E3.5 2nGFP<-^2n
Chimeras





1 42 28 21 53 27 30
2 43 40 48 39 35 46
3 56 26 80 42 1 1 49
4 62 45 48 83 51 37
5 59 29 61 57 32 26
6 49 48 48 50 39 60
7 79 40 95 60 33 48
8 61 88 67 50 79 95
9 32 50 1 5 59 49 51
1 0 54 55 84 26 50 58
1 1 66 35 1 00 39 31 39
1 2 47 51 72 27 32 70
1 3 71 77 100 53 86 69
1 4 60 41 100 44 1 3 74
1 5 48 71 1 0 88 81 59
1 6 62 93 48 86 1 00 90
1 7 83 51 1 00 65 49 52
1 8 82 52 83 81 48 56
1 9 56 34 92 1 0 1 7 53
20 53 36 69 43 29 46
21 54 50 61 43 49 52
Mean % Lenqth 58.06 66.67 52.42
Mean % Area 49.46 44.82 55.13
SE 2.86 4.07 6.20 4.46 5.26 3.76
N 21 21 21 21 21 21
SD 13.13 18.64 28.40 20.44 24.12 17.24
Table 5.2:
Individual and mean % length of GFP cells in the TE, mTE & pTE and the %
area of GFP cells in the ICM, including the presumptive epiblast and
hypoblast, of E3.5 2nGFP<-*2n chimeras.
SE= Standard Error, N= Number, SD= Standard Deviation.
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Fig 5.5:

























































Region of the Blastocyst Region of the Blastocyst
Fig 5.5: The mean % length in the TE and % area in the ICM, including the presumptive
epiblast and hypoblast, of a: GFP cells in 2nGFP<->2n control chimeras, b: 4n cells in
4nGFP<->2n chimeras, c: GFP cells in 4n<->2nGFP chimeras, d: 4n cells in 4n< >2nGFP.
* P<0.05, * * P<0.01 (Mann-Whitney U-tests)
Mann-Whitney U-test probabilities for comparisons of %GFP in comparable tissues between control
and experimental chimeras (a-c).
E3.5 TE ICM mTE pTE Eoiblast Flypoblast
2nGFP<->2n v 4nGFP<->2n (avb) P=0.4592 P=0.001 5 P=0.01 77 P=0.1101 P=0.0051 P=0.0264
2nGFP<->2n v 4n<->2nGFP (avc) P=0.3311 P=0.0936 P=0.0051 P=0.0475 P=0.0246 P=0.1 698
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5.3.1.2 E3.5 4nGFP^2n Chimeras
Overlay images of E3.5 4nGFP<->2n chimeras are shown in Fig 5.6. The
individual percentage GFP contribution were measured and means
calculated (Table 5.3).
Figure 5.5b and Mann-Whitney U-tests show that at E3.5 the contribution of
4n tissue (GFP) was greater in the TE than ICM (P<0.01), greater in the mTE
than the pTE (p<0.01) and greater in the presumptive hypoblast than the
presumptive epiblast (p<0.01). Individual tissue differences between the
4nGFP<-»2n and control 2nGFP<->2n chimeras are shown in the footnote to
Fig 5.5 but it is more helpful to compare the differences between relevant
pairs of tissues. The three pairwise differences are greater in the 4nGFP<->2n
chimeras than in the control chimeras (Fig 5.5a compared to 5.5b, Table 5.4)
and are significantly greater for the first two comparisons (TE v ICM and
mTE v pTE). This suggests that tetraploid cells are not randomly distributed
among different tissues of the blastocyst.
Table 5.4: Comparison between 4nGFP<->2n and control chimeras, for
differences in % GFP for three pairs of tisssues
E3.5 TE-ICM mTE-pTE Hypoblast-Epiblast
2nGFP<->2n (n=21) Fig 5.5a 8.60 ± 4.61 14.25 ± 9.0 10.31 ± 4.48
4nGFP<->2n (n=23) Fig 5.5b 28.17 ± 3.04 40.88 ± 8.12 20.65 ± 5.25
2nGFP<->2n v 4nGFP<->2n (avb) P=0.022 P=0.016 P=0.142
The mean percentages of 4n cell numbers were estimated from the means of
the % GFP contribution (see section 5.2.5 of this chapter), and are shown in
Table 5.3. The histograms show that the same trends were observed for cell
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Fig 5.6: Confocal Images of E3.5 4nGFP<->2n
Chimeras
Fig 5.6:Overlay images of 22 E3.5 4nGFP«-»2n chimeras.
Scale bar=50microns.
Table 5.3:
% Contribution of 4n cells in E3.5 4nGFP<->2n
Chimeras





1 61 18 100 20 1 39
2 72 41 100 56 41 41
3 60 36 100 38 10 54
4 79 29 100 59 20 39
5 67 30 86 45 22 43
6 68 36 100 33 33 40
7 45 23 67 28 0 46
8 65 31 86 55 8 56
9 63 11 100 16 0 18
10 53 25 76 32 6 43
11 76 46 100 57 37 58
12 48 32 65 36 34 30
13 60 25 100 38 0 55
14 60 35 100 22 6 72
15 52 30 85 21 3 64
16 48 42 18 77 46 37
17 48 35 59 39 29 43
18 44 8 77 20 0 15
19 96 87 100 92 85 90
20 38 46 0 68 51 42
21 75 35 100 62 44 26
22 61 13 91 0 0 22
23 72 48 100 58 57 37
Mean % Length 61.30 83.01 42.13
Mean % Area 33.14 23.13 43.79
SE 2.84 3.35 5.62 4.60 4.89 3.61
N 23 23 23 23 23 23
SD 13.62 16.08 26.95 22.06 23.46 17.31
Corrected Value
for % Cell Number 55.7 23.77 79.5 36.62 15.91 32.88
Table 5.3:
Individual and mean % length of 4n cells in the TE, mTE & pTE, and the %
area of 4n cells in the ICM, including the presumptive epiblast and
hypoblast, of E3.5 4nGFP<->2n chimeras. The corrected values for the %
number of 4n cells is shown. These were calculated as described in section
5.2.5. If there was an equal contribution of 4n cells to all the regions of the
blastocyst a proportion of 33.3% in each tissue would be expected.
SE= Standard Error, N= Number, SD=Standard Deviation.
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number (Fig 5.7a) as were observed for percentage area and length
contribution (Fig 5.5b). If 4n cells divided at the same rate as 2n cells, and
both types of cell contributed equally to all regions of the blastocyst, the
number of 2n cells would be expected to be twice the number of 4n cells.
Therefore, the percentage 4n cell number would be expected to be 33.3% in
each region of the blastocyst. However, this is not the case, more 4n cells are
present in the TE, specifically the mTE, and there are more 4n cells in the
hypoblast compared to the epiblast. This implies that the distribution of 4n
cells (Fig 5.7a) is similar to the measured GFP tissue area or length (Fig 5.5b),
discussed above.
5.3.1.3 E3.5 4n<->2nGFP Chimeras
Figure 5.8 shows the individual overlay images of 22 E3.5 4n<->2nGFP
analysed chimeras. The individual and mean percentages of GFP (2n)
contribution are shown in Table 5.5a and the mean percentages of non-GFP
(4n) contribution are shown in Table 5.5b.
The histograms showing the mean % GFP (2n) contribution (Fig 5.5c) and
mean % 4n contribution (Fig 5.5d) shows a slightly lower percentage of GFP
contribution (higher % 4n) in the TE than the ICM. This difference is not
significant. There was however, a significantly lower % GFP (higher % 4n) in
the mTE than the pTE (P<0.01 by Mann-Whitney U-test) and in the mTE than
the ICM (P<0.05 by Mann-Whitney U-test). When compared to the control
chimeras in Fig 5.5a the 4ne->2nGFP chimeras in Fig 5.5c showed a trend
towards less GFP (more 4n) in the TE than ICM. Comparison with control
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Fig 5.7:
% of estimated 4n cell number in E3.5 & E4.5 Chimeras
Region of the Blastocyst Region of the Blastocyst
100 100-
Region of the Blastocyst Region of the Blastocyst
Fig 5.7:
The mean % estimated 4n cell number in the ICM, the presumptive epiblast,
hypoblast, TE, mTE & pTE in a: E3.5 4nGFP<->2n chimeras, b: E3.5
4n<-»2nGFP chimeras, c: E4.5 4nGFP<-^2n chimeras, d: E4.5 4n<->-2nGFP.
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Fig 5.8: Overlay images of 4n<-»2nGFP chimeric embryos.
Scale bar=50microns.
Table 5.5:
% Contribution of GFP and 4n cells in E3.5 4n<->2nGFP
Chimeras
(a) % GFP
Blastocyst Total TE Total ICM mTE PTE Epiblast Hypoblast
1 70 43 94 42 32 51
2 33 32 34 30 45 22
3 14 47 6 21 0 79
4 79 36 100 53 32 41
5 56 55 1 8 85 65 42
6 61 52 37 89 88 22
7 51 65 0 100 94 38
8 47 47 77 1 4 32 58
9 60 56 0 83 75 39
1 0 61 48 50 71 49 46
1 1 33 42 1 6 45 60 1 9
1 2 41 57 0 62 76 40
1 3 66 59 39 100 49 65
1 4 72 53 92 53 38 67
1 5 61 61 34 100 64 59
1 6 41 63 25 60 84 48
1 7 52 65 28 100 94 44
1 8 43 74 1 9 72 98 50
1 9 61 35 83 36 34 36
20 43 80 0 90 96 65
21 64 50 64 65 64 43
22 44 100 0 100 100 100
Mean % Lenqth 52.49 37.1 1 66.90
Mean % Area 55.51 62.31 48.80
SE 3.24 3.34 7.20 5.87 5.89 4.03
N 22 22 22 22 22 22
SD 15.18 15.68 33.78 27.53 27.61 18.91
(b) % 4n
Mean % Lenqth 47.51 62.89 33.10
Mean % Area 44.49 37.69 51.20
SE 3.24 3.34 7.20 5.87 5.89 4.03
Corrected Value
for % Cell Number 41.80 33.51 57.36 28.20 27.56 39.75
Table 5.5:
Showing a: the individual and mean % length of GFP cells in the TE, mTE
& pTE, and the % area of GFP cells in the ICM, including the presumptive
epiblast and hypoblast, of E3.5 4n<-»2nGFP chimeras and b: the mean %
length of 4n cells in the TE, mTE & pTE and the % area of 4n cells in the
ICM, epiblast & hypoblast. The corrected values for the % number of 4n
cells is shown. If there was an equal contribution of 4n cells to all the
regions of the blastocyst a proportion of 33.3% in each tissue would be
expected.
SE= Standard Error, N= Number, SD=Standard Deviation.
132
chimeras for pairwise differences by Mann-Whitney U-tests showed
significantly less GFP (more 4n) in the mTE than pTE and also significantly
less GFP (more 4n) in the hypoblast than epiblast (Table 5.6).
Table 5.6: Comparison between 4ne->2nGFP and control chimeras for
differences in % GFP for three pairs of tisssues
E3.5 TE-ICM mTE-pTE Hypoblast-Epiblast
2nGFP<->2n (n=21) Fig 5.5a 8.6 ± 4.61 14.25 ± 9.0 10.31 ± 4.48
4n<->2nGFP (n=22) Fig 5.5c - 3.02 ± 5.01 - 29.8 ±11.2 - 13.51 ± 7.32
2nGFP<->2n v 4n<->2nGFP (avc) P=0.0985 P=0.01 P=0.007
The mean percentages of 4n cell numbers were calculated (Table 5.5). This
data shows the same trends as the % 4n contribution measured by area and
length (Fig 5.7b compared to Fig 5.5d). The percentage of 4n cells in the TE,
mTE and hypoblast is higher than the expected 33%.
5.3.1.4 Comparison between E3.5 Chimera Groups
The proportion of blastocysts that contained chimeric ICM's, epiblasts or
hypoblasts did not vary significantly among the three groups (P>0.05 by
Fisher's Exact test). However, the analysis of percentage cell contribution and
the calculated values of percentage cell numbers show, at E3.5, 4n cells were
preferentially allocated to the mTE rather than the pTE of 4n<-*2n chimeras.
One series, 4nGFPe->2n, had significantly more 4n in the TE than the ICM
and although the other series also had a higher percentage in the TE this was
not significant. Tetraploid cells were present in the presumptive epiblast
region but there appeared to be a higher contribution of 4n cells to the
presumptive hypoblast.
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5.3.2 In Vitro Analysis of E4.5 4n<->2n Chimeras
A separate series of the same chimera combinations, 2nGFPe->2n, 4nGFP<->2n
and 4n<->2nGFP were aggregated, cultured in vitro and imaged at E4.5.
Again the epiblast and hypoblast regions could not be identified so the
blastocysts were analysed as before (see section 5.2.5 of this chapter).
5.3.2.1 Control E4.5 2nGFP<->2n Chimeras
Overlay images of control 2nGFP<-»2n E4.5 blastocysts are shown in figure
5.9. The individual and mean percentage GFP contributions are shown in
Table 5.7, and histograms of the mean percentage GFP contribution are
shown in Figure 5.10a. These results show that there was a higher mean
percentage of GFP in the ICM than the TE, in the pTE than the mTE and in
the presumptive epiblast than the presumptive hypoblast. These differences
were not significant. The mean percentage of GFP was higher in the
presumptive epiblast than the other tissues of the blastocyst. This was
probably attributable to the small sample size, as 5 out of 8 blastocysts had a
% GFP in the presumptive epiblast higher than 85% (Table 5.7).
The contribution from the GFP-positive embryo differed in the E3.5 and E4.5
control chimeras. This difference was significant for the mTE. It is probable
that random allocation of cells occurs in 2nGFPo2n chimeras because
significant changes in composition between these ages in this group seem
unlikely, between E3.5 and E4.5.
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Fig 5.9: Confocal Images ofControl E4.5 2nGFP<-»2n
Chimeras
Fig 5.9 : Overlay images of 7 out of 8 control E4.5 2nGFP<->2n chimeras.
Scale bar=50microns.
Table 5.7: % Contribution of GFP cells in E4.5 Chimeras
(a) Control 2nGFP<->2n





1 26 96 11 63 92 100
2 55 52 52 63 88 19
3 38 97 41 26 100 95
4 40 11 43 28 25 0
5 47 56 51 29 50 60
6 44 74 23 90 98 50
7 66 65 60 88 99 33
8 61 0 76 23 0 0
Mean % Length 47.16 44.57 51.10
Mean % Area 56.44 68.99 44.65
SE 4.62 12.62 7.26 9.96 13.79 13.76
N 8 8 8 8 8 8
SD 13.07 35.69 20.52 28.16 39.00 38.92
(b) 4nGFP<-2n





1 50 19 52 46 18 20
2 49 0 60 26 0 0
3 71 0 100 20 0 0
4 70 12 70 70 16 9
5 53 13 66 12 3 19
6 63 53 84 26 86 53
7 69 84 58 100 80 90
8 47 23 39 81 42 11
9 88 14 100 56 4 17
10 90 17 100 66 10 20
11 39 0 46 0 0 0
Mean % Length 62.57 70.46 45.74
Mean % Area Ocs 23.45 21 .74
SE 5.04 7.70 6.73 9.50 9.62 8.18
SD 16.78 25.55 22.33 31.50 31.91 27.14
N 1 1 1 1 1 1 1 1 1 1 1 1
Corrected Value
for % Cell Number 57.02 14.62 65.43 40.08 16.15 14.87
(c) 4n<->2nGFP (% GFP)





1 55 75 55 56 78 73
2 56 59 39 86 55 63
3 25 60 13 63 67 50
4 51 79 52 51 80 79
5 55 83 43 90 97 67
6 24 43 13 51 64 34
7 33 74 24 44 60 92
8 22 86 13 43 100 73
Mean % Length 40.20 31 .37 60.40
Mean % Area 69.98 74.97 66.14
SE 5.42 5.12 6.29 6.35 5.96 6.31
SD 15.33 14.48 17.80 17.96 16.86 17.86
N 8 8 8 8 8 8
(d) 4n<->2nGFP (% 4n)
Mean % Length 59.80 68.63 39.60
Mean % Area 30.02 25.03 33.86
SE 5.42 5.12 6.29 6.35 5.96 6.31
SD 15.33 14.48 17.80 17.96 16.86 17.86
N 8 8 8 8 8 8
Corrected Values
for % Cell Number 54.14 21.25 63.45 34.23 17.35 24.36
Table 5.7: Showing the individual and mean % length of GFP cells in the TE and the mean % area of
GFP cells in the ICM, including the presumptive epiblast and presumptive hypoblast, of E4.5 a
2nGFP<->2n, b 4nGFP<->2n chimeras, c 4n<->2nGFP chimeras and d the % 4n contribution in
4n<->2nGFP chimeras. SE= Standard Error, N= Number, SD=Standard Deviation.
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Fig 5.10:
% Contribution of GFP or 4n cells in E4.5 Chimeras
Region of the Blastocyst Region of the Blastocyst
Fig 5.10:
The mean % contribution in the TE and the ICM, including the presumptive epiblast and
hypoblast, of a: GFP contribution in 2nGFP<->2n control chimeras, b: 4ncontribution in
4nGFP<->2n chimeras, c: GFPcontribution in 4n<->2nGFP chimeras, d: 4n contribution in
4n<->2nGFP.
+P<0.05, * * P<0.01.
Mann-Whitney U-test probabilities for comparisons of %GFP in comparable tissues between control
and experimental chimeras (a-c).
E4.5 TE ICM mTE PTE Epiblast Hypoblast
2nGFP<->2n v 4nGFP<->2n (avb) P=0.0430 P=0.0746 P=0.031 4 P=0.5624 P=0.01 44 P=0.1962
2nGFP<->2n v 4n<->2nGFP (avc) P=0.3431 P=0.4306 P=0.291 5 P=0.4929 P=0.8747 P=0.1883
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5.3.2.2 E4.5 4n^2n Chimeras
Eleven E4.5 4nGFPo2n chimeras and 8 4n<-^2nGFP chimeras were imaged
(Fig 5.11 & 5.12). Table 5.7 shows the individual and mean percentage GFP
contributions in both experimental chimera groups and the mean percentage
4n contribution in 4n<->2nGFP chimeras.
Figure 5.10b shows there was a higher mean % GFP (4n cell) contribution to
the TE than the ICM and the mTE than the pTE. This difference was
significant for the TE versus the ICM comparison (p<0.01 by Mann-Whitney
U test). There was no significant difference between the presumptive epiblast
and hypoblast of 4nGFPe->2n chimeras.
The mean percentage of GFP contribution was significantly less (more 4n) in
the TE than the ICM (p<0.01 by Mann-Whitney U test) and significantly less
in the mTE compared to the pTE (p<0.05 by Mann-Whitney U test) of
4n<->2nGFP chimeras (Fig 5.10c & d). There was no significant difference
between the % GFP contribution in the presumptive epiblast and
presumptive hypoblast of 4n<->2nGFP chimeras.
The proportion of blastocysts that contained chimeric ICM's, epiblasts or
hypoblasts did not vary significantly among the three groups (P>0.05 by
Fisher's Exact test).
Statistical analysis comparing both experimental groups of E4.5 chimeras
with the control group is shown in the footnote to Fig 5.10. Pairwise
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Fig 5.11: Confocal Images of E4.5 4nGFP<-»2n
Chimeras
Fig 5.11: Overlay confocal images of 10 E4.5 4nGFP<-»2n Chimeras.
Scale bar=50microns.
Fig 5.12: Confocal Images of E4.5 4n<-»2nGFP
Chimeras
Fig 5.12: Overlay images ofE4.5 4n<->2nGFP chimeras.
Scale bar=50 microns.
differences were also compared (Table 5.8). There was a greater pairwise
difference between the TE and ICM, and between the mTE and pTE but a
smaller difference between the presumptive epiblast and hypoblast of
experimental chimeras than control chimeras. The pairwise difference
between the TE and ICM was significant between the control and the
4nGFP<->2n groups. The pairwise difference between the mTE and pTE was
not significant between these groups probably because of the small sample
size in this series. There was also no significant difference in the pairwise
difference between the hypoblast and epiblast between the control and the
4nGFP<->2n groups. The GFP (2n) cells in the 4n<->2nGFP group followed the
same trends as the GFP cells in the control group and the pairwise
differences were not significant.
Table 5.8: Comparison between 4n<->2nGFP and Control Chimeras for
differences in % GFP for three pairs of tisssues
E4.5 TE-ICM mTE-pTE Hypoblast-Epiblast
2nGFP<->2n (n=8) Fig 5.11a - 9.28 ± 15.45 - 6.53 ± 14.33 - 24.34 ± 11.54
4nGFP<->2n (n=11) Fig 5.11b 41.17 ± 8.48 24.72 ± 11.94 -1.72 ± 4.95
4n<->2nGFP (n=8) Fig 5.11c - 29.78 ± 6.31 - 29.03 ± 7.17 - 8.83 ± 7.69
2nGFP<->2n v 4nGFP<->2n (avb) P =0.0082 P=0.0989 P=0.0970
2nGFP<->2n v 4n<->2nGFP (avc) P=0.2480 P=0.248 P=0.5995
The relative % 4n cell number was estimated (see section 5.2.5 of this chapter)
for both combinations of E4.5 chimeras (Table 5.7). These results show that
there is an unequal contribution of 4n cells to each region of the blastocyst as
both types of experimental chimera groups have more 4n cells in the TE and
particularly the mTE.
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The analysis of % GFP (4n) and % 4n cell number in 4nGFP<->2n chimeras
(Figures 5.10b and 5.7c) and % 4n contribution and % 4n cell number in
4n<->2nGFP chimeras at E4.5 (Figures 5.10d and 5.7d) show the same trends
of a higher contribution of 4n cells to the TE in particular the mTE. There was
no preferential allocation of 4n cells to the presumptive hypoblast compared
to the presumptive epiblast in 4nGFPo2n and 4n<->2nGFP chimeras.
5.3.3 Analysis of Expanded E5.5 & E7.5 2nGFP<->2n and 4nGFP<->2n
Blastocysts
The epiblast and hypoblast was not differentiated in the chimeric blastocysts
that had been cultured in vitro. Expanded blastocysts were therefore
produced by transferring them to pseudopregnant females which had been
injected with tamoxifen (see section 5.2.3). This prevented the blastocysts
from implanting and allowed them to grow in an in vivo environment. The
epiblast and hypoblast can be more easily distinguished in the enlarged
blastocysts that are in a state of diapause.
Before starting these experiments two methods of inducing diapause were
compared. Ten embryos were each transferred into four pseudopregnant
females which had been injected with tamoxifen. Nine embryos were
recovered. This was compared to a recovery of nine embryos from the
transfer of ten embryos each into three pseudopregnant females that had
been ovariectomised. Therefore, this technique is probably as effective as
using ovariectomy to produce expanded blastocysts but is preferable to use,
as it is less invasive.
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As the previous results had revealed that both 4ru->2n chimera combinations
followed the same trends, only 4nGFP<-^2n and control 2nGFP<->2n chimeras
were produced. These chimera combinations were analysed at E5.5 & E7.5.
5.3.3.1 E5.5 Chimeras:
Overlay images of E5.5 4nGFP<-+2n chimeras are shown in figure 5.13. The
individual and mean percentages of GFP contribution to control and
4nGFP<->2n blastocysts are shown in Table 5.9.
The results from the E5.5 series of control chimeras revealed no significant
difference between the percentage contribution of GFP cells to any of the
regions of the blastocysts (Fig 5.14a). The 4nGFP<->2n chimeras had a
significantly higher percentage contribution of 4n cells in the TE than the
ICM and no significant difference between the mTE than the pTE or between
the epiblast and the hypoblast (Fig 14b).
There was no significant difference in the number of blastocysts with
chimeric epiblasts between the control and experimental groups (5/7 versus
3/7; Fisher's Exact P-value >0.05). There was also no significant difference in
the proportion of 4nGFP<-»2n chimeras that had a 4n contribution to the
epiblast versus the hypoblast (3/7 versus 4/7; Fisher's Exact P-value >0.05).
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Fig 5.13: Confocal Images of E5.5 4nGFP<-»2n
Chimeras
Fig 5.13: Overlay images of expanded E5.5 4nGFP<->2n chimeras. Most of the
GFP, 4n cells are allocated to the TE, however chimeras 1 and 7 clearly show 4n
cells present within both the epiblast and hypoblast regions.
Scale bar=50 microns.
Table 5.9:
% Contribution of GFP cells in E5.5 2nGFP<-+2n
Chimeras & E5.5 4nGFP^2n Chimeras Cultured in
Delayed Implantation Pseudopregnant Females
a: 2nGFP<->2n
Blastocyst Total TE Total ICM mTE PTE Epiblast Hypoblast
1 1 4 52 0 50 56
n
50
2 54 65 42 90 100 50
3 21 0 29 0 0 0
4 84 43 78 100 50 40
5 33 65 1 5 68 67 64
6 38 53 44 1 9 72 44
7 23 26 29 0 0 38
Mean % Lenqth 38.05 33.90 46.77
Mean % Area 43.53 49.17 40.71
SE 9.1 1 8.86 9.41 15.65 14.05 7.52
SD 24.1 1 23.43 24.88 41.41 37.17 19.89
N 7 7 7 7 7 7
b: 4nGFP<->2n
Blastocyst Total TE Total ICM mTE pTE Epiblast Hypoblast
1 70 61 58 1 00 86 36
2 31 1 5 1 0 66 27 2
3 29 0 37 0 0 0
4 52 5 33 97 0 1 0
5 58 0 81 0 0 0
6 49 0 64 0 0 0
7 64 40 51 91 37 45
Mean % Lenqth 50.19 47.74 50.59
Mean % Area 17.27 21.40 13.32
SE 5.94 9.10 8.81 18.35 12.23 7.25
N 7 7 7 7 7 7
SD 15.72 24.08 23.32 48.56 32.35 19.18
Corrected Value
for % Cell Number 44.44 11.61 42.03 44.83 14.62 8.81
Table 5.9:
Showing the individual and mean % length of GFP cells in the TE, mTE &
pTE and the % area of GFP cells in the ICM, including the epiblast and
hypoblast, of E5.5 chimeras cultured in delayed implantation females,
a: 2nGFP«-»2n chimeras, and b: the % length & area of GFP (4n cells) in
4nGFP<-+2n chimeras and the corrected values for % cell number. If there
was an equal contribution of 4n cells to all the regions of the blastocyst a
proportion of 33.3% in each tissue would be expected.
SE= Standard Error, N= Number, SD=Standard Deviation.
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Fig 5.14:
% Contribution of GFP or 4n cells in E5.5 & E7.5
Chimeras Cultured in Delayed Implantation Females
Fig 5.14:
The mean % length in the TE, mTE & pTE and % area in the ICM, including the epiblast and
hypoblast, of a: GFP cells in 7 E5.5 2nGFP<->2n control chimeras, b: 4n cells in 7 E5.5
4nGFP<->2n chimeras, c: GFP cells in 5 2nGFP<->2n control chimeras, d: 4n cells in 4 E7.5




Therefore, although there was a lower 4n contribution to the ICM, 4n cells
were present in the epiblast and were not significantly more abundant in the
hypoblast than the epiblast.
5.3.3.2 E7.5 Chimeras:
E7.5 control 2nGFP<->2n and 4nGFP<->-2n blastocysts were imaged (Fig 5.15).
The individual and mean percentages are shown in table 5.10. The E7.5
control data showed no significant difference between the percentage
contribution of GFP cells to any of the regions of the blastocyst (Fig 5.14c).
However, there appeared to be a lower contribution of GFP in the hypoblast
and mTE compared to the epiblast and pTE. This is possibly due to the small
sample size, as only 5 chimeras were analysed.
The percentage 4n contribution to all the lineages of the 4nGFP<-»2n
blastocysts varied widely among the 4 chimeras. Blastocyst 1 had a high
overall percentage contribution of 4n cells. The other three chimeras had low
proportions of 4n cells, with blastocyst 2 having only 2n cells in the TE and
another having only 2n cells in the ICM. Blastocysts 2 and 3 had a higher
percentage of 4n cell contribution to the hypoblast than the epiblast.
There was no significant difference in the numbers of chimeric epiblasts and
hypoblasts within and between control and 4nGFP<-*2n blastocysts (P>0.05
by Fisher's Exact test). This suggests that 4n cells are frequently present in
the epiblast of E7.5 chimeras.
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Fig 5.15: Confocal Images of E7.5 Chimeras
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Fig 5.15:Overlay images of expanded E7.5 control 2nGFP<->2n and 4nGFP<-»2n




% Contribution of GFP cells in E7.5 2nGFP^2n &
4nGFP<->2n Chimeras Cultured in Delayed
Implantation Pseudopregnant Females
a: 2nGFP<->2n
Blastocyst Total TE Total ICM mTE PTE Epiblast Hypoblast
1 76 57 69 100 78 31
2 52 9 46 68 1 5 0
3 25 1 6 33 0 1 4 1 9
4 30 30 31 26 37 1 3
5 48 49 43 63 60 27
Mean % Lenqth 46.32 44.42 51.34
Mean % Area 32.15 40.99 18.03
SE 9.06 9.19 6.69 17.43 12.62 5.54
N 5 5 5 5 5 5
SD 20.27 20.55 14.96 38.98 28.23 12.38
b: 4nGFP<->2n
Blastocyst Total TE Total ICM mTE PTE Epiblast Hypoblast
1 63 72 58 75 95 39
2 0 29 0 0 1 5 48
3 1 0 1 0 1 4 0 4 23
4 1 3 0 1 9 0 0 0
Mean % Length 21.21 22.94 18.82
Mean % Area 27.82 28.53 27.58
SE 14.04 16.01 12.49 18.82 22.28 10.57
N 4 4 4 4 4 4
SD 28.07 32.01 24.98 37.63 44.56 21.15
Corrected Value
for % Cell Number 17.60 19.51 19.11 15.54 20.07 19.32
Table 5.10:
Showing the individual and mean % length of GFP cells in the TE, mTE &
pTE and the % area of GFP cells in the ICM, including the presumptive
epiblast and hypoblast, of E7.5 chimeras cultured in delayed implantation
females, a: 2nGFP<->2n chimeras, and b: the mean % area & length of GFP
(4n cells) in 4nGFP<-»2n chimeras and the corrected values for % cell
number. If there was an equal contribution of 4n cells to all the regions of
the blastocyst a proportion of 33.3% in each tissue would be expected.
SE= Standard Error, N= Number, SE)=Standard Deviation.
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5.3.4 Comparison of % GFP Contribution at different ages
Fig 5.16 shows the percentage contribtion of GFP cells in the same regions of
control 2nGFP<->2n and 4nGFP<->-2n blastocysts between E3.5 and E7.5.
There was a reduction in the % GFP (4n) contribution in the TE, particularly
the mTE between E3.5 and E7.5 of 4nGFP-<->2n blastocysts which was not the
case in control chimeras. Most of the reduction occurred at E5.5 and E7.5
when fewer chimeras were analysed. There was a significantly higher
proportion of 4n cells in the ICM and the hypoblast at E3.5 than at E4.5 in
4nGFP<-T2n blastocysts (PcO.Ol for hypoblast, P<0.05 for ICM by Mann-
Whitney U-test). This was also seen in the 4n<->2nGFP chimera group (P<0.05
for hypoblast, P<0.01 for ICM). Comparison of pairwise differences between
the hypoblast and epiblast showed there was a significantly greater
difference at E3.5 than E4.5 in the 4nGFP<->2n group (see footnote to Fig
5.16). This might suggest that the percentage of 4n cells are reduced in the
hypoblast between E3.5 and E4.5. There is no significant difference in the %
contribution to the hypoblast between E4.5 and E7.5.
There is a lower % GFP contribution in the presumptive epiblast and epiblast
of the 4nGFP<->2n group than the control group at all stages. FFowever, the %
GFP in the 4nGFP<->2n group does not increase or decrease significantly
between E3.5 and E7.5.
150
Fig 5.16: % GFP Contribution to individual regions






















Fig 5.16:Mean % GFP contribution to control and 4nGFP<->2n chimeras in individual
regions of the blastocyt at different ages. The numbers of blastocyst in each group at each
age are shown. Mann-Whitney U-tests for comparisonof %GFP between different ages.
E3.5 v E4.5 TE ICM mTE PTE Epiblast Hypoblast
2nGFP<->2n v 2nGFP<->2n P=0.079 P=0.2046 P=0.0452 P=0.9223 P=0.0876 P=0.4206
4nGFP<->2n v 4nGFP<->2n P=0.8684 P=0.01 94 P=0.0619 P=0.8252 P=0.711 P=0.0029
E3.5 v E4.5 TE-ICM mTE-pTE Hypoblast-Epiblast
2nGFP<->2n v 2nGFP<->2n P=0.171 9 P=0.2046 P=0.0112
4nGFP<->2n v 4nGFP<->2n P=0.101 4 P=0.261 5 P=0.01 75
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5.3.5 Blastocyst Formation in E3.5 Chimeras
The E3.5 data showed a higher proportion of 4n cells in the presumptive
hypoblast compared to the presumptive epiblast (5.3.1). However, at E4.5
there was no significant difference between the two lineages. It is possible
that there is a higher tendency for the blastocyst cavity to form within the 4n
half of the chimera, thus resulting in a higher proportion of 4n cells within
the mTE and hypoblast (adjacent to the cavity) compared to the pTE and
epiblast.
The percentage GFP in the pTE plus epiblast was subtracted from that in the
mTE plus hypoblast and compared between chimera groups by Mann-
Whitney U-tests (Table 5.11). This difference was significantly greater in the
4nGFP<-»2n chimeras than the 2nGFP<->-2n controls (P=0.0264) indicating a
higher GFP (4n) contribution to the mTE plus hypoblast. The difference was
significantly lower in the 4n<-»2nGFP chimeras than the controls (P=0.0081)
indicating a lower GFP (high 4n) contribution to the mTE plus hypoblast.
This shows that there were significantly more GFP (4n) cells surrounding the
blastocyst cavity of 4nGFP<-»2n blastocysts than GFP cells in 2nGFP^2n
control blastocysts. There were significantly fewer GFP (2n) cells
surrounding the blastocyst cavity of 4n<->2nGFP blastocysts than GFP cells in
2nGFP<-»2n control blastocysts. This would therefore imply that the
blastocyst cavity does form preferentially within the 4n half of 4n<->2n
chimeras.
152







































































































































































































































































































































Table5.11:he%GFPcontributionitmTE&presumptivehyp last(tr giowhichblastocystavityfo m d)compare pTE&presumptiveepiblastandthediff encebetw n(mreshy o last)pTumptiveepibl t). H=presumptivehypoblast,Epresepi last. SE=tandardError,N=umberD=StandardDevi tion.
5.4 Conclusion
The experiments in this study were designed to determine the mechanisms
responsible for the exclusion of 4n cells from the epiblast derivatives of mid-
gestation chimeras. These results indicate that 4n cells are present within the
presumptive epiblast region and the differentiated epiblast region of 4n<->2n
chimeric blastocysts.
The analysis of E3.5 and E4.5 4n<->2n chimeras showed that 4n cells are
preferentially allocated to the TE (particularly the mTE) compared to the
ICM. Previous analysis of chimeric blastocysts at E3.5 is in agreement with
these data which showed a significantly greater contribution of 4n cells to the
TE than the ICM. This was due entirely to a difference between the mTE and
ICM (Everett and West, 1996).
The results presented in this chapter also suggest that 4n cells were
preferentially allocated to the hypoblast at E3.5 but not at E4.5. This indicates
that some form of cell selection decreases the percentage of 4n cells in the
presumptive hypoblast between E3.5 and E4.5. Analysis of the E3.5 series
suggested that the blastocyst cavity preferentially forms within the 4n part of
a 4n<-»2n chimera. This explains the non-random distribution of 4n cells
within 4n<->-2n chimeras that can be seen in both E3.5 and E4.5 chimera series
analysed in this study, and in 4n<->2n blastocysts previously analysed
(Everett and West, 1996). It could also provide an explanation for the initial
prefential allocation of 4n cells to the hypoblast.
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Previous analysis of E4.5 4n<->2n chimeric blastocysts showed a reduction in
4n cells in both the ICM and TE at E4.5 compared to E3.5 (Everett and West,
1996, 1998). Everett and West's results differ from the results presented in
this chapter which do not show a decrease in the % 4n contribution between
E3.5 and E4.5 in the TE. This difference could be caused by the different
techniques used to analyse both types of 4n<->2n blastocyst. Alternatively it
could be because the blastocysts analysed in this study were imaged at a
slightly earlier stage than the blastocysts analysed by Everett and West,
(1996,1998).
The analysis of E5.5 and E7.5 diapause 4n<->2n blastocysts indicates that 4n
cells are initially present within the differentiated epiblast region of late
blastocysts. Absence from the lineage at later stages must therefore imply
subsequent loss of 4n cells from this region by some form of cell selection.
There have been reported cases of 4n cells surviving in the epiblast
derivatives of 4n<-+2n adult chimeras (see section 1.5.1.2 of Chapterl) (Lu and
Markert, 1980; Tarkowski et al., 2001; Goto et al., 2002). However, these
chimeras had a higher ratio of 4n cells to 2n cells at aggregation. 4n cells have
been shown to be largely excluded from E7.5 and E12.5 4n<->-2n chimeras
produced using the same techniques as described in this chapter (James et al.,
1995).
Although only 4 E7.5 4n<-*2n diapause chimeras were analysed the results
differ from the normally implanted E7.5 postimplantation chimeras
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previously analysed by James et al. (1995). Only 2 out of 12 4n<->-2n
postimplantation chimeras contained 4n cells in the epiblast derivatives both
of which were abnormal. The diapause E7.5 blastocyst data differs from this
as, although the proportion of 4n cells in the epiblast were low in 2 of the
chimeric blastocysts, 3 out 4 contained 4n cells in the epiblast. This could be
caused by differences in the age of the chimeras. The 4n<->-2n chimeras
studied by James, et al. (1995) were staged according to the age of the
pseudopregnant female and were therefore a day older than the expanded
blastocysts analysed in this chapter. Alternatively it could be because cell
proliferation (and possibly apoptosis) is suppressed in these diapause
blastocysts. It is therefore possible that following implantation and the
growth and differentiation of the epiblast further cell selection takes place,
eliminating 4n cells from the epiblast between the late blatocyst stage and
E7.5. One abnormal E7.5 postimplantation chimera studied by James et al.
(1995) had a high overall proportion of 4n cells, which was similar to the
diapause E7.5 blastocyst with a high contribution of 4n cells in all the regions
of the blastocyst.
In conclusion the experiments in this study suggest there are several
mechanisms taking place within 4n<->2n chimeras resulting in the restricted
distribution of 4n cells within the blastocyst and the loss of 4n cells from the
epiblast derivatives. The model shown in Fig 5.17 illustrates the mechanisms
that may be involved. It is likely that initially the cavity tends to form more
often within the 4n part of the chimera resulting in a higher proportion of 4n
cells in the mTE and hypoblast compared to the pTE and epiblast. Following
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Fig 5.17:
Proposed Model Resulting in the Exclusion of 4n
















□ 4n Cells Absent




Proposed model explaining the gradual loss of 4n cells from the epiblast derivatives of
mid gestation 4n<->2n chimeras. Three mechanisms appear to be taking place, initially
preferential allocation of 4n cells to the mTE, and the hypoblast within the ICM as a
result of the cavity preferentially forming within the 4n part of the chimera.
Subsequently 4n cells are reduced from the presumptive hypoblast region by cell
selection, followingwhich cell selection takes place in the epiblast derivatives to
eliminate 4n cells. Finally it is likely that any fetuses containing 4n cells are eliminated
through embryo selection.
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this there is possibly a significant reduction in the percentage of 4n cells in
the hypoblast. 4n cells are therefore, greatly reduced in the ICM region
compared to the TE. However, the analysis of enlarged blastocysts in
diapause indicates when the epiblast and hypoblast are formed 4n cells are
present in the epiblast and are not exclusively allocated to the hypoblast
within the ICM. Following the late blastocyst stage it is likely that 4n cells are
reduced from the epiblast derivatives by cell selection against 4n cells. As
James et al. (1995) showed that both E7.5 chimeras with 4n cells in the
epiblast were abnormal, it is possible that a limited amount of selection
against embryos with a significant number of 4n cells occurs, as a final
mechanism to exclude 4n cells from the epiblast lineage. This proposed
model may be relevant to the origin of some cases of CPM.
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Chapter 6: Using Confocal Microscopy to Determine
the Fate of BALB/c Cells in tau-GFP Aggregation
Chimeras
6.1 Introduction
As discussed in chapter 1, section 1.5.1.2, BALB/c strain cells make a poor
contribution to BALB/c mouse aggregation chimeras (Mullen and Whitten,
1971; West and Flockhart, 1994; Dvorak et ah, 1995; Tang and West, 2001).
Previous analysis showed that BALB/c cells were under-represented in
epiblast, hypoblast and pTE derivatives of E12.5 BALB/cv->(C57BL x CBA)F2
chimeras, aggregated at the 8-cell stage (West and Flockhart, 1994). Of these
chimeras, 20 out of 34 did not have a BALB/c contribution to the fetus but
did have BALB/c cells in at least one extraembryonic tissue suggesting
BALB/c chimeras could provide another mouse model of confined placental
mosaicism. Consequently it is relevant to investigate how the depletion of
BALB/c cells occurs. As the mural trophectoderm (mTE) contributes little to
the 12.5 day conceptus, it is possible that, like 4n cells in 4no2n chimeras,
BALB/c cells become preferentially allocated to the mTE. Alternatively some
form of generalised cell selection against BALB/c cells could be responsible
for the lower contribution of BALB/c embryos to these chimeras. The
experiments presented in this chapter were designed to test the first
possibility using confocal microscopy of BALB/c<->(BF1 x TgTP6.3) chimeras
and a control series of (BALB/c x A/J)F2^(BF1 xTgTP6.3) chimeras.
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As a new chimera combination was being used it was necessary to analyse
the composition of two chimera series at E12.5 to determine that (BALB/c x
A/J)F2<->(BF1 x TgTP6.3) chimeras are a balanced strain combination and
BAFB/ce^(BF1 x TgTP6.3) chimeras are unbalanced with a low contribution
of BALB/c cells.
To follow the fate of BALB/c cells within a chimeric blastocyst, BALB/c
embryos were aggregated to (BFj x TgTP6.3) embryos at the 8-cell stage and
cultured on the confocal microscope for time-lapse microscopy using the
method described in chapter 3. It is possible to follow the fate of the tau-GFP
expressing cells in a tau-GFP chimera during a period of preimplantation
development and therefore, determine if the BALB/c (non tau-GFP) cells are
preferentially allocated to the mTE. For time-lapse microscopy studies
BALB/c<->(BFj x TgTP6.3) and (BALB/c x A/J)F2^(BF1 x TgTP6.3) chimeras
were produced by aggregating the embryos at the 8-cell stage. These chimera
combinations were also aggregated at the 2-cell stage and individually
imaged at the late blastocyst stage, to determine if aggregating at an earlier
stage had an effect on the allocation of BALB/c cells within the chimeric
blastocyst.
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6.2 Materials and Methods
6.2.1 Aggregation of Chimeras
Details of the mouse strains used in these experiments are described in Table
2.1.
(BALB/c x A/J)F2 embryos were aggregated to (BFj x TgTP6.3) embryos to
produce control chimeras and BALB/c embryos were aggregated to (BFt x
TgTP6.3) embryos to produce experimental chimeras. These embryos were
aggregated at the 8-cell stage and 2-cell stage respectively in two separate
series of experiments. 8-cell stage embryos were flushed using M2 handling
medium and aggregation chimeras were cultured in Ml6 handling medium.
The experiments with 2-cell stage aggregates were done after the 8-cell
aggregates and by this time KSOM had replaced M16 as our standard culture
medium. 2-cell stage embryos were flushed using KSOMH handling
medium and cultured in KSOM culture medium following aggregation.
(BFj x TgTP6.3) 8-cell embryos that were hemizygous for the GFP transgene
were identified using a Leica fluorescent dissecting microscope prior to
aggregation. GFP positive 2-cell stage (BFtx TgTP6.3) embryos could not be
identified at this stage therefore were identified after aggregation.
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6.2.2 E12.5 Chimeric Embryo Dissection
E12.5 embryos were dissected for GPI1 electrophoresis. The decapitated fetus
and placenta of E12.5 conceptuses were each homogenised and stored
individually in lOOpl of 50% glycerol in water in a 1.5 ml eppendorf
microfuge tube in a freezer. The amnion, yolk sac mesoderm and yolk sac
endoderm were dissected and stored individually in 10pl of 50% glycerol in
water in a well of a 96 well plate in a freezer. The mesoderm and endoderm
layers of the visceral yolk sac were separated by incubating the yolk sac in a
trypsin/pancreatin solution (0.5g trypsin and 2.5g pancreatin in 100ml
phosphate buffered saline) for approximately 3 hours at 4°C, followed by a
wash in M2 medium for 30 minutes (Levak-Svajger et al., 1969). The yolk sac
endoderm was then removed from the yolk sac mesoderm using dissecting
forceps (Richardsons of Leicester).
6.2.3 GPI Electrophoresis
The proportions of the two cell populations in the chimeric tissues were
estimated from the proportions of GPI1-A and GPI1-B allozymes.
The sample tissues from the E12.5 conceptus were mechanically disrupted
after being thawed and were then frozen and thawed a further two times to
lyse the samples.
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Cellulose acetate plates (Helena Laboratories, Titan III, cat. No. 3023) were
soaked in GPI buffer (3g of Tris and 14.4g of glycine dissolved in 1 litre of
distilled water, pH 8.1) for 30 minutes. The plates were then dried with a
paper towel and put on an aligning base (Helena Laboratories, cat. No. 4086).
Diluted samples were loaded into the sample well plates (Helena
Laboratories, super Z, cat. No. 4085) then transferred to the acetate plates by
a sample applicator (Helena Laboratories, super Z, cat. No. 4084).
Samples were run on an electrophoresis chamber (Helena Laboratories, cat.
No. 1283), filled with 50 ml of GPI buffer in each of the buffer reservoirs,
with a power supply (Bioblock Scientific, E455) at 200volts for an hour. The
plates were then stained for GPI activity for 3-10 minutes on a 37°C hotplate
in the dark. The reaction was stopped by immersing the plates in water. The
plates were fixed in 5% acetic acid for 5 mins and rinsed in distilled water
for at least 10 minutes. The plates were dried for 24 hours and scanned using
a Helena Process-24 gel scanner to quantify the proportions of each GPI
allozyme (Fig 6.1).
6.2.4 Confocal Microscopy
Prior to time-lapse or individual imaging on the confocal micoscope
chimeras were cultured in a conventional C02 incubator. The 9
BALB/ce^(BF1 x TgTP6.3) chimeras imaged with the xlO lens were cultured
on the confocal microscope within the incubation chamber in Ml6 culture
medium on a gasket attached to a plastic petri dish with a hole cut out the
bottom as described in chapter 3 (Fig 3.2c). The remaining chimeras imaged
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Fig 6.1: GPI Electrophoresis
Figure 6.1: GPI Electrophoresis.
a: Example of an acetate plate after running homogenised tissue
samples and staining for GPI activity. The different intensities of the A
and B bands can be seen, b: An example of a printout from the Helena
Process-24 gel scanner showing a GPI1-B proportion of 69.2% and a
GPI1-A proportion of 30.8%.
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using time-lapse confocal microscopy were cultured on the confocal
microscope in Ml6 culture medium in Willcowell glass-bottomed dishes as
described in chapter 3. Chimeras that were aggregated at the 2-cell stage
were cultured in KSOM culture medium for 4 days in a conventional C02
incubator (the culture medium was changed after 2 days). Chimeras were
imaged when the embryos were at the late/ expanded blastocyst stage (E5.5).
Images were captured as described in chapter 2, section 2.3.
6.2.5 Analysis of Chimeric Embryos
Overlays of GFP and transmitted light images were produced using Adobe
Photoshop. Time-lapse movies were produced using Adobe Premier.
Early, late & expanded blastocysts were defined by the size of the blastocyst
cavity in proportion to the rest of the blastocyst. In early blastocysts the
blastocyst cavity compromised <50% of the total area, the cavity was 50-75%
of the total area in late blastocysts and greater than 75% for expanded
blastocysts (Fig 6.2). Abnormal blastocysts or blastocysts with two cavities
were excluded from the analysis.
The % contribution of GFP to chimeric embryos was analysed in selected
images using Image pro plus (Media Cybernetics, MD, USA). The area of
green and non-green were calculated for the ICM without dividing it into
presumptive epiblast and hypoblast regions. The % green and non green in
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Fig 6.2 : Blastocyst stages, a; Early, b; Late and e; Expanded, d; the GFP chimeric blastocysts
were analysed by measuring the % area GFP in the ICM, and length ofGFP in the pTE and mTE.
the pTE and mTE were measured as % lengths using the Image pro plus
measurements software (Fig 6.2).
6.3 Results
6.3.1 GPI1 Control Experiment
Previous work has shown that if GPI1 electrophoresis plates are overstained,
the contribution of the minor band is often overestimated (West and Green,
1983). To determine the accuracy of the staining technique, samples of
known proportions of GPI1-A and GPI1-B were tested. A series of mixtures
were prepared for homogenates of mouse kidneys from a GPI1-A strain and
a GPI1-B strain. These were mixed in known quantities, ranging from 0 to
100% GPI1-A and coded prior to electrophoresis. Samples were separated
using cellulose acetate electrophoresis and scanned to compare the
percentage of GPI1-A and B detected on the gel plate, with the known
percentages of GPI1 in the mixture. Fig 6.3 shows a plot of the expected
percentage of GPI1-A against the percentage of GPI1-A detected. Fig 6.3
shows that the conditions used can estimate the %GPI1-A with sufficient
accuracy for the present purpose.
6.3.2 GPI1 Analysis of E12.5 Chimeras
Two series of E12.5 GFP chimeras were produced and analysed by
quantitative GPI1 electrophoresis to determine whether (BFjxTgTPbB)
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Figure 6.3 Assessment of staining linearity
Fig 6.3:
Relationship between the expected percentage of GPI1-A and the
detected percentage of GPI1-A in the mixtures of GPI1-A and
GPI1-B homogenised kidneys.
embryos were capable of contributing normally to (BALB/c x
A/J)F2<-»(BF1xTgTP6.3) mouse chimeras and to test whether the
BALB/c<->(BF1xTgTP6.3) combination was unbalanced. BALB/c and
(BALB/c x A/J)F2 mice are homozygous for Gpil" and BFj ,(C57BL x CBA^,
mice and TgTP6.3 mice are homozygous for Gpilb.
The percentages of GPI1-A in the fetus, amnion, yolk sac mesoderm, yolk sac
endoderm and placenta of 24 (BALB/c x A/J)F2e->(BF1xTgTP6.3) chimeras
are shown in Table 6.1. 4 of these were non chimeric. With the exception of
the yolk sac endoderm the mean %GPI1-A for each tissue sample was close
to 50%, indicating that this is a balanced strain combination.
The percentages of GPI1-A in the five tissue types tested of
BALB/c<-»(BF1xTgTP6.3) E12.5 chimeras are shown in Table 6.2. Out of the 29
chimeras analysed 8 were non-chimeric. The mean %GPI1-A for all the five
tissue types are lower in this series of chimeras than in the (BALB/c x A/J)F2
<-^(BFjxTgTP6.3) chimeras. These differences are significant for the fetus and
yolk sac mesoderm (P<0.05 by Mann-Whitney U test). This is shown in
Figure 6.4, which compares the mean %GPI1-A between both series of
chimeras analysed. These results indicate that BALB/c<->(BF!xTgTP6.3) is an
unbalanced strain combination so the distribution of BALB/c cells was
investigated at the blastocyst stage (below).
169
Table 6.1: GPI1 analysis of E12.5
(BALB/c x AJ)F2<->(BFlxTgTP6.3) chimeras
Chimera ref % GPI-1 A
Fetus Amnion Yolk sac Mes Yolk sac End Placenta
non-chimeric
GMA 12 0.0 0.0 0.0 0.0 0.0
GMA 21 0.0 0.0 0.0 0.0 0.0
GMA 1 100.0 no sample 100.0 no sample 100.0
GMA 15 100.0 100.0 100.0 100.0 100.0
chimeric Fetus Amnion Yolk sac Mes Yolk sac End Placenta
GMA 7 * 0.0 14.7 5.5 0.0 0.0
GMA 19 15.6 5.9 0.0 0.0 0.0
GMA 16 20.5 19.0 19.4 5.8 0.0
GMA 6 24.6 8.3 22.1 22.5 8.9
GMA 5 24.7 25.5 14.2 27.5 70.9
GMA 18 25.0 24.0 34.0 53.4 80.8
GMA 24 32.9 8.9 0.0 28.4 76.0
GMA 13 42.7 8.6 38.0 21.6 30.3
GMA 17 43.6 56.0 62.9 17.3 91.7
GMA 2 44.5 41.3 41.0 46.5 42.5
GMA 20 62.4 50.5 74.6 66.0 100.0
GMA 4 62.8 50.8 48.5 14.6 97.5
GMA 22 63.5 100.0 65.4 40.2 100.0
GMA 9 63.9 63.6 68.7 14.4 0.0
GMA 11 65.0 66.4 75.9 86.4 66.9
GMA 10 67.7 27.6 40.1 31.3 92.4
GMA 8 75.5 75.4 100.0 80.4 100.0
GMA 14 * 100.0 100.0 100.0 44.2 100.0
GMA 23 * 100.0 100.0 100.0 47.5 100.0
GMA 3 * 100.0 100.0 100.0 70.0 100.0
Mean 51.75 47.33 50.52 35.90 62.90
SE 6.53 7.63 7.71 5.74 9.17
N 20 20 20 20 20
SD 29.20 34.14 34.47 25.67 41.01
Table 6.1: % of GPI1-A in the fetus, amnion, yolk sac mesoderm (Yolk
sac Mes), yolk sac endoderm (Yolk sac End) and placenta in a series of
E12.5 (BALB/c x A/J)F2~(BFlxTgTP6.3) chimeras.
* Chimerism was confined to extraembryonic tissues in 4 of the 20
chimeric conceptuses.
Mes = mesoderm, End = endoderm.
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Table 6.2:
GPI1 analysis of E12.5 BALB/c^(BFlxTgTP6.3)
chimeras
Chimera ret % GPI-1 A
Fetus Amnion Yolk sac Mes Yolk sac End Placenta
non-chimeric
GMB 8 0.0 0.0 0.0 0.0 0.0
GMB9 0.0 0.0 0.0 0.0
GMB 14 0.0 0.0 0.0 0.0 0.0
GMB 17 0.0 0.0 0.0 0.0 0.0
GMB 18 0.0 0.0 0.0 0.0 0.0
GMB 20 0.0 0.0 0.0 0.0 0.0
GMB 29 0.0 0.0 0.0 0.0 0.0
GMB 21 100.0 100.0 no sample no sample 100.0
chimeric Fetus Amnion Yolk sac Mes Yolk sac End Placenta
GMB 16 * 66.3 54.7 70.6 23.2 77.3
GMB 3 + 0.0 0.0 0.0 10.4 0.0
GMB 11 + 0.0 0.0 0.0 14.7 0.0
GMB 4 + 0.0 0.0 0.0 15.7 0.0
GMB 12 + 0.0 0.0 0.0 24.4 0.0
GMB 25 14.1 12.6 12.4 21.6 0.0
GMB 22 20.1 11.8 no sample 12.4 34.3
GMB 5 21.0 no sample 8.5 5.6 33.8
GMB 19 24.8 27.2 33.2 58.1 34.1
GMB 28 25.1 30.5 31.2 21.7 62.4
GMB 24 26.1 25.3 32.9 25.4 73.5
GMB 15 29.9 14.9 32.6 62.2 47.0
GMB 27 30.0 20.8 27.2 34.5 100.0
GMB 6 31.7 8.0 17.1 4.4 0.0
GMB 1 33.0 16.1 21.0 37.7 38.6
GMB 13 33.5 22.7 35.5 42.5 0.0
GMB 23 41.4 49.1 48.4 16.3 77.4
GMB 10 53.3 31.0 32.5 0.0 100.0
GMB 26 55.9 66.1 62.6 45.6 82.1
GMB 2 + 100.0 100.0 86.6 15.9 0.0
GMB 7 + 100.0 100.0 100.0 49.1 100.0
Mean 32.00 28.22 30.62 25.91 39.16
SE 6.32 6.99 6.44 4.04 8.67
N 20 1 9 1 9 20 20
Table 6.2:
% of GPI1-A in the fetus, amnion, yolk sac mesoderm (Yolk sac Mes), yolk sac endoderm
(Yolk sac End), and placenta in a series of E12.5 BALB/o->(BFlxTgTP63) chimeras.
* not included as it was dead
+Chimerism was confined to the extraembryonic tissue in 6 of the 20 chimeras
Mes = mesoderm, End = endoderm.
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Fig. 6.4:
Mean % GPI1-A in (BALB/cxA/J)<-^(BF1xTgTP6.3) and












Fetus Amnion YS mes YS end placenta
Tissue
Fig. 6.4 : Mean % (+SE) of GPI1-A in the fetus, amnion, YS mesoderm, YS
endoderm and placenta of (BALB/c x A/J)<-^(BF1 x TgTP6.3) and
BALB/c<-^(BF1xTgTP6.3) chimeras
* P<0.05 (Mann-Whitney U test)
YS = Visceral yolk sac
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The proportion of chimeric conceptuses whose chimerism was confined to
the extraembryonic tissues was not significantly greater in the unbalanced
series (14/20 versus 16/20; %2= 0.13, P>0.05).
6.3.3 Time-Lapse Analysis of Tau-GFP Chimeras
Preimplantation chimeric embryos were imaged from the morula to the
blastocyst stage to determine if BALB/c cells are preferentially allocated to
the mTE during blastocyst development. As all chimeras do not develop at
the same rate and this occurs over a period of approximately 24 hours, it was
decided to use time-lapse confocal microscopy to image the embryos during
constant time intervals. This allowed analysis of blastocysts at similar stages
of development.
The % contribution of GFP embryos to (BALB/c x A/J)F2<-^(BF1xTgTP6.3)
and BALB/c<-^(BF1xTgTP6.3) chimeras was calculated to determine if
BALB/c cells are preferentially allocated to the mTE. The analysis estimated
the % area of GFP positive cells so a high contribution of BALB/c cells in the
mTE would be seen as a low contribution of GFP cells in the mTE.
An initial time-lapse study using the lOx lens of the confocal microscope was
carried out on 10 control (BALB/c x A/J)F2<-^(BF1xTgTP6.3) chimeras and 9
BALB/ce->(BF1xTgTP6.3) chimeric embryos aggregated at the 8-cell stage (Fig
6.5, 6.6 & 6.7a & b). The % contribution of the GFP embryos to the ICM, pTE
and mTE of chimeric blastocysts was estimated from a single optical section
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Fig 6.5: xlO Time-lapse Images of Control
(BALB/c xA/J)F2<-»(BF1 xTgTP6.3) Chimeras
Fig 6.5 : Single section overlay images of control (BALB/cxA/J)F2<-KBF1xTgTP6.3) chimeras
imaged using the xlO lens of the confocal microscope. Embryos were aggregated at the 8-cell
stage, and cultured for 24hrs in a normal incubator prior to the start of the time-lapse. Not all
embryos are in focus as only the mid section for the whole group is shown (the ICMs of three
blastocysts are not in focus in the last image). The images show a high proportion ofGFP in the
ICM region of the blastocysts which remains the case at the expanded blastocyst stage. The time
elapsed from the start of the time-lapse is shown. Scale bar=50p
Fig 6.6:
Time-lapse Microscopy of BALB/c<-»(BFjxTgTP6.3)







Fig 6.6 : Single section overlay images of BALB/c<-»(BFjxTgTP6.3) chimeras imaged using the
xl 0 lens of the confocal microscope. The time elapsed from the start of the time-lapse is shown.
Not all embryos are in focus as only one optical section is shown for the whole group. These
images show that the BALB/c (non GFP) cells are not consistently preferentially allocated to the
mural trophectoderm. Scale bar =50p
18hrs 20mins
Fig. 6.7: Mean % contribution of GFP to control
(BALB/c xA/J)F2<->(BF1xTgTP6,3) chimeras and to
experimental BALB/c <->(BF1xTgTP6.3) chimeras
■■ Inner cell mass
Polar Trophectoderm
Mi Mural Trophectoderm
Early blstocyst Late blastocyst Expanded blastocyst Early blstocyst Late blastocyst Expanded blastocyst
Fig.6.7:
% contribution of GFP embryos to the ICM, pTE and mTE at the early, late and
expanded blastocyst stage, of a: 10 control (BALB/c x A/J)F2^(BF1 x TgTP6.3)
chimeras imaged using the lOx lens, b: 9 experimental BALB/c<->(BF1 x
TgTP6.3) chimeras imaged using the lOx lens, c: 13 control (BALB/c x
A/J)F2<->(BF1 x TgTP6.3) chimeras imaged using the 20 x lens, d: 11
experimental BALB/c<-^(BF1 x TgTP6.3) chimeras imaged using the 20x lens
*P< 0.05, **P< 0.01
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(the mid section of the blastocyst where the ICM can be clearly seen) at 3
developmental stages, the early, late and expanded blastocyst (Fig 6.2).
Figure 6.7a shows the mean % contribution of GFP positive cells in 10 control
(BALB/c x A/J)F2<-^(BF1xTgTP6.3) blastocysts. The histogram shows there
was a significantly lower overall contribution of GFP cells to the mTE in this
chimera combination at all 3 developmental time points (pTE v mTE P<0.01
at all 3 stages, ICM v mTE at the early & late stage P<0.01, ICM v mTE at the
expanded stage P<0.05 by Mann-Whitney U-test). This shows there is a high
contribution of (BALB/c x A/J)F1 cells in the mTE. There was no significant
difference in composition of the ICM and pTE (ICM v pTE P>0.05 by Mann-
Whitney U-test). Fig 6.5 also shows that there is a high proportion of non
GFP cells within the mTE region of the majority of the chimeras at the early,
late and expanded blastocyst stages.
Fig 6.7b shows there was no significant difference in the contribution of GFP
cells between the 3 regions of the blastocyst in the experimental series of
BALB/c<-^(BF1xTgTP6.3) chimeras at all 3 developmental time points (P>0.05
by Kruskal Wallis test). Therefore, despite the control data indicating that the
GFP cells do not contribute well to the mTE there is an equal contribution of
GFP cells and BALB/c cells to the mTE of the experimental series. Fig 6.7b
and the images shown in Fig 6.6 suggests that there is no preferential
allocation of the BALB/c cells to the mTE of the 9 blastocysts analysed (i.e
the % GFP contribution is not low in the mTE). Also comparison of Figs 6.7a
and 6.7b raises the possibility that BALB/c cells are less likely to be allocated
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to mTE than (BALB/c x A/J)F2 cells. This is the opposite of the hypothesis
being tested.
Further time-lapse studies of a second control series of
(BALB/cxA/J)F2<H>(BF1xTgTP6.3) chimeras and a second experimental series
of BALB/c<->(BF1xTgTP6.3) chimeras aggregated at the 8-cell stage were
carried out at a higher magnification using a x20 objective (Fig 6.7 c,d, 6.8 &
6.9). This was because it was easier to analyse the images captured using the
x20 lens. As discussed in chapter 3, it may be optimal for embryo growth to
image the embryos with a xlO lens. However, over a 24 hr time-lapse the
blastocysts imaged using the x20 lens expanded to the late blastocyst stage,
so were suitable for analysis. The % contribution of the GFP embryos to the
ICM, pTE and mTE of chimeric blastocysts was calculated from an average of
three optical sections at 3 developmental time points, the early, late and
expanded blastocyst.
Fig 6.7c shows the average contributions of GFP positive cells in 13 control
(BALB/c x A/J)F2o(BF1xTgTP6.3) blastocysts. The results from this second
series, the chimeras shown in Fig 6.8, showed that there was no significant
difference between the average percentage contribution of GFP cells in the
mTE, pTE and ICM at all 3 developmental stages (P>0.05 by Kruskal Wallis
test). Fig 6.7d and 6.9 shows the average percentage contribution of GFP cells
to the mTE of the experimental series of BALB/c<->(BFjxTgTP6.3) chimeras
was significantly higher than the contribution to the pTE and ICM (ICM v
mTE at early & late stage P<0.01, P<0.05 at expanded stage, pTE v mTE at
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Fig 6.8: x20 Time-lapse Images of Control
(BALB/cxA/J)<-»(BF1xTgTP6.3) Chimeras
Fig 6.8: Single section overlay images of control (BALB/cxA/J)<-»(BFjxTgTP6.3) chimeras
imaged using the x20 lens of the confocal microscope. Not all embryos are in focus as only the
mid section for the whole group is shown. The time elapsed from the start of the time-lapse is
shown. Scale bar=50p
Fig 6.9: x20 Time-lapse Images of
BALB/c<-»(BF1xTgTP6.3) Chimeras
Fig 6.9 : Single section overlay images ofBALB/c<->(BF,xTgTP6.3) chimeras imaged using the
x20 lens of the confocal microscope. Not all embryos are in focus as only the mid section is
shown for each group. The images show that there is a high %GFP contribution to the mTE of the
chimeric blastocysts. Scale bar=50p
early stage PcO.05, at late & expanded stage P<0.01 by Mann-Whitney li¬
test). This shows that there is a lower contribution of BALB/c cells to the
mTE in this series of blastocysts. There is also a significantly higher % of GFP
cells in the pTE compared to the ICM at the early blastocyst stage in this
series of BALB/c<-^(BF1xTgTP6.3) chimeras (P<0.05 by Mann-Whitney IJ-
test). Again, there was no evidence to support the hypothesis that BALB/c
cells (non-GFP cells) were preferentially allocated to the mTE.
The percentage of GFP in the ICM, pTE and mTE was compared between the
different control and experimental groups (Table 6.3). This data shows that
there was no consistant significant differences between any tissues, at all
blastocyst stages, between any two experiments. The differences between the
pTE and ICM, the mTE and ICM, and the mTE and pTE were also compared
among the same combination of control and experimental groups (Table 6.3).
The difference between the pTE and ICM (pTE-ICM) did not differ
significantly between groups. There were some significant differences
between the composition of the mTE and either the pTE or ICM at some
stages of blastocyst development. However, there were as many significant
differences found when comparing both control groups or both experimental
groups, as there were when comparing experimental and control chimeras.
Although the results from the two series of time-lapse experiments produced
different results, neither provided any support for the hypothesis that
BALB/c cells are preferentially allocated to the mTE of
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comparisons, BALB/c cells tended to make a poorer contribution to the mTE
than the (BALB/c x A/J)F2 cells did in the control chimeras.
Fig 6.7 also shows that the % of GFP cells in each region of the blastocyst
does not differ significantly during the development of the blastocyst, in all
four chimera series (P>0.05 by Kruskal Wallis test). This shows that BALB/c
cells are not significantly depleted in the ICM, pTE and mTE during the
development of BALB/ce-^BFjxTgTPb.S) chimeric blastocysts from the early
to expanded blastocyst stage.
6.3.4 Confocal Microscopy of BALB/c^BF^TgTPG.S) Chimeras
Aggregated at the 2-Cell Stage
It is possible that by aggregating these embryos at the 8-cell stage there is
little time to affect the randomness of cell allocation. Therefore a further
series of both control and experimental chimeras were aggregated at the 2-
cell stage and single optical sections, imaged at the late blastocyst stage using
confocal microscopy, were analysed (Fig 6.10).
Fig 6.11a shows the percentage contribution of GFP embryos to 8 control
(BAFB/c x A/J)F2o(BF1xTgTP6.3) blastocysts. There is no significant
difference between the percentage contribution of GFP cells to the three
regions of the blastocyst (P>0.05 by Kruskal Wallis test). Fig 6.11b shows the
percentage contribution of GFP embryos to 8 experimental
BALB/ce->(BF1xTgTP6.3) chimera series. There is no significant difference




Chimeras, Aggregated at the 2-cell Stage
Fig 6.10: Overlay images of chimeras aggreagated at the 2-cell stage, cultured for 4 days and
imaged at the late blastocyst stage, a&b; BALB/c<->(BF, xTgTP6.3) chimeras, c&d;
(BALB/cxA/J)F2<-HBF,xTgTP6.3) chimeras.
Scale bar=50|i
Fig. 6.11: Mean % contribution of GFP to
(BALB/c x A/J) F2 ^(BF! x TgTP6.3) chimeras and to
BALB/c<->(BF1 x TgTP6.3) chimeras aggregated at the
2-cell stage
Region of the blastocyst
Fig. 6.11:
% contribution of GFP embryos to the ICM, pTE and mTE of chimeras
produced by aggregating two 2-cell stage embryos,
a: 8 (BALB/c x A/J)F2<->(BF1 x TgTP6.3) chimeras imaged at the expanded
blastocyst stage, b: 8 BALB/c <->(BF1 x TgTP6.3) chimeras imaged at the
expanded blastocyst stage.
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compared to the contribution to the ICM and pTE (P>0.05 by Kruskal Wallis
test). There is no tendency for BALB/c cells to colonise the trophectoderm
rather than the ICM. If anything there was a higher proportion of BALB/c
cells (lower % GFP) in the ICM than the trophectoderm. Therefore, like the
other results presented in this chapter, this shows that the BALB/c cells are
not preferentially allocated to the mTE even when the embryos are
aggregated at an earlier stage.
6.4 Conclusion
Preliminary studies of E12.5 chimeras showed that BALB/c strain embryos
contributed poorly to BALB/c<->(BF1xTgTP6.3) chimeras but the control
series of (BALB/cxA/J)F2e^(BF1xTgTP6.3) chimeras was more balanced in
composition. Three series of experimental BALB/c<->(BF1xTgTP6.3) chimeras
(Two 8-celle->8-cell and one 2-celle^2-cell) showed BALB/c cells were
consistently allocated to the mTE but were not preferentially allocated to the
mTE. This implies that some other mechanism is responsible for the
depletion of BALB/c cells in the epiblast, hypoblast and pTE derivatives of
BALB/c<->(BF1xTgTP6.3) chimeras. This is likely to be some form of
generalised cell selection against BALB/c cells.
BALB/c<->(BF1xTgTP6.3) chimeras were aggregated at the 2-cell stage, as it
was possible that late stage aggregation prevented BALB/c cells from being
preferentially allocated to the mTE. As discussed in chapter 1, (section 1.1.3)
previous studies have shown that the advanced blastomeres in an embryo
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tend to contribute disproportionately more descendants to the inner cells of
the morula or the ICM of the blastocyst (Kelly et al., 1978; Graham and
Lehtonen, 1979; Piotrowska et al., 2001). However, previous analysis of
aggregation chimeras to determine if the more advanced embryo contributes
more readily to the ICM has revealed conflicting results (chapter 1, section
1.5.1.2). As noted earlier, BALB/c strain embryos tend to develop relatively
slowly. Nevertheless, the data presented in this chapter showed that early
aggregation of BALB/c<->(BF1xTgTP6.3) chimeras did not affect the
allocation of BALB/c cells to the different regions of the blastocyst.
Another study has examined the composition of groups of whole
BALB/ce-^(BF1xTGB) and control (BALB/cxA/J)F2<->(BF1xTGB) chimeras at
E4.5 and E6.5 by GPI electrophoresis (Tang, 1999). This revealed that there is
no significant genotypic imbalance in BALB/c^ (BF,xTGB) chimeras at these
embryonic stages. Dvorak et al (1995) also showed that BALB/c cells are not
reduced at the blastocyst stage. The results described in this chapter are in
agreement with this showing that BALB/c cells are not depleted in
BALB/c<->(BF1xTgTP6.3) chimeras by the expanded blastocyst stage. As the
mechanism of preferential allocation of BALB/c cells to the mTE can now be
excluded, this indicates that BALB/c cells are reduced in BALB/c chimeras
after E6.5. Preferential death of BALB/c cells in the blastocyst is unlikely.
However, this could be confirmed by analysing apoptosis in BALB/c
chimeric embryos.
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The most likely mechanism responsible for the depletion of BALB/c cells in
aggregation chimeras would appear to be due to a difference between the
developmental rates of the aggregated embryos. The pre-implantation
embryo development (Ped) gene has already been identified as having a role
in the rate of development of preimplantation embryos (Warner et al., 1998).
Although the BALB/c embryos analysed in this chapter have a fast allele of
the Ped gene, previous data has indicated that BALB/c embryos have a slow
rate of development (West, unpublished data). Therefore, different growth
rates could result in fewer BALB/c cells present within BALB/c chimeras.
Varying developmental rates of different strain embryos have been
previously detected. Differences between the time of cleavage starting has
been found in certain strain embryos (McLaren and Bowman, 1973; Niwa et
al., 1980). McLaren et al, have shown that the cleavage rates are the same,
however the difference in the initiation of cleavage is sufficient to
significantly delay the embryo development. Although both embryos were
aggregated at either the 8-cell stage or the 2-cell stage it is possible that the
BALB/c cells do not cleave as quickly as the other cells. This lag in
development could be sufficient to reduce the numbers of BALB/c cells
contributing to the chimera. This mechanism has been suggested for another
unbalanced strain combination (Mystkowska et al., 1979). However, evidence
against this would be the fact that there is not a gradual decline in the
proportion of BALB/c cells during blastocyst development but appears to be
a decrease following implantation. (Tang, 1999), found no difference at E6.5
however, Dvorak et al, 1995 showed a difference at E7.5 and Tang
188
(unpublished) at E8.5. Further studies to test this hypothesis could include
investigations of cell proliferation in these chimeras.
The results presented in this chapter show 4 individual BALB/c chimeras in
the E12.5 series are only chimeric in the yolk sac endoderm and do not
contain BALB/c cells in any of the other tissues. This is in agreement with
previous data, which has shown chimerism is sometimes confined to either
the placenta or yolk sac endoderm. However, unlike the 4n<->2n model the
unbalanced BALB/c chimera does not consistently show confined
chimerism.
It seems likely that the poor contribution of BALB/c cells to the epiblast and
other lineages is a result of generalised cell selection rather than non random
allocation of BALB/c cells to different developmental lineages. If so this
indicates that CPM may occasionally result from generalised selection which




7.1 Confocal Microscopy to image Mouse Chimeras
Two different methods of analysing mouse aggregation chimeras by confocal
microscopy were used in this study, time-lapse microscopy and single time
point microscopy of chimeras. This study has shown that both techniques are
useful and have their advantages and disadvantages.
The time-lapse confocal microscopy technique provided an effective method
for imaging preimplantation embryos over a period of approximately 24hrs.
This was a particularly useful approach for investigating the timing of GFP
expression and further experiments could be performed to better define
when embryo encoded GFP is first detectable. It also provided the most
effective way of analysing several chimeric blastocysts at equivalent
developmental stages. However, the culture system on the confocal
microscope was more prone to failure than culture in a normal C02
incubator.
As discussed previously in chapter 3 exposure to high intensity laser power
affects the viability of mouse embryos (Squirrell et al., 1999). This technique
was compatible with normal development using a lOx and 20x lens however
it would probably not be suitable to image embryos with a higher objective
lens, for example a 40x lens. It may also be more advantageous to image
embryos at fewer time points to reduce the exposure to the confocal laser.
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Another disadvantage of the time-lapse technique is that fewer optical
sections are acquired at each time point, therefore not all embryos in a group
will be in the best plane of focus for analysis. If more optical sections are
required for image analysis, for example for 3D reconstructions and volume
analysis it would probably be more suitable to image embryos at a single
time point and culture them in a standard incubator.
As discussed previously it would have been useful for the analysis of the
chimeras to label the partner embryo in the chimera. Of the exogenous
markers analysed PKH-26 could be a suitable marker. However, this was not
available for the BALB/c experiments which were carried out prior to the
4n<->2n experiments. PKH-26 was not used for the 4n+-»2n study as it could
have affected the allocation of cells in a chimera, as it is a membrane dye. It
was also decided to analyse all the chimeras in a consistent manner. If red
fluorescent protein (RFP) (produced by Living Colors, Clontech Inc, Palo
Alto, USA) transgenic mice had been available for this study they could have
been used in conjunction with the tau-GFP embryos (Nakamura et al., 2002;
Lu et al., 2003). As time-lapse microscopy was not used for the analysis of the
4n<->2n chimeras or the BALB/c chimeras aggregated at the 2-cell stage it
may have been useful to have fixed them and stained them with a nuclear
marker for example propidium iodide. However, after attempts to fix
blastocysts the cavity collapsed. Therefore, it was decided not to use this
technique as it was necessary to distinguish the different areas of the
blastocyst for analysis.
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7.2 Studies of 4n^2n Chimeras
This study investigated 4n<-»2n chimeras specifically as a mouse model of
CPM. This demonstrated that there are several mechanisms responsible for
the exclusion of 4n cells from the epiblast derivatives. The results in chapter 5
demonstrate it is likely that the blastocyst cavity forms within the 4n half of
the chimera, resulting in a larger proportion of 4n cells being allocated to the
trophectoderm. This could be due to an increase in the activity of the sodium
pump in the 4n cells.
Tang et al. (2000) previously demonstrated that larger 2n blastomeres make a
greater contribution to the TE of 2n<->2n chimeras. This is probably due to
mechanical reasons, as smaller cells are likely to be positioned in the centre
of the chimeric morula. Larger cells would be pushed to the outside region,
which forms the TE. Therefore, the size of the 4n cells analysed in this study
could also be responsible for the preferential allocation to the TE, as the 4n
cells analysed in this study are larger than the 2n cells. However, Tang et al.
(2000) also demonstrated that 4n cells which did not differ in cell size from
the cells of the partner 2n cells, also made a significantly greater contribution
to the mTE. Thus cell size is probably not solely responsible for the
preferential allocation of cells to the TE.
It is possible that similar mechanisms are involved in the removal of 4n cells
from the epiblast, and the reduction of BALB/c cells from all lineages of the
blastocyst. As noted earlier, BALB/c strain embryos tend to develop
relatively slowly, and it is possible that this is also true of 4n cells. Therefore,
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slower proliferation rates of one type of cell in a chimeric embryo could
significantly reduce these cells within the chimera. The proliferation rates of
4n embryos could be analysed following cavitation, along with nuclear
morphology to assess apoptosis. Apoptosis could also play a role in the
removal of cells from a specific lineage.
It is therefore possible that some of these mechanisms resulting in the
depletion or loss of cells within specific regions of mouse chimeras could also
be responsible for the exclusion of chromosomally abnormal cells from
human epiblast lineage derivatives resulting in CPM.
There are also other uses of 4n chimeras that are relevant to developmental
biology. Studies have made use of the fact that 4n cells do not tend to
contribute to the derivatives of the epiblast at mid-gestation, but do
contribute to the hypoblast and trophectoderm lineages. Therefore, the
aggregation or injection of 4n cells with 2n cells or blastocysts has been used
to investigate if mutants, with severe defects in the developing embryo at
gastrulation, have primary defects in these extraembryonic lineages rather
than the epiblast (Rossant and Spence, 1998). Using this technique
researchers have shown that signalling events within the derivatives of the
trophectoderm and hypoblast are responsible for the development of the
embryo.
Mash-2, a mammalian member of the achaete-scute family, encodes a
transcription factor. This gene is strongly expressed in the ectoplacental cone,
the chorion and their derivatives in the placenta. The mutants of Mash-2 die
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at 10 days p.c and fail to form a placenta (Guillemot et al., 1994). By
aggregating wild-type 4n embryos to Mash-2 mutant embryos Guillemot et al
(1994) produced viable and developmentally normal adult mice. This shows
that Mash-2 is essential for the development of the mammalian trophoblast
lineage but does not have a role in the development of the embryo itself.
The mutants of HNF4, a transcription factor, and SMAD4, a signal
transduction molecule, do not reach gastrulation and therefore fail to form
mesoderm structures. However, they can be "rescued" by a wild-type 4n
placenta and yolk sac endoderm (Duncan et al., 1997; Sirard et al., 1998). This
shows that these genes are acting in a non-cell autonomous manner as they
have a direct effect on the fetus itself. Alternatively, the injection of wild type
ES cells into mutant 4n blastocysts for the type I activin receptor ACTR1B or
the signalling molecule SMAD2 fails to produce embryos (Gu et al., 1998;
Waldrip et al., 1998). More recently the retinoblastoma (Rb) tumour supressor
gene has been demonstrated as having a key function in the placenta that is
responsible for embryonic development and viability (Wu et al., 2003). By
aggregating wild-type 4n cells with mutant 2n cells Wu et al, (2003),
demonstrated that a wild-type placenta could carry a mutant fetus to term.
Although it is not known if this is the case, it has sometimes been previously
assumed that 4n cells are excluded from the epiblast of 4n<-> ES cell
aggregation chimeras (Fig 1, (Rossant and Spence, 1998)). The findings of this
study, that 4n cells are present in the epiblast of 4n<-»2n chimeras, indicate
that 4n cells could also be present in the epiblast of 4n^ES cell aggregation
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chimeras. The same techniques used in the 4n<->2n chimera study could be
used to analyse 4n<->ES cell chimeras to determine if this is the case.
7.3 Future Experiments
The BALB/c study showed that BALB/c cells were not preferentially
allocated to the mTE. Other unpublished work (P.C. Tang) indicate that
BALB/c cells are significantly depleted by E8.5 (see section 6.4). Therefore,
BALB/c cells could be depleted from mid-gestation chimeras by a slower
rate of proliferation compared to the cells from the partner embryo.
Alternatively there could be specific cell death of BALB/c cells. BrdU or
TUNEL staining could be used to investigate these possibilities. The same
techniques could also be applied to investigate the mechanisms of cell
selection against 4n cells remaining in the epiblast of 4n<-»2n chimeras.
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Appendix A:
M16 Embryo Culture Media
Stock solutions for handling and culture medium:
Stock A (lOx) (100ml)
Stock B (lOx) (100ml)
Stock C (lOOx) (100ml)
Stock D (lOOx) (100ml)





0.23M Na Lactate (60% solution)
5.5mM Glucose






0.25M HEPES (Ultrapure Calibiochem)
O.Olg phenol red
Stock E was adjusted to pH 7.4 with 5M NaOH before making up to 100ml
lOOmls of stocks A, B and E and 10ml of C and D were made using sterile cell
culture grade H20 (BDH). All Stocks were sterilised using a (0.22mm) millipore
filter and stored at 4°C Stocks A,D & E were renewed every 3 months and stocks B
and C every two weeks.
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H2O (sterile culture grade BDH) 7.8ml
BSA 40mg
Solutions were sterilised using a millipore filter (0.22mm) before use.





H2O (sterile culture grade BDH) 7.8ml
BSA 40mg
Solutions were sterilised using a millipore filter (0.22mm) before use.
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Appendix B:
KSOM Embryo Culture Media:
Stock Solutions:
Stock A (lOx) (100ml)





lOmM Na lactate (60%)
0.20mM Glucose
0.01 EDTA




Stock C (lOOx) (10ml)
Stock D (lOOx) (10ml)
Stock E (lOOx) (10ml)





Stock F was adjusted to pH 7.2 with 5M NaOH (use 30mls NaOH plus 40mls of
water in first instance) before making up to 100ml
All stocks were filter sterilised using a millipore filter (0.22mm) and stored at 4°C.
Stocks A,D,E & F were kept for 3 months then discarded. Stocks B and C were
replaced every second week
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H2O (sterile culture grade BDH) 7.5ml
BSA lOmg
Solutions were sterilised using a millipore filter (0.22mm) before use.






H2O (sterile culture grade BDH) 7.7ml
BSA lOmg












Adjusted to pH 2.5 with 5M HC1. Filter sterilised using a millipore filter
(0.22mm) and stored at 4°C
200
Bibliography:
Alonso, L., Melaragno, I., Bortolai, A., Takeno, S., and Brunoni, D. (2002).
Tetraploid/diploid mosaicism: case report and review of the literature. Annales
de Genetique 45, 177-180.
Angell, R. R., Sumner, A. T., West, J. D., Thatcher, S. S., Glasier, A. F., and Baird,
D. T. (1987). Post-fertilization polyploidy in human preimplantation embryos
fertilized in vitro. Human Reproduction 2, 721-727.
Bachvarova, R., and DeLeon, V. (1980). Polyadenylated RNA of mouse ova and
loss of maternal RNA in early development. Developmental Biology 74,1-8.
Barlogie, B. (1984). Abnormal Cellular DNA Content As a Marker of Neoplasia.
European Journal ofCancer & Clinical Oncology 20, 1123-1125.
Barlow, P. W., and Sherman, M. I. (1972). The biochemistry of differentiation of
mouse trophoblast: studies on polyploidy. J. Embryol. Exp. Morphol. 27, 447-465.
Benkhalifa, M., Janny, L., Vye, P., Malet, P., Boucher, D., and Menezo, Y. (1993).
Assessment of polyploidy in human morulae and blastocysts using co-culture
and fluorescent in-situ hybridization. Human Reproduction 8, 895-902.
Benn, P. (1998). Trisomy 16 and trisomy 16 mosaicism: A review. American
Journal ofMedical Genetics 79, 121-133.
Bower, J. (1987). Chromosome organisation in polyploid mouse trophoblast
nuclei. Chromosoma 95, 76-80.
Brenner, C. A., Adler, R. R., Rappolee, D. A., Pedersen, R. A., and Werb, Z.
(1989). Genes for extracellular matrix-degrading metalloproteinases and their
inhibitor, TIMP, are expressed during early mammalian development. Genes
Devel. 3, 848-859.
Brodsky, V. Y., and Uryvaeva, I. V. (1985). "Genome Multiplication in Growth
and Development. Biology of Polyploid and Polytene Cells." Cambridge
University Press, Cambridge.
Brodsky, W. Y., and Uryvaeva, I. V. (1977). Cell polyploidy: its relation to tissue
growth and function, hit Rev Cytol 50, 275-332.
Carroll, S. G., Davies, T., Kyle, P. M., Abdel-Fattah, S., and Soothill, P. W. (1999).
Fetal karyotyping by chorionic villus sampling after the first trimester. Br. J.
Obstet. Gynaecol. 106, 1035-1040.
201
Carson, D. D., Tang, J. P., and Julian, J. (1993). Heparan-Sulfate Proteoglycan
(Perlecan) Expression By Mouse Embryos During Acquisition of Attachment
Competence. Developmental Biology 155, 97-106.
Chapman, V. M., Ansell, J. D., and McLaren, A. (1972). Trophoblast giant cell
differentiation in the mouse: expression of glucose phosphate isomerase (GPI-1)
electrophoretic variants in transferred and chimeric embryos. Developmental
Biology 29, 48-54.
Chapman, V. M., Whitten, W. R., and Ruddle, F. H. (1971). Expression of
paternal glucose phosphate isomerase-1 (Gpi-1) in preimplantation stages of
mouse embryos. Devi. Biol. 26,153 -158.
Ciemerych, M. A., Mesnard, D., and Zernicka-Goetz, M. (2000). Animal and
vegetal poles of the mouse egg predict the polarity of the embryonic axis, yet are
nonessential for development. Development 127, 3467-3474.
Clegg, K. B., and Piko, L. (1983). Quantitative Aspects of Rna-Synthesis and
Polyadenylation in 1- Cell and 2-Cell Mouse Embryos. Journal ofEmbryology and
Experimental Morphology 74, 169-182.
Clouston, H. J., Fenwick, J., Webb, A. L., Herbert, M., Murdoch, A., and
Wolstenholme, J. (1997). Detection of mosaic and non-mosaic chromosome
abnormalities in 6- to 8-day-old human blastocysts. Human Genetics 101, 30-36.
Cox, D. R., Smith, S. A., Epstein, L. B., and Epstein, C. J. (1984). Mouse trisomy
16 as an animal model for human trisomy 21 (Down syndrome): production of
viable trisomy 16 <-> diploid mouse embryos. Dev. Biol. 101, 416-424.
Culotta, E. (1991). How Many Genes Had to Change to Produce Corn. Science
252, 1792-1793.
Davies, T. J., and Gardner, R. L. (2002). The plane of first cleavage is not related
to the distribution of sperm components in the mouse. Human Reproduction 17,
2368-2379.
Delhanty, J. D. A., Griffin, D. K., Handyside, A. H., Harper, J., Atkinson, G. H.
G., Pieters, M., and Winston, R. M. L. (1993). Detection of Aneuploidy and
Chromosomal Mosaicism in Human Embryos During Preimplantation Sex
Determination By Fluorescent in-Situ Hybridization, (Fish). Human Molecular
Genetics 2, 1183-1185.
Delhanty, J. D. A., and Handyside, A. H. (1995). The Origin Of Genetic-Defects
In the Human and Their Detection In the Preimplantation Embryo. Oxford
Reviews OfReproductive Biology 17, 125-157.
202
Delhanty, J. D. A., Harper, J. C., Ao, A., Handyside, A. H., and Winston, R. M. L.
(1997). Multicolour FISH detects frequent chromosomal mosaicism and chaotic
division in normal preimplantation embryos from fertile patients. Human
Genetics 99, 755-760.
Duncan, S. A., Nagy, A., and Chan, W. (1997). Murine gastrulation requires
HNF-4 regulated gene expression in the visceral endoderm: Tetraploid rescue of
Hnf-4(-/-) embryos. Development 124, 279-287.
Dvorak, P., Yoshiki, A., Dvorakova, D., Flechon, J. E., and Kusakabe, M. (1995).
Cell mixing during the early development of mouse aggregation chimera. Int. J.
Dev. Biol. 39, 645-652.
Dyban, A. P., and Baranov, V. S. (1987). "Cytogenetics of Mammalian
Embryonic Development." Clarendon, Oxford.
Eiben, B., Bartels, I., Bahrporsch, S., Borgmann, S., Gatz, G., Gellert, G., Goebel,
R., Hammans, W., Hentemann, M., Osmers, R., Rauskolb, R., and Hansmann, I.
(1990). Cytogenetic Analysis of 750 Spontaneous-Abortions With the Direct-
Preparation Method of Chorionic Villi and Its Implications For Studying Genetic
Causes of Pregnancy Wastage. American Journal ofHuman Genetics 47, 656-663.
Eisenberg, B., and Wapner, R. J. (2002). Clinical proceduress in prenatal
diagnosis. Best Practice & Research in Clinical Obstetrics & Gynaecology 16, 611-627.
Epstein, C. J. (1985). Mouse monosomies and trisomies as experimental systems
for studying mammalian aneuploidy. Trends Genet. 1,129-134.
Epstein, C. J. (1986). "The Consequences of Chromosome Imbalance."
Cambridge University Press, New York.
Epstein, C. J., Smith, S. A., and Cox, D. R. (1984). Production and properties of
mouse trisomy 15<->diploid chimeras. Dev. Genet. 4, 159-165.
Epstein, C. J., and Travis, B. (1979). Preimplantation lethality of monosomy for
mouse chromosome 19. Nature 280, 144-145.
Everett, C. A., Stark, M. H., West, J. D., Davidson, D., and Baldock, R. A. (2000).
Three-dimensional reconstruction of tetraploid<->diploid chimaeric mouse
blastocysts. J. Anatomy 196, 341-346.
Everett, C. A., and West, J. D. (1996). The influence of ploidy on the distribution
of cells in chimaeric mouse blastocysts. Zygote 4, 59-66.
Everett, C. A., and West, J. D. (1998). Evidence for selection against tetraploid
cells in tetraploid<->diploid mouse chimaeras before the late blastocyst stage.
Genetical Research 72, 225-228.
203
Evsikov, S., and Verlinsky, Y. (1998). Mosaicism in the inner cell mass of human
blastocysts. Human Reproduction 13, 3151-3155.
Flaherty, L., Dibiase, K., Lynes, M. A., Siedman, J. D., Weinberger, O., and
Rinchik, E. M. (1985). Characterisation of a Q subregion gene in the murine
major histocompatability complex. Proc.Natl.Acad.Sci. USA 82, 1503-1507.
Fleming, T. (1987). A quantitative analysis of cell allocation to trophectoderm
and inner cell mass in the mouse blastocyst. Dev. Biol. 119, 520-531.
Fleming, T. P., and Pickering, S. J. (1985). Maturation and Polarization of the
Endocytotic System in Outside Blastomeres During Mouse Preimplantation
Development. Journal of Embryology and Experimental Morphology 89, 175-208.
Fleming, T. P., Warren, P. D., Chrisholm, J. C., and Johnson, M. H. (1984).
Trophectoderm processes regulate the expression of totipotency within the
inner cell mass of the mouse expanding blastocyst. J. Embryol. Exp. Morph. 84, 63-
90.
Friedrich, G., and Soriano, P. (1991). Promoter traps in embryonic stem cells: a
genetic screen to identify and mutate developmental genes in mice. Genes and
Development 5, 1513-1523.
Fundele, R., Jagerbauer, E.-M., Kolbus, U., Winking, H., and Gropp, A. (1985).
Viability of trisomy 12 cells in mouse chimaeras. Roux's Arch Dev Biol 194, 178-
180.
Gardner, L. I. (1982). The Lessons of Polyploidy - Relation to Congenital
Asymmetry and the Russell-Silver Syndrome. American Journal of Diseases of
Children 136, 292-293.
Gardner, R. L. (1996). Can Developmentally Significant Spatial Patterning Of the
Egg Be Discounted In Mammals. Human Reproduction Update 2, 3-27.
Gardner, R. L., and Cockroft, D. L. (1998). Complete dissipation of coherent
clonal growth occurs before gastrulation in mouse epiblast. Development 125,
2397-2402.
Garner, W., and McLaren, A. (1974). Cell distribution in chimaeric mouse
embryos before implantation. J. Embryol. Exp. Morphol. 32, 495-503.
Giebelhaus, D. H., Heikkila, J. J., and Schultz, G. A. (1983). Changes in the
Quantity of Histone and Actin Messenger-Rna During the Development of Pre-
Implantation Mouse Embryos. Developmental Biology 98,148-154.
204
Giebelhaus, D. H., Weitlauf, H. ML, and Schultz, G. A. (1985). Actin Messenger-
Rna Content in Normal and Delayed Implanting Mouse Embryos. Developmental
Biology 107, 407-413.
Golbus, M. S., Bachmann, R., Wiltse, S., and Hall, B. D. (1976). Tetraploidy in a
live-born infant. J. Med. Genet. 13, 329-332.
Goldstein, S. R., Kerenyi, T., Scher, J., and Papp, C. (1996). Correlation between
karyotype and ultrasound findings in patients with failed early pregnancy.
Ultrasound Obstet. Gynecol. 8, 314-317.
Goto, Y., Matsui, J., and Takagi, N. (2002). Developmental potential of mouse
tetraploid cells in diploid <- > tetraploid chimeric embryos. International Journal
ofDevelopmental Biology 46, 741-745.
Graham, C. F., and Deussen, Z. A. (1978). Features of cell lineage in
preimplantation mouse development. J. Embryol. Exp. Morphol. 48, 53-72.
Graham, C. F., and Lehtonen, E. (1979). Formation and consequences of cell-
patterns in preimplantation mouse development. /. Embryol. Exp. Morphol. 49,
277-294.
Gropp, A. (1976). Morphological consequences of trisomy in mammals. In
"Embryogenesis in Mammals. Ciba Symposium 40", pp. 155-175. Elsevier,
Amsterdam.
Gu, Z. Y., Nomura, M., Simpson, B. B., Fei, H., Feijen, A., van den Eijnden-van
Raaij, J., Donahoe, P. K., and Li, E. (1998). The type I activin receptor ActRIB is
required for egg cylinder organization and gastrulation in the mouse. Genes &
Development 12, 844-857.
Guillemot, F., Nagy, A., Auerbach, A., Rossant, J., and Joyner, A. L. (1994).
Essential role of Mash-2 in extraembryonic development. Nature 371, 333-336.
Lu, J. Y., Chen, H. C., Chu, R. Y. Y., Lin, T. C. E., Hsu, P. I., Huang, M. S., Tseng,
C. J., and Hsiao, M. (2003). Establishment of red fluorescent protein-tagged
HeLa tumor metastasis models: Determination of DsRed2 insertion effects and
comparison of metastatic patterns after subcutaneous, intraperitoneal, or
intravenous injection. Clinical & Experimental Metastasis 20, 121-133.
Hadjantonakis, A., Gertenstein, M., Ikawa, M., Okabe, M., and Nagy, A. (1998a).
Non-invasive sexing of preimplantation stage mammalian embryos. Nature
genetics 19, 220-222.
Hadjantonakis, A. K., Gertsenstein, M., Ikawa, M., Okabe, M., and Nagy, A.
(1998b). Generating green fluorescent mice by germline transmission of green
fluorescent ES cells. Mechanisms ofDevelopment 76, 79-90.
205
Hahnemann, J. M., and Vejerslev, L. O. (1997). European collaborative research
on mosaicism in CVS (EUCROMIC) - Fetal and extrafetal cell lineages in 192
gestations with CVS mosaicism involving single autosomal trisomy. American
Journal ofMedical Genetics 70, 179-187.
Harper, J. C., Dawson, K., Delhanty, J. D. A., and Winston, R. M. L. (1995). The
use of fluorescent in-situ hybridization (FISH) for the analysis of in-vitro
fertilization embryos: A diagnostic tool for the infertile couple. Human
Reproduction 10, 3255-3258.
Harper, J. C., and Delhanty, J. D. A. (1996). Detection of chromosomal
abnormalities in human preimplantation embryos using FISH. Journal ofAssisted
Reproduction and Genetics 13, 137-139.
Harrison, R. H., Kuo, H. C., Scriven, P. N., Handyside, A. H., and Ogilvie, C. M.
(2000). Lack of cell cycle checkpoints in human cleavage stage embryos revealed
by a clonal pattern of chromosomal mosaicism analysed by sequential
multicolour FISH. Zygote 8, 217-224.
Hassold, T. J. (1980). A cytogenetic study of repeated spontaneous abortions.
Am. J. Hum. Genet. 44, 151-78.
Henery, C., and Kaufman, M. H. (1991). Cleavage Rates of Diploid and
Tetraploid Mouse Embryos During the Preimplantation Period. Journal of
Experimental Zoology 259, 371-378.
Henery, C. C., Bard, J. B. L., and Kaufman, M. H. (1992). Tetraploidy in Mice,
Embryonic-Cell Number, and the Grain of the Developmental Map.
Developmental Biology 152, 233-241.
Hillman, N., Sherman, M. I., and Graham, C. F. (1972). The effect of spatial
arrangement on cell determination during mouse development. J. Embryol. Exp.
Morphol. 28, 263-278.
Hogan, B., Beddington, R., Costantini, F., and Lacy, E. (1994). "Manipulating the
mouse embryo. A laboratory manual." Cold spring Harbor Laboratory Press,
Hunter, S. M., and Evans, M. (1999). Non-surgical method for the induction of
delayed implantation and recovery of viable blastocysts in rats and mice by the
use of tamoxifen and Depo-Provera. Molecular Reproduction and Development 52,
29-32.
James, R. M., Klerkx, A., Keighren, M., Flockhart, J. H., and West, J. D. (1995).
Restricted distribution of tetraploid cells in mouse tetraploide-^diploid
chimaeras. Developmental Biology 167, 213-226.
206
Jenkins, T. M., and Wapner, R. J. (1999). First trimester prenatal diagnosis:
Chorionic villus sampling. Seminars in Perinatology 23, 403-413.
Johnson, M. H., and Ziomek, C. A. (1981a). The Foundation of 2 Distinct Cell
Lineages Within the Mouse Morula. Cell 24, 71-80.
Johnson, M. H., and Ziomek, C. A. (1981b). Induction of Polarity in Mouse 8-Cell
Blastomeres - Specificity, Geometry, and Stability. Journal of Cell Biology 91, SOS-
SOS.
Johnson, M. H., and Ziomek, C. A. (1983). Cell-Interactions Influence the Fate of
Mouse Blastomeres Undergoing the Transition From the 16-Cell to the 32-Cell
Stage. Developmental Biology 95, 211-218.
Johnson, P., Duncan, K., Blunt, S., Bell, G., Ali, Z., Cox, P., and Moore, G. E.
(2000). Apparent confined placental mosaicism of trisomy 16 and multiple fetal
anomalies: case report. Prenatal Diagnosis 20, 417-421.
Kalousek, D., Barrett, I. J., and McGillivray, B. C. (1989). Placental mosaicism
and intrauterine survival of trisomies 13 and 18. Am. J. Hum. Genet. 44, 338-343.
Kalousek, D. K. (1994). Current Topic: Confined placental mosaicism and
intrauterine fetal development. Placenta 15, 219-230.
Kalousek, D. K., and Dill, F. ]. (1983). Chromosome mosaicism confined to the
placenta in human conceptions. Science 221, 665-667.
Kalousek, D. K., and Vekemans, M. (1996). Confined placental mosaicism.
Journal ofMedical Genetics 33, 529-533.
Kaufman, M. H. (1992). "The Atlas of Mouse Development." Academic Press,
London.
Kawarsky, S. J., Basrur, P. K., Stubbings, R. B., Hansen, P. J., and King, W. A.
(1996). Chromosomal abnormalities in bovine embryos and their influence on
development. Biology ofReproduction 54, 53-59.
Keighren, M., and West, J. D. (1993). Analysis of cell ploidy in histological
sections of mouse tissues by DNA-DNA in situ hybridization with digoxygenin
labelled probes. Histochem. J. 25, 30-44.
Kelly, A., and West, J. D. (1996). Genetic evidence that glycolysis is necessary for
gastrulation in the mouse. Developmental Dynamics 207, 300-308.
Kelley, T. E., and Rary, J. M. (1974). Mosaic tetraploidy in a two-year-old female.
Clin. Genet. 6, 221-224.
207
Kelly, S. J., Mulnard, J. G., and Graham, C. F. (1978). Cell division and cell
allocation in early mouse development. J. Embryol. Exp. Morphol. 48, 37-51.
Klisch, K., Schuler, G., Miglino, M. A., and Leiser, R. (2000). Genome
multiplication in trophoblast giant cells of sheep, goat, water buffalo and deer:
An image cytophotometric study. Reproduction in Domestic Animals 35,145-148.
Ko, M. S. H., Kitchen, J. R., Wang, X. H., Threat, T. A., Wang, X. Q., Hasegawa,
A., Sun, T., Grahovac, M. J., Kargul, G. J., Lim, M. K., Cui, Y. S., Sano, Y.,
Tanaka, T., Liang, Y. L., Mason, S., Paonessa, P. D., Sauls, A. D., DePalma, G. E.,
Sharara, R., Rowe, L. B., Eppig, J., Morrell, C., and Doi, H. (2000). Large-scale
cDNA analysis reveals phased gene expression patterns during preimplantation
mouse development. Development 127,1737-1749.
Kohn, G., Mayall, B. H„ Miller, M. E„ and Mellman, W. J. (1967). Tetraploid-
diploid mosaicism in a surviving infant. Pediat. Res. 1, 461-469.
Koizumi, N., and Fukuta, K. (1995). Preimplantation Development of Tetraploid
Mouse Embryo Produced By Cytochalasin-B. Experimental Animals 44,105-109.
Laverge, H., DeSutter, P., VerschraegenSpae, M. R., DePaepe, A., and Dhont, M.
(1997). Triple colour fluorescent in-situ hybridization for chromosomes X, Y and
1 on spare human embryos. Human Reproduction 12, 809-814.
Ledbetter, D. H., Zachary, J. M., Simpson, J. L., Golbus, M. S., Pergament, E.,
Jackson, L., Mahoney, M. J., Desnick, R. J., Schulman, J., Copeland, K. L.,
Verlinsky, Y., Yangfeng, T., Schonberg, S. A., Babu, A., Tharapel, A., Dorfmann,
A., Lubs, H. A., Rhoads, G. G., Fowler, S. E., and Delacruz, F. (1992). Cytogenetic
Results From the United-States Collaborative Study On Cvs. Prenatal Diagnosis
12, 317-345.
Lestou, V. S., Desilets, V., Lomax, B. L., Barrett, I. J., Wilson, R. D., Langlois, S.,
and Kalousek, D. K. (2000). Comparative genomic hybridization: A new
approach to screening for intrauterine complete or mosaic aneuploidy. American
Journal ofMedical Genetics 92, 281-284.
Lestou, V. S., and Kalousek, D. K. (1998). Confined placental mosaicism and
intrauterine fetal growth. Archives of Disease in Childhood 79, F223-F226.
Levak-Svajger, B., Levak-Svajger, A., and Skreb, N. (1969). Separation of germ
layers in presomite rat embryos. Experientia 25,1311-1312.
Lo, C. (1983). Transformation by iontophoretic microinjection of DNA: multiple
integrations without tandem insertions. Mol. Cell. Biol. 3,1803-1814.
Lo, C. (1986). Localization of low abundance DNA sequences in tissue sections
by in situ hybridization. J. Cell Sci. 81, 143-162.
208
Lu, T. Y., and Markert, C. L. (1980). Manufacture of diploid/tetraploid chimeric
mice. Proc. natn. Acad. Sci. U.S.A. 77, 6012-6016.
Lyon, M. F. (1970). X-ray induced dominant lethal mutations in male guinea-
pigs, hamsters and rabbits. Mutat. Res. 10,133-140.
Ma, J., Svoboda, P., Schultz, R. M., and Stein, P. (2001). Regulation of zygotic
gene activation in the preimplantation mouse embryo: Global activation and
repression of gene expression. Biology ofReproduction 64, 1713-1721.
Magnuson, T., Smith, S., and Epstein, C. J. (1982). The development of
monosomy 19 mouse embryos. J. Embryol. Exp. Morphol. 69, 223-236.
Maro, B., Johnson, M. H., Pickering, S. J., and Louvard, D. (1985). Changes in the
distribution of membranous organelles during mouse early development. J.
Embryol. Exp. Morph. 90, 287-309.
McLaren, A. (1976). "Mammalian Chimaeras." Cambridge University Press,
Cambridge.
McLaren, A., and Bowman, P. (1973). Genetic effects on the timing of early
development in the mouse. }. Embryol. Exp. Morphol. 30, 491-498.
Mintz, B., Gearhart, J. D., and Guymont, A. G. (1973). Phytohemagglutinin-
mediated blastomere aggregation and development of allophenic mice. Dev.
Biol. 31, 195-199.
Mullen, R. J., and Whitten, W. K. (1971). Relationship of genotype and degree of
chimerism in coat color to sex ratios and gametogenesis in chimeric mice. /. Exp.
Zool. 178, 165-176.
Munne, S., Magli, C., Adler, A., Wright, G., deBoer, K., Mortimer, D., Tucker,
M., Cohen, J., and Gianaroli, L. (1997). Treatment-related chromosome
abnormalities in human embryos. Human Reproduction 12, 780-784.
Mystkowska, E. T., Ozdzenski, W., and Niemierko, A. (1979). Factors regulating
the degree and extent of experimental chimaerism in the mouse. /. Embryol. Exp.
Morph. 51, 217-225.
Nagy, A., Gocza, E., Merentes Diaz, E., Prideaux, V., Ivanyi, E., Markkula, M.,
and Rossant, J. (1990). Embryonic stem cells alone are able to support fetal
development in the mouse. Development 110, 815-821.
Nagy, A., and Rossant, J. (1993). Production of completely ES cell-derived
fetuses. In "Gene Targeting. A Practical Approach." (A. L. Joyner, Ed.), pp. 147-
179. IRL Press; Oxford University Press, Oxford.
209
Nakamura, Y., Yamamoto, M., and Matsui, Y. (2002). Introduction and
expression of foreign genes in cultured mouse embryonic gonads by
electroporation. Reproduction Fertility and Development 14, 259-265.
Neganova, I. E., Augustin, M., Sekirina, G. G., and Jockusch, H. (1998). LacZ
transgene expression as a cell marker to analyse rescue from the 2-cell block in
mouse aggregation chimeras. Zygote 6, 223-226.
Niwa, Kv Araki, M., and Iritani, A. (1980). Fertilization in vitro of Eggs and First
Cleavage of Embryos in Different Strains of Mice. Biology of Reproduction 22,
1155-1159.
Noomen, P., van den Berg, C., de Ruyter, J. L. M., Van Opstal, D., and Los, F. J.
(2001). Prevalence of tetraploid metaphases in semidirect and cultured chorionic
villi. Fetal Diagnosis and Therapy 16, 129-132.
Pedersen, R. A. (1986). Potency, lineage and allocation in preimplantation mouse
embryos. In "Experimental approaches to mammalian embryonic development"
(J. Rossant and R. A. Pedersen, Eds.), pp. 3-33. Cambridge University Press,
Cambridge.
Peyrieras, N., Hyafil, F., Louvard, D., Ploegh, H. L., and Jacob, F. (1983).
Uvomorulin - a Non-Integral Membrane-Protein of Early Mouse Embryo.
Proceedings of the National Academy of Sciences of the United States of America-
Biological Sciences 80, 6274-6277.
Piko, L., and Clegg, K. B. (1982). Quantitative Changes in Total Rna, Total
Poly(a), and Ribosomes in Early Mouse Embryos. Developmental Biology 89, 362-
378.
Piotrowska, K., Wianny, F., Pedersen, R. A., and Zernicka-Goetz, M. (2001).
Blastomeres arising from the first cleavage division have distinguishable fates in
normal mouse development. Development 128, 3739-3748.
Piotrowska, K., and Zernicka-Goetz, M. (2001). Role for sperm in spatial
patterning of the early mouse embryo. Nature 409, 517-521.
Piotrowska, K., and Zernicka-Goetz, M. (2002). Early patterning of the mouse
embryo - contributions of sperm and egg. Development 129, 5803-5813.
Pratt, H. P. M., Ziomek, C. A., Reeve, W. J. D., and Johnson, M. H. (1982).
Compaction of the Mouse Embryo - an Analysis of Its Components. Journal of
Embryology and Experimental Morphology 70, 113-132.
Pratt, H. P. M. (1987). Isolation, culture and manipulation of pre-implantation
mouse embryos. In "Mammalian development: a practical approach" (M. Monk,
Ed.), pp. 29-42. IRE Press, Oxford.
210
Pratt, T., Sharp, L., Nichols, T., Price, D. J., and Mason, J. O. (2000). Embryonic
stem cells and transgenic mice ubiquitously expressing a tau-tagged green
fluorescent protein. Developmental Biology 228, 19-28.
Ram, P. T., and Schultz, R. M. (1993). Reporter Gene-Expression in G2 of the 1-
Cell Mouse Embryo. Developmental Biology 156, 552-556.
Randle, B. J. (1982). Cosegregation of Monoclonal-Antibody Reactivity and Cell
Behavior in the Mouse Pre-Implantation Embryo. Journal of Embryology and
Experimental Morphology 70, 261-278.
Renard, J. P., Baldacci, P., Richouxduranthon, V., Pournin, S., and Babinet, C.
(1994). A Maternal Factor Affecting Mouse Blastocyst Formation. Development
120, 797-802.
Rinkenberger, J. L., Cross, J. C., and Werb, Z. (1997). Molecular genetics of
implantation in the mouse. Developmental Genetics 21, 6-20.
Robinson, W. P. (2000). Mechanisms leading to uniparental disomy and their
clinical consequences. Bioessays 22, 452-459.
Rossant, J., and Spence, A. (1998). Chimeras and mosaics in mouse mutant
analysis. Trends In Genetics 14, 358-363.
Rossant, J., and Vijh, K. M. (1980). Ability of outside cells from preimplantation
mouse embryos to form inner cell mass derivatives in vivo. Dev. Biol. 76, 475-482.
Rothstein, J. L., Johnson, D., Deloia, J. A., Skowronski, J., Solter, D., and
Knowles, B. (1992). Gene-Expression During Preimplantation Mouse
Development. Genes & Development 6, 1190-1201.
Sharp, L. W. (2001). Using laser scanning confocal microscopy to characterise a
transgenic mouse expressing tau tagged green fluorescent protein. MSc Thesis,
The University of Edinburgh. .
Shimada, H., Kaname, T., Suzuki, M., Hitoshi, Y., Araki, K., Imaizumi, T., and
Yamamura, K. I. (1999). Comparison of ES cell fate in sandwiched aggregates
and co-cultured aggregates during blastocyst formation by monitored GFP
expression. Molecular Reproduction and Development 52, 376-382.
Sirard, C., de la Pompa, J. L., Elia, A., Itie, A., Mirtsos, C., Cheung, A., Hahn, S.,
Wakeham, A., Schwartz, L., Kern, S. E., Rossant, J., and Mak, T. W. (1998). The
tumor suppressor gene Smad4/Dpc4 is required for gastrulation and later for
anterior development of the mouse embryo. Genes & Development 12,107-119.
211
Smith, K., Lowther, G., Maher, E., Hourihan, T., Wilkinson, T., and
Wolstenholme, J. (1999). The predictive value of findings of the common
aneuploidies, trisomies 13, 18 and 21, and numerical sex chromosome
abnormalities at CVS: Experience from the ACC UK Collaborative Study.
Prenatal Diagnosis 19, 817-826.
Snow, M., and Ansell, J. D. (1974). The chromosomes of giant trophoblast cells of
the mouse. Proc. R. Soc. Lond. Series B 187, 93-98.
Snow, M. H. L. (1975). Embryonic development of tetraploid mice during the
second half of gestation. J. Embryol Exp Morph 34, 707-721.
Spindle, A. (1982). Cell allocation in preimplantation mouse chimeras. /. exp.
Zool. 219, 361-367.
Squirrell, J. M., Wokosin, D. L., White, J. G., and Bavister, B. D. (1999). Long-
term two-photon fluorescence imaging of mammalian embryos without
compromising viability. Nature Biotechnology 17, 763-767.
Steuerwald, N., Cohen, J., Herrera, R. J., and Brenner, C. A. (1999). Analysis of
gene expression in single oocytes and embryos by real-time rapid cycle
fluorescence monitored RT-PCR. Molecular Human Reproduction 5,1034-1039.
Stipoljev, F., Latin, V., Kos, M., Miskovic, B., and Kurjak, A. (2001). Correlation
of confined placental mosaicism with fetal intrauterine growth retardation - A
case control study of placentas at delivery. Fetal Diagnosis and Therapy 16, 4-9.
Strickland, S., Reich, E., and Sherman, M. I. (1976). Plasminogen Activator in
Early Embryogenesis: Enzyme Production by Trophoblast and Parietal
Endoderm. Cell 9, 231-240.
Stutz, A., Conne, B., Huarte, J., Gubler, P., Volkel, V., Flandin, P., and Vassalli, J.
D. (1998). Masking, unmasking, and regulated polyadenylation cooperate in the
translational control of a dormant mRNA in mouse oocytes. Genes &
Development 12, 2535-2548.
Surani, M. A., Barton, S. C., and Norris, M. L. (1984). Development of
reconstituted mouse eggs suggests imprinting of the genome during
gametogenesis. Nature 308, 548-550.
Sutherland, A. E., and Calarcogillam, P. G. (1983). Analysis of Compaction in the
Pre-Implantation Mouse Embryo. Developmental Biology 100, 328-338.
Sutherland, A. E., Speed, T. P., and Calarco, P. G. (1990). Inner Cell Allocation In
the Mouse Morula - the Role Of Oriented Division During 4th Cleavage.
Developmental Biology 137, 13-25.
212
Svoboda, P., Stain, P., Hayashi, H., and Schultz, R. M. (2000). Selective reduction
of dormant maternal mRNAs in mouse oocytes by RNA interference.
Development 127, 4147-4156.
Tanaka, M., Hadjantonakis, A. K., and Nagy, A. (2001). Aggregation chimeras,
combining ES cells, diploid and tetraploid embryos. Methods Mol. Biol. 158, 135-
54.
Tang, P. C. (1999). Factors that influence the composition of mouse chimeras.
PhD Thesis, The University of Edinburgh. .
Tang, P.-C., Ritchie, W. A., Wilmut, I., and West, J. D. (2000). The effects of cell
size and ploidy on cell allocation in mouse chimaeric blastocysts. Zygote 8, 33 -
43.
Tang, P.-C., and West, J. D. (2000). The effects of embryo stage and cell number
on the composition of mouse aggregation chimaeras. Zygote 8, 235-243.
Tang, P.-C., and West, J. D. (2001). Size regulation does not cause the
composition of mouse chimaeras to become unbalanced. Int. J. Dev. Biol. 45, 583-
590.
Tarkowski, A., and Wroblewska, J. (1967). Development of blastomeres of
mouse eggs isolated at the 4- and 8-cell stage. J. Embryol. Exp. Morphol. 18, 155-
180.
Tarkowski, A. K. (1961). Mouse chimaeras developed from fused eggs. Nature
190, 857-860.
Tarkowski, A. K., Ozdzenski, W., and Czolowska, R. (2001). Mouse singletons
and twins developed from isolated diploid blastomeres supported with
tetraploid blastomeres. International Journal of Developmental Biology 45, 591-596.
Tarkowski, A. K., Witkowska, A., and Opas, J. (1977). Development of
cytochalasin B-induced tetraploid and diploid/tetraploid mosaic mouse
embryos. J. Embryol. Exp. Morphol. 41, 47-64.
Taylor, K. D., and Piko, L. (1987). Patterns of Messenger-Rna Prevalence and
Expression of Bl- Transcript and B2-Transcript in Early Mouse Embryos.
Development 101, 877-892.
Telford, N. A., Watson, A. J., and Schultz, G. A. (1990). Transition From
Maternal to Embryonic Control in Early Mammalian Development - a
Comparison of Several Species. Molecular Reproduction and Development 26, 90-
100.
213
Theiler, K. (1989). "The House Mouse Atlas of Embryonic Development."
Springer-Verlag, New York.
Varmuza, S., Prideaux, V., Kothary, R., and Rossant, J. (1988). Polytene
chromosomes in mouse trophoblast cells. Development 102, 127-134.
Vaughan, J., Ali, Z., Bower, S., Bennett, P., Chard, T., and Moore, G. (1994).
Human Maternal Uniparental Disomy For Chromosome-16 and Fetal
Development. Prenatal Diagnosis 14, 751-756.
Viuff, D., Greve, T., Avery, B., Hyttel, P., Brockhoff, P. B., and Thomsen, P. D.
(2000). Chromosome aberrations in in vitro-produced bovine embryos at days 2-
5 post-insemination. Biology of Reproduction 63, 1143-1148.
Viuff, D., Hendriksen, P. J. M., Vos, P., Dieleman, S. J., Bibby, B. M., Greve, T.,
Hyttel, P., and Thomsen, P. D. (2001). Chromosomal abnormalities and
developmental kinetics in in vivo-developed cattle embryos at days 2 to 5 after
ovulation. Biology ofReproduction 65, 204-208.
Viuff, D., Rickords, F., Offenberg, H., Hyttel, P., Avery, B., Olsaker, I., Williams,
J. F., Callesen, H., and Thomsen, P. D. (1999). Mixoploidy is more frequent in
bovine blastocysts produced in vitro than in blastocysts developed in vivo.
Theriogenology 51, 335-335.
Waldrip, W. R., Bikoff, E. K., Hoodless, P. A., Wrana, J. L., and Robertson, E. J.
(1998). Smad2 signaling in extraembryonic tissues determines anterior- posterior
polarity of the early mouse embryo. Cell 92, 797-808.
Wang, Z. Q., Kiefer, F., Urbanek, P., and Wagner, E. F. (1997). Generation of
completely embryonic stem cell-derived mutant mice using tetraploid blastocyst
injection. Mechanisms ofDevelopment 62, 137-145.
Warner, C. M., Exley, G. E., McElhinny, A. S., and Tang, C. Y. (1998). Genetic
regulation of preimplantation mouse embryo survival. Journal Of Experimental
Zoology 282, 272-279.
Weber, R. J., Pedersen, R. A., Wianny, F., Evans, M. J., and Zernicka-Goetz, M.
(1999). Polarity of the mouse embryo is anticipated before implantation.
Development 126, 5591-5598.
Wells, D., and Delhanty, J. D. A. (2000). Comprehensive chromosomal analysis
of human preimplantation embryos using whole genome amplification and
single cell comparative genomic hybridization. Molecular Human Reproduction 6,
1055-1062.
214
Wells, D., Sherlock, J. K., Handyside, A. H., and Delhanty, J. D. A. (1999).
Detailed chromosomal and molecular genetic analysis of single cells by whole
genome amplification and comparative genomic hybridisation. Nucleic Acids
Research 27,1214-1218.
West, J. D. (1984). Cell markers. In "Chimeras in Developmental Biology" (N. L.
Douarin and A. McLaren, Eds.), pp. 39-63. Academic Press, London.
West, J. D. (1999). Insights into development and genetics from mouse chimeras.
Current Topics in Developmental Biology 44, 21-66.
West, J. D., Angell, R. R., Thatcher, S. S., Gosden, J. R., Hastie, N. D., Glasier, A.
F., and Baird, D. T. (1987). Sexing the human pre-embryo by DNA-DNA in situ
hybridization. Lancet 1, 1345-1347.
West, J. D., and Flockhart, J. H. (1994). Genotypically Unbalanced
DiploidsDiploid Fetal Mouse Chimeras - Possible Relevance to Human
Confined Mosaicism (Vol 63, Pg 87,1994). Genetical Research 63, 236-236.
West, J. D., Flockhart, J. H., and Kissenpfennig, A. (1995). A Maternal Genetic
Effect On the Composition of Mouse Aggregation Chimeras. Genetical Research
65, 29-40.
West, J. D., Gosden, J. R., Angell, R. R., West, K. M., Glasier, A. F., Thatcher, S.
S., and Baird, D. T. (1988). Sexing whole human pre-embryos by in situ
hybridization with a Y- chromosome specific DNA probe. Human Reproduction 3,
1010-1019.
West, J. D., and Green, J. F. (1983). The transition from oocyte-coded to embryo-
coded glucose phosphate isomerase in the early mouse embryo. J. Embryol. Exp.
Morphol. 78, 127-140.
Wianny, F., and Zernicka-Goetz, M. (2000). Specific interference with gene
function by double-stranded RNA in early mouse development. Nature Cell
Biology 2, 70-75.
Wiley, L. M. (1984). Cavitation in the Mouse Preimplantation Embryo - Na/K-
Atpase and the Origin of Nascent Blastocele Fluid. Developmental Biology 105,
330-342.
Wilson, G. N., Vekemans, M. J. J., and Kaplan, P. (1988). Mca/Mr Syndrome in a
Female Infant With Tetrnploidy Mosaicism - Review of the Human Polyploid
Phenotype. American Journal ofMedical Genetics 30, 953-961.
Winkel, G. K., Ferguson, j. E., Takeichi, M., and Nuccitelli, R. (1990). Activation
of Protein Kinase-C Triggers Premature Compaction in the 4-Cell Stage Mouse
Embryo. Developmental Biology 138,1-15.
215
Wolstenholme, J. (1996). Confined placental mosaicism for trisomies 2, 3, 7, 8, 9,
16, and 22: Their incidence, likely origins, and mechanisms for cell lineage
compartmentalization. Prenatal Diagnosis 16, 511-524.
Wong, M. H., Hermiston, M. L., Syder, A. J., and Gordon, J. I. (1996). Forced
Expression Of the Tumor-Suppressor Adenomatosis Polyposis-Coli Protein
Induces Disordered Cell-Migration In the Intestinal Epithelium. Proceedings Of
the National Academy OfSciences Of the United States OfAmerica 93, 9588-9593.
Wu, L. Z., de Bruin, A., Saavedra, H. I., Starovic, M., Trimboli, A., Yang, Y.,
Opavska, J., Wilson, P., Thompson, J. C., Ostrowski, M. C., Rosol, T. J., Woollett,
L. A., Weinstein, M., Cross, J. C., Robinson, M. L., and Leone, G. (2003). Extra¬
embryonic function of Rb is essential for embryonic development and viability.
Nature 421, 942-947.
Zambrowicz, B. P., Imamoto, A., Fiering, S., Herzenberg, L. A., Kerr, W. G., and
Soriano, P. (1997). Disruption of overlapping transcripts in the ROSA beta geo
26 gene trap strain leads to widespread expression of beta- galactosidase in
mouse embryos and hematopoietic cells. Proceedings of the National Academy of
Sciences of the United States ofAmerica 94, 3789-3794.
Zernicka-Goetz, M., Pines, J., Hunter, S. M., Dixon, J. P. C., Siemering, K. R.,
Haseloff, J., and Evans, M. J. (1997). Following cell fate in the living mouse
embryo. Development 124, 1133-1137.
Zimmet, J., and Ravid, K. (2000). Polyploidy: Occurrence in nature, mechanisms,
and significance for the megakaryocyte-platelet system. Experimental Hematology
28, 3-16.
Ziomek, C. A., Johnson, M. H., and Handyside, A. H. (1982). The developmental
potential of mouse 16-cell blastomeres. ]. Exp. Zool. 221, 343-355.
216
